
<html lang="en"     class="pb-page"  data-request-id="98ab49f0-4336-40a8-bcfa-cead6f2e2850"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.9b00631;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2019.62.issue-12"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Identification and Optimization of Novel Cathepsin C Inhibitors Derived from EGFR Inhibitors" /></meta><meta name="dc.Creator" content="Weijie  Hou" /></meta><meta name="dc.Creator" content="Huan  Sun" /></meta><meta name="dc.Creator" content="Yongfen  Ma" /></meta><meta name="dc.Creator" content="Chunyan  Liu" /></meta><meta name="dc.Creator" content="Zhiyuan  Zhang" /></meta><meta name="dc.Description" content="In the course of developing the biochemistry to chemistry activity-based protein profiling (BTC-ABPP) method, we herein unexpectedly discovered that the epidermal growth factor receptor irreversibl..." /></meta><meta name="Description" content="In the course of developing the biochemistry to chemistry activity-based protein profiling (BTC-ABPP) method, we herein unexpectedly discovered that the epidermal growth factor receptor irreversibl..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 30, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00631" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00631" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00631" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00631" /></link>
        
    
    

<title>Identification and Optimization of Novel Cathepsin C Inhibitors Derived from EGFR Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00631" /></meta><meta property="og:title" content="Identification and Optimization of Novel Cathepsin C Inhibitors Derived from EGFR Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0022.jpeg" /></meta><meta property="og:description" content="In the course of developing the biochemistry to chemistry activity-based protein profiling (BTC-ABPP) method, we herein unexpectedly discovered that the epidermal growth factor receptor irreversible inhibitor WZ4002 also functioned as a low micromolar inhibitor of cathepsin C (CatC), a promising target for the treatment of numerous inflammatory and autoimmune diseases. Building on from this discovery, and following structure–activity relationship investigations guided by computational modeling, a novel series of pyridine scaffold compounds were developed as irreversible CatC inhibitors, further culminated in identifying a highly potent and selective inhibitor 22, which displays good metabolic stability and oral bioavailability. In vivo studies revealed that compound 22 clearly displays the ability to inhibit CatC, consequently leading to efficient inhibition of downstream neutrophil serine proteases in both bone marrow and blood. The overall excellent profile of compound 22 made it an interesting candidate for further preclinical investigation." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00631"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00631">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00631&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00631&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00631&amp;href=/doi/10.1021/acs.jmedchem.9b00631" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 5901-5919</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00517" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00844" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification and Optimization of Novel Cathepsin C Inhibitors Derived from EGFR Inhibitors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Weijie Hou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Weijie Hou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">National Institute of Biological Sciences (NIBS), 7 Science Park Road, ZGC Life Science Park, Beijing 102206, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Weijie++Hou">Weijie Hou</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Huan Sun</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Huan Sun</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">National Institute of Biological Sciences (NIBS), 7 Science Park Road, ZGC Life Science Park, Beijing 102206, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Huan++Sun">Huan Sun</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yongfen Ma</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yongfen Ma</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">National Institute of Biological Sciences (NIBS), 7 Science Park Road, ZGC Life Science Park, Beijing 102206, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yongfen++Ma">Yongfen Ma</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chunyan Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chunyan Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">National Institute of Biological Sciences (NIBS), 7 Science Park Road, ZGC Life Science Park, Beijing 102206, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chunyan++Liu">Chunyan Liu</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Zhiyuan Zhang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhiyuan Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">National Institute of Biological Sciences (NIBS), 7 Science Park Road, ZGC Life Science Park, Beijing 102206, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#bbc1d3dad5dcc1d3d2c2cedad5fbd5d2d9c895dad895d8d5"><span class="__cf_email__" data-cfemail="700a18111e170a18190905111e301e1912035e11135e131e">[email protected]</span></a>. Phone: +86-10-80726688. Ext 8575.</span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhiyuan++Zhang">Zhiyuan Zhang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2910-1986" title="Orcid link">http://orcid.org/0000-0002-2910-1986</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00631&amp;href=/doi/10.1021%2Facs.jmedchem.9b00631" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 5901–5919</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 30, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 April 2019</li><li><span class="item_label"><b>Published</b> online</span>30 May 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 June 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00631" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00631</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5901%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DWeijie%2BHou%252C%2BHuan%2BSun%252C%2BYongfen%2BMa%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D12%26contentID%3Dacs.jmedchem.9b00631%26title%3DIdentification%2Band%2BOptimization%2Bof%2BNovel%2BCathepsin%2BC%2BInhibitors%2BDerived%2Bfrom%2BEGFR%2BInhibitors%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5919%26publicationDate%3DJune%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00631"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1944</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">4</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00631" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification and Optimization of Novel Cathepsin C Inhibitors Derived from EGFR Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Weijie&quot;,&quot;last_name&quot;:&quot;Hou&quot;},{&quot;first_name&quot;:&quot;Huan&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Yongfen&quot;,&quot;last_name&quot;:&quot;Ma&quot;},{&quot;first_name&quot;:&quot;Chunyan&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Zhiyuan&quot;,&quot;last_name&quot;:&quot;Zhang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;5901-5919&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00631&quot;},&quot;abstract&quot;:&quot;In the course of developing the biochemistry to chemistry activity-based protein profiling (BTC-ABPP) method, we herein unexpectedly discovered that the epidermal growth factor receptor irreversible inhibitor WZ4002 also functioned as a low micromolar inhibitor of cathepsin C (CatC), a promising target for the treatment of numerous inflammatory and autoimmune diseases. Building on from this discovery, and following structure–activity relationship investigations guided by computational modeling, a novel series of pyridine scaffold compounds were developed as irreversible CatC inhibitors, further culminated in identifying a highly potent and selective inhibitor 22, which displays good metabolic stability and oral bioavailability. In vivo studies revealed that compound 22 clearly displays the ability to inhibit CatC, consequently leading to efficient inhibition of downstream neutrophil serine proteases in both bone marrow and blood. The overall excellent profile of compound 22 made it an interesting candidate fo&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00631&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00631" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00631&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00631" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00631&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00631" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00631&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00631&amp;href=/doi/10.1021/acs.jmedchem.9b00631" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00631" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00631" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00631%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DHou%26date%3D2019%26atitle%3DIdentification%2Band%2BOptimization%2Bof%2BNovel%2BCathepsin%2BC%2BInhibitors%2BDerived%2Bfrom%2BEGFR%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D12%26spage%3D5901%26epage%3D5919%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/jmcmar.2019.62.issue-12/20190627/jmcmar.2019.62.issue-12.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In the course of developing the biochemistry to chemistry activity-based protein profiling (BTC-ABPP) method, we herein unexpectedly discovered that the epidermal growth factor receptor irreversible inhibitor WZ4002 also functioned as a low micromolar inhibitor of cathepsin C (CatC), a promising target for the treatment of numerous inflammatory and autoimmune diseases. Building on from this discovery, and following structure–activity relationship investigations guided by computational modeling, a novel series of pyridine scaffold compounds were developed as irreversible CatC inhibitors, further culminated in identifying a highly potent and selective inhibitor <b>22</b>, which displays good metabolic stability and oral bioavailability. In vivo studies revealed that compound <b>22</b> clearly displays the ability to inhibit CatC, consequently leading to efficient inhibition of downstream neutrophil serine proteases in both bone marrow and blood. The overall excellent profile of compound <b>22</b> made it an interesting candidate for further preclinical investigation.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16388" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16388" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cathepsin C (CatC), also known as dipeptidyl peptidase 1, is an important lysosomal cysteine protease<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> that can activate granule-associated proinflammatory serine proteases, including neutrophil elastase (NE), cathepsin G (CatG), and proteinase 3 (PR3). Upon such activation, these neutrophil serine proteases (NSPs) are secreted into the extracellular space, where their hydrolysis activity protects host cells from invading pathogens.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> However, in certain cases, excessive recruitment of neutrophils can increase the secretion of NSPs to such an extent that they become destructive even after the clearance of pathogens have been completed, thereby driving the pathogenesis of several disorders. Specifically, NSPs participate in the progression of a variety of chronic inflammatory diseases, such as rheumatoid arthritis,<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> sepsis,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and antineutrophil cytoplasmic antibody-associated necrotizing crescentic glomerulonephritis.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Further, chronic respiratory disorders, including chronic obstructive pulmonary disease<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> (COPD; the fourth leading cause of death globally in 2010 and rose to the third position in 2016<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a>), bronchiectasis, and cystic fibrosis,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> are also now understood to be NSPs related. Owing to its function in activating NSPs, CatC is now viewed as a promising therapeutic target for a variety of NSPs-related diseases.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Biological studies have shown that CatC knock-out mice and CatC inhibitor-treated wild-type (WT) mice, demonstrate protection from smoke-induced pulmonary inflammation and associated alveolar destruction.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> These observations support the hypothesis that CatC is viewed as a therapeutic target against COPD. Human CatC is known to occur as a homotetrameric complex comprising four identical subunits, each of which contains a light chain, a heavy chain, and an exclusion domain (unique to CatC amongst the cathepsin family proteases).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> As a peptidase, CatC removes dipeptide moieties from the N-terminal of the substrates.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Studies have shown that the aspartic acid at position 1 of the N-terminal exclusion domain keeps the exopeptidase activity of CatC via its interaction with α-amino groups of peptide substrates; moreover, Cys234 has been demonstrated as a key catalytic residue in the active site.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">A number of CatC inhibitors have been developed in recent decades; most of these are peptide mimics derived from known preferred dipeptide substrates of CatC, including irreversible inhibitors such as diazoketones,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> vinyl sulfone,<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a><i>O</i>-acyl-hydroxamates,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> as well as reversible covalent inhibitors with nitrile groups<a onclick="showRef(event, 'ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21">(18−21)</a> as warheads. In the development of CatC inhibitors, metabolic stability given by their peptidic and electrophilic nature may be a serious issue.<a onclick="showRef(event, 'ref14 ref22'); return false;" href="javascript:void(0);" class="ref ref14 ref22">(14,22)</a> To date, only two drug candidates entered clinical trials: GSK-2793660<a onclick="showRef(event, 'ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25">(23−25)</a> (terminated in phase I) and INS1007/AZD7986<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> (currently in phase II) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), and their chemotypes are dipeptide derived.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0001.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of GSK-2793660 and INS1007/AZD7986.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In the course of a biochemistry to chemistry activity-based protein profiling (BTC-ABPP) study using an activity-based probe derived from an irreversible epidermal growth factor receptor (EGFR) inhibitor (canertinib) to study off-target effects, we identified a probe-modified peptide from CatC, thus indicating binding to this protease potentially via the catalytic cysteine.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Subsequently, results from both enzymatic assay and cell assays confirmed that canertinib was indeed a CatC inhibitor, and a small screen of other irreversible EGFR inhibitors identified WZ4002 as an additional CatC inhibitor. Docking studies informed our proposal of a plausible binding mode for WZ4002 within the CatC active site, and subsequent rational design efforts based on this mode, alongside structure–activity relationship (SAR) studies, ultimately enabled the identification of a low nanomolar inhibitor. Extensive in vitro/in vivo assays demonstrate that the candidate compound <b>22</b> from our study is highly metabolically stable, exhibits potent CatC inhibitory effects, and results in the anticipated inhibition on the activation of downstream NSPs in mice.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04718" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04718" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">The preparation of this series compounds was achieved using the synthetic routes illustrated in <a class="ref internalNav" href="#sch1" aria-label="scheme 1">scheme 1</a>–<named-content content-type="anchor" rid="sch2" type="simple"></named-content><named-content content-type="anchor" rid="sch3" type="simple"></named-content><named-content content-type="anchor" rid="sch4" type="simple"></named-content><named-content content-type="anchor" rid="sch5" type="simple"></named-content><a class="ref internalNav" href="#sch6" aria-label="6">6</a>. The synthetic routes of compounds <b>1</b>–<b>8</b> started from 3-nitrophenol. 3-Nitrophenol was regioselectively introduced to the C-2 position of 2,3,6-trichloropyridine to afford the intermediate <b>36</b>. Amination of C-6 with different substituted anilines was accomplished through a palladium-catalyzed Buchwald–Hartwig coupling. The nitro group in <b>38a</b>–<b>f</b> was reduced by iron power/ammonium chloride. Acylation of <b>39a</b>–<b>f</b> by acryloyl chloride gave rise to compounds <b>1</b>, <b>2</b>, <b>4</b>, and <b>40d</b>–<b>f</b>. The subsequent step of <i>tert</i>-butoxycarbonyl (Boc) deprotection afforded compounds <b>3</b>–<b>6</b>. The analogues of <b>10</b> and <b>11</b> were obtained in a similar manner, using an appropriate substituted pyridine in step (a) of <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>1</b>–<b>8</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, dimethylformamide (DMF), 110 °C; (b) Cs<sub>2</sub>CO<sub>3</sub>, (±)-2,2′-bis(diphenylphosphino)-1,1′-binaphthyl (BINAP), Pd(OAc)<sub>2</sub>, dioxane, microwave, 130 °C, 1 h; (c) Fe, NH<sub>4</sub>Cl, EtOH/tetrahydrofuran (THF)/H<sub>2</sub>O, 80 °C; (d) acryloyl chloride, triethylamine (TEA), dichloromethane (DCM), 0 °C, 1 h; (e) trifluoroacetic acid (TFA), DCM, room temperature (RT), 2 h; (f) (bromomethyl)cyclopropane or (bromomethyl)cyclopentane, K<sub>2</sub>CO<sub>3</sub>, 70 °C, 4 h.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>10</b> and <b>11</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMF, 110 °C; (b) 2-methoxy-4-(4-methylpiperazin-1-yl)aniline, Cs<sub>2</sub>CO<sub>3</sub>, BINAP, Pd(OAc)<sub>2</sub>, dioxane, microwave, 130 °C, 1 h; (c) Fe, NH<sub>4</sub>Cl, EtOH/THF/H<sub>2</sub>O, 80 °C; (d) acryloyl chloride, TEA, DCM, 0 °C, 1 h.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>14</b> and <b>17</b>–<b>20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMF, 110 °C; (b) pyrrolidine, Cs<sub>2</sub>CO<sub>3</sub>, BINAP, Pd<sub>2</sub>(dba)<sub>3</sub>, toluene, 110 °C; (c) 2-methoxy-4-(4-methylpiperazin-1-yl)aniline, Cs<sub>2</sub>CO<sub>3</sub>, BINAP, Pd(OAc)<sub>2</sub>, dioxane, microwave, 130 °C, 1 h; (d) PtO<sub>2</sub>, H<sub>2</sub>, MeOH/THF, RT, overnight; (e) acryloyl chloride, TEA, DCM, 0 °C, 1 h.</p></p></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0011.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>21</b>–<b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, BINAP, Pd<sub>2</sub>(dba)<sub>3</sub>, toluene, 110 °C or Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub> (2 M), 1,2-dimethoxyethane, 80 °C; (b) 2-methoxy-4-(4-methylpiperazin-1-yl)aniline, Cs<sub>2</sub>CO<sub>3</sub>, BINAP, Pd(OAc)<sub>2</sub>, dioxane, microwave, 130 °C, 1 h; (c) PtO<sub>2</sub>, H<sub>2</sub>, MeOH/THF, RT, overnight; (d) acryloyl chloride, TEA, DCM, 0 °C, 1 h; (e) tetra-<i>n</i>-butylammonium fluoride (TBAF), THF, 0 °C to RT, 2 h.</p></p></figure><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0012.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compounds <b>27</b>–<b>31</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, BINAP, Pd(OAc)<sub>2</sub>, dioxane, microwave, 130 °C, 1 h; (b) PtO<sub>2</sub>, H<sub>2</sub>, MeOH/THF, RT, overnight; (c) acryloyl chloride, TEA, DCM, 0 °C, 1 h.</p></p></figure><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0013.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compounds <b>32</b>–<b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMF, 110 °C; (b) Fe, NH<sub>4</sub>Cl, EtOH/H<sub>2</sub>O, 80 °C; (c) (Boc)<sub>2</sub>O, 4-dimethylaminopyridine (DMAP), TEA, THF, RT, overnight; (d) pyrrolidine or piperidine, Cs<sub>2</sub>CO<sub>3</sub>, BINAP, tris(dibenzylideneacetone)dipalladium(0) (Pd<sub>2</sub>(dba)<sub>3</sub>), toluene, 110 °C; (e) 2-methoxy-4-(4-methylpiperazin-1-yl)aniline, Cs<sub>2</sub>CO<sub>3</sub>, BINAP, Pd(OAc)<sub>2</sub>, dioxane, microwave, 130 °C, 1 h; (f) TFA, DCM, RT; (g) acryloyl chloride, TEA, DCM, 0 °C, 1 h.</p></p></figure><div class="NLM_p last">The synthetic routes of compounds <b>14</b>, <b>17</b>–<b>20</b>, and <b>21</b>–<b>26</b> are illustrated in <a class="ref internalNav" href="#sch3" aria-label="Schemes 3">Schemes 3</a> and <a class="ref internalNav" href="#sch4" aria-label="4">4</a> and start from 3-bromo-2,6-dichloropyridine. For preparation of compounds <b>14</b> and <b>17</b>–<b>20</b>, appropriate phenols were regioselectively introduced to the C-2 position of 3-bromo-2,6-dichloropyridine to afford the intermediate <b>47a</b>–<b>e</b>. Amination of C-3 with pyrrolidine and subsequent amination of C-6 with 2-methoxy-4-(4-methylpiperazin-1-yl) aniline was accomplished through palladium-catalyzed Buchwald–Hartwig coupling. The nitro group in <b>49a</b>–<b>e</b> was reduced by PtO<sub>2</sub>/H<sub>2</sub>. Acylation of <b>50a</b>–<b>e</b> by acryloyl chloride gave rise to compounds <b>14</b> and <b>17</b>–<b>20</b>. The analogues of <b>21</b>–<b>26</b> and <b>27</b>–<b>31</b> were obtained in a similar manner, using the appropriate amines in step (a) of <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a> and appropriate substituted anilines in step (a) of <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>, respectively. Compounds <b>32</b> and <b>33</b> were synthesized as shown in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Hit Compound Development</h3><div class="NLM_p">In our previous work, CatC was identified as one of the off-targets of canertinib; the CatC active site residue Cys234, known to be essential for its peptidase, was modified by our probe.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Most irreversible CatC inhibitors reported to date covalently bind to Cys234 via their electrophilic warheads.<a onclick="showRef(event, 'ref14 ref22'); return false;" href="javascript:void(0);" class="ref ref14 ref22">(14,22)</a> We therefore asked whether other known irreversible inhibitors of EGFR could likewise inhibit CatC activity. As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, canertinib and WZ4002 displayed better inhibition of CatC (IC<sub>50</sub> = 2.7 and 2.1 μM, respectively) than the other three inhibitors (IC<sub>50</sub> > 10 μM). Both canertinib and WZ4002 were selected as the initial hits for further optimization; the rest of the paper reports our SAR development of WZ4002.</div><figure id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0002.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures and CatC enzymatic inhibitory activity of selected irreversible inhibitors of EGFR and AZD5248<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (a known CatC inhibitor as a tool compound).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Understanding the possible binding mode of WZ4002 in the active site of CatC could provide useful guidance for designing analogues to conduct structure–activity relationship (SAR) studies. Docking studies with WZ4002 based on the CatC/AZD5248 complex crystal structure (Protein Data Bank (PDB) ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CDE">4CDE</a>) identified two inhibitor–acceptor interactions as potentially related to our observed effects: a potential covalent attachment between the acrylamide fragment of WZ4002 and Cys234 in the CatC active site and salt-bridge interaction between the piperazine N-4 of WZ4002 and Asp1 in the exclusion domain (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Its predicted binding mode suggested that improvements in potency could perhaps be achieved via modification of the pyrimidine at C-5 position and/or the phenyl at the C-4 position.</div><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0003.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Putative binding mode of WZ4002 (orange) within the active site of CatC (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CDE">4CDE</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Using the docking study data as a guide, we aimed to develop a highly potent CatC inhibitor, while depleting the activity against EGFR. We first explored the possibility of eliminating WZ4002’s kinase binding capability by focusing on the known “hinge binding” regions of the inhibitor: a hydrogen bond between pyrimidine N1 and EGFR Met793 facilitates the crucial hinge binding.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Notably, according to our proposed binding mode, however, WZ4002’s pyrimidine N1 does not contribute to ligand interactions with CatC, suggesting that replacing N1 with a carbon may eliminate its EGFR inhibitory effects without affecting its binding affinity for the CatC active site (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div><div class="NLM_p">We synthesized compound <b>1</b> to test this hypothesis and observed that the EGFR IC<sub>50</sub> of compound <b>1</b> was reduced by more than 5000-fold (IC<sub>50</sub> > 10 μM) compared to that of WZ4002 (IC<sub>50</sub> = 1.7 nM) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) whereas its inhibitory effect against CatC was slightly increased compared to that of WZ4002 (IC<sub>50</sub> of 810 nM vs 2.1 μM in the enzymatic assay and IC<sub>50</sub> = 538 nM in the U937 cell). We also tested the metabolic stability of compound <b>1</b>: their CL<sub>int</sub> (μL/(min mg protein)) in liver microsomes (human, rat, and mouse) were 5.4, 39.7, and 26.3, respectively (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00631/suppl_file/jm9b00631_si_001.csv" class="ext-link">Table S1</a>, Supporting Information), which strongly encouraged our additional efforts to further develop this novel series of compounds.</div><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0004.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Hit validation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Hit To Lead</h3><div class="NLM_p">First, 4-methyl-piperazine compound <b>2</b>, removal of the methoxy group from the phenyl ring, showed slightly better potency than <b>1</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). In general, a salt-bridge provides strong interactions between a ligand and its receptor so we made efforts to identify potentially superior salt-bridge interaction groups. Several analogues with various aniline substitutions at pyridine C-6 position were prepared to compare with the piperazine analogue <b>2</b>. Piperazine compound <b>3</b> maintained its inhibitory activity, while the salt-bridge interaction between piperazine and Asp1 was undisrupted (according to the proposed binding mode); however, morpholine compound <b>4</b> showed a significant loss in potency (IC<sub>50</sub> > 10 μM), which could be explained by the absence of salt-bridge interaction. Compounds <b>5</b> and <b>6</b>, with flexible amine chains at different positions of the phenyl ring, were synthesized and tested, and 4-fold enzymatic activity reduction was observed with both compounds as compared with compound <b>3</b>. On adding a larger alkyl group on N-4 with the hope of improving potency, cyclopropylmethyl compound <b>7</b> maintained the potency, whereas the cyclopentylmethyl group of compound <b>8</b> was apparently too bulky to be tolerated by the surrounding environment of CatC, leading to a more than 10-fold loss in potency. Although compound <b>2</b> was slightly more potent than <b>1</b>, its liver microsome stability in mouse and rat was poorer (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00631/suppl_file/jm9b00631_si_001.csv" class="ext-link">Table S1</a>, Supporting Information). Thus, we decided to continue to use the C-6 2-methoxy-4-(4-methylpiperazin-1-yl)-aniline moiety in further SAR investigation.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of Substitutions at the Pyridine Core C-6 Position</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0014.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0015.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Human recombinant CatC isolated enzyme assay. Mean values from a minimum of two experiments.</p></div></div><div></div></div><div class="NLM_p">Reviewing our proposed docking mode, the unfilled space near the C-3 position at pyridine of compound <b>1</b> appeared attractive as a potential site for generating additional desired binding interactions. We therefore conducted SAR studies for the modification of the C-3 position: the results are shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. Replacing the −Cl with −H (compound <b>9</b>) or cyano (compound <b>11</b>) at pyridine C-3 position had little impact on IC<sub>50</sub> values. Trifluoromethyl compound <b>10</b> and dimethylamino compound <b>13</b> conferred a slight loss (2-fold) of potency. However, replacement with a larger pyrrolidine group as in compound <b>14</b> resulted in a 5-fold increase in potency. Another two cyclic amine compounds were also synthesized: <b>15</b> with a piperdinyl moiety and <b>16</b> with an azepanyl moiety. These two compounds showed similar activity to compound <b>14</b>. Compounds <b>14</b>–<b>16</b> strongly suggested that the increased potency likely results from additional hydrophobic interaction between the cyclic amines and the nearby CatC Trp405 residue.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of Substitutions at the Pyridine Core C-3 Position</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0016.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0017.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Human recombinant CatC isolated enzyme assay. Mean values from a minimum of two experiments.</p></div></div><div></div></div><div class="NLM_p">These encouraging results further supported our proposed binding mode and led us to suspect that fine tuning of the phenyl ring bearing the acrylamide could confer yet additional improvements in potency. As per results shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, when a methyl group was introduced to the C-2 position, compound <b>17</b> lost almost all CatC inhibitory activity (IC<sub>50</sub> > 10 μM). However, a 4-fold improvement in potency was observed when a methyl group (<b>19</b>) was incorporated into C-4 position of <b>14</b>. These results implied that the orientation of acrylamide relative to Cys234 made a significant influence on potency. In addition, the methyl group of compound <b>19</b> established hydrophobic interaction with nearby residues. Compound <b>18</b>, bearing a methyl group at the C-6 position, was 3-fold less potent than <b>14</b>, probably due to the unfavorable angle between phenyl-<i>O</i>-pyridine.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Phenyl Ring Substituent Modifications</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0023.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">compd</th><th class="colsep0 rowsep0" align="center">R<sup>3</sup> =</th><th class="colsep0 rowsep0" align="center">CatC Enz (IC<sub>50</sub>, nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">THP1 cell (IC<sub>50</sub>, nM)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">U937 cell (IC<sub>50</sub>, nM)<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>14</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">175 ± 77</td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>17</b></td><td class="colsep0 rowsep0" align="left">2-Me</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>18</b></td><td class="colsep0 rowsep0" align="left">6-Me</td><td class="colsep0 rowsep0" align="left">505 ± 35</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>19</b></td><td class="colsep0 rowsep0" align="left">4-Me</td><td class="colsep0 rowsep0" align="left">44 ± 3.8</td><td class="colsep0 rowsep0" align="left">12.3 ± 7.3</td><td class="colsep0 rowsep0" align="left">40.8 ± 16.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20</b></td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="left">139.8 ± 41.6</td><td class="colsep0 rowsep0" align="left">21.3 ± 5.9</td><td class="colsep0 rowsep0" align="left">70 ± 3.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Human recombinant CatC isolated enzyme assay. Mean values from a minimum of two experiments.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">CatC cell assay using THP1 cell line. Mean values from a minimum of two experiments.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">CatC cell assay using U937 cell line. Mean values from a minimum of two experiments.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">NT = not test.</p></div></div></div><div class="NLM_p">Having successfully improved the potency from a low micromolar initial hit WZ4002 to low nanomolar compounds in enzymatic and cellular assays, we next turned our attention to the metabolic stability issue. As a starting point, compound <b>19</b> suffered from poor stability in liver microsomes (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>a) and in plasma (data not shown). The liver microsome stability data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00631/suppl_file/jm9b00631_si_001.csv" class="ext-link">Table S1</a>, Supporting Information) suggested that pyridine C-3 substituents apparently strongly influenced metabolic stability. To address this issue, we conducted optimization of substitutions at pyridine C-3 position.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Further Optimization at the Pyridine C-3 Position (a) and C-6 Position (b)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0018.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Human recombinant CatC isolated enzyme assay. Mean values from a minimum of two experiments.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">CatC cell assay using THP1 cell line. Mean values from a minimum of two experiments.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">CatC cell assay using U937 cell line. Mean values from a minimum of two experiments.</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">CL<sub>int</sub>: μL/(min mg protein), determined in human/rat/mouse microsomes.</p></div><div class="footnote" id="t4fn5"><sup><sup>e</sup></sup><p class="last">It was racemic.</p></div><div class="footnote" id="t4fn6"><sup><sup>f</sup></sup><p class="last">ND = not detected at 0 min.</p></div><div class="footnote" id="t4fn7"><sup><sup>g</sup></sup><p class="last">NT = not test.</p></div></div><div></div></div><div class="NLM_p">First, we synthesized compound <b>21</b>, in which an additional hydroxyl was introduced to the meta position of compound <b>19</b>. Compound <b>21</b> was rapidly metabolized in all three tested liver microsomes systems; note that it had slightly increased potency over compound <b>19</b>. We then replaced the pyrrolidine with a piperidine to obtain compound <b>22</b>: excitingly, compound <b>22</b> exhibited an improvement in liver microsome stability (human/rat/mouse liver microsomes CL<sub>int</sub> = 1.8, 6.3, and 10.8 μL/(min mg), <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>a) and was more potent than compound <b>19</b> in both enzymatic and cellular assays. Next, adding a hydroxyl group to the meta position of the piperidine as in compound <b>23</b> led to a slight improvement in metabolic stability in mouse liver microsomes but reduced stability in both human and rat liver microsomes. When the piperidine was replaced by morpholine as in compound <b>24</b> or 4-methylpiperazine as in compound <b>25</b>, the enzymatic activity decreased about 3-fold compared with compound <b>22</b>; further, although the stability of compound <b>25</b> was maintained, compound <b>24</b> showed was less stable in rat and mouse liver microsomes. A planar structure phenyl group was also introduced to the pyridine C-3 position (compound <b>26</b>); however, this led to a 9-fold loss in inhibitory activity.</div><div class="NLM_p last">The effect of pyridine C-6 substituents on the metabolic stability was also evaluated in all three liver microsome systems (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>b). Removing the methoxy group from the phenyl (compound <b>27</b>) or replacing the methoxyphenyl with a methoxypyridine (compound <b>28</b>) caused poorer stability than <b>22</b> in liver microsomes of all three species. Compound <b>29</b>, with an acetyl group at its N4-position that disrupts the salt-bridge interaction with CatC, exhibited only a moderate decrease in potency (about 8-fold less potent than <b>22</b>). The change in potency might be explained by a likely hydrogen bond occurring between the carbonyl of <b>29</b> and CatC Asp1 that was predicted in docking simulations. Replacement of piperazine (compound <b>22</b>) with <i>N</i>,<i>N</i>-dimethylpiperidin (compound <b>30</b>) had little effect on potency and liver microsome metabolic stability. Compound <b>27</b> implied that the modification of ortho position at phenyl probably improved the metabolic stability, so an N-atom substitution analogue was prepared (compound <b>31</b>), for which a dramatic loss (about 20-fold) in potency was observed. Although introduction of trifluoromethyl to the 4-position of phenyl at pyridine C-2 increased the potencies (compounds <b>32</b> and <b>33</b>), these modifications made the compounds metabolically unstable in liver microsomes. Overall, compound <b>22</b> exhibited the best combination of strong potency and liver microsome stability so it was selected as a potential candidate for further in vitro evaluation.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Molecular Docking</h3><div class="NLM_p">To better understand the SAR results observed for our compounds, we performed molecular docking of compound <b>22</b> within the active site of CatC based on the CatC/AZD5248 complex crystal structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CDE">4CDE</a>). The acrylamide formed two hydrogen bond donor–acceptor motifs, respectively, with Asn380 and Gln228, and these two hydrogen bonds enabled the β-carbon atoms of acrylamide to readily reach the sulfhydryl group of Cys234 (within 4.0 Å), thereby facilitating a Michael addition to form the covalent bond (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b00631/suppl_file/jm9b00631_si_001.csv" class="ext-link">Table S2</a>, Supporting Information). Salt-bridge interaction was also observed between the piperazine N-4 of compound <b>22</b> and the Asp1 residue of the CatC exclusion domain, and hydrophobic interaction was predicted between the piperidine and Trp405 (with a 4–5 Å distance between the two rings). The methyl group of the phenyl ring generated slightly hydrophobic interaction with nearby residues and also forced the acrylamide to retain its proper orientation relative to Cys234 for Michael addition to form the covalent bond.</div><figure id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0005.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Putative binding mode of compound <b>22</b> (orange) within the active site of CatC (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CDE">4CDE</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> In Vitro/in Vivo Profiling</h3><div class="NLM_p">As our compounds are derived from an EGFR inhibitor, several compounds with favorable CatC activity were selected for evaluation of their EGFR inhibitory activity (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00631/suppl_file/jm9b00631_si_001.csv" class="ext-link">Figure S1</a>, Supporting Information). For all tested compounds, no inhibition of EGFR WT kinase was observed (when tested up to 10 μM). To evaluate the cathepsin selectivity for our compounds, assays with compounds <b>19</b>, <b>22</b>, and <b>24</b> were conducted against human recombinant enzymes CatB, CatL, and CatS. These three compounds exhibited generally high cathepsin selectivity (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Cathepsin Selectivity of Compound <b>19</b>, <b>22</b>, and <b>24</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="–" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">compd</th><th class="colsep0 rowsep0" align="center" char=".">CatC Enz (IC<sub>50</sub>, nM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="–">CatB Enz (IC<sub>50</sub>, μM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">CatL Enz (IC<sub>50</sub>, μM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">CatS Enz (IC<sub>50</sub>, μM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>19</b></td><td class="colsep0 rowsep0" align="char" char=".">44</td><td class="colsep0 rowsep0" align="char" char="–">3–10</td><td class="colsep0 rowsep0" align="left">3–10</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>22</b></td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="char" char="–">3–10</td><td class="colsep0 rowsep0" align="left">3–10</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>24</b></td><td class="colsep0 rowsep0" align="char" char=".">59</td><td class="colsep0 rowsep0" align="char" char="–">3–10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Human recombinant CatC/CatB/CatL/CatS isolated enzyme assay.</p></div></div></div><div class="NLM_p">We also tested the inhibitory activity against cytochrome P450s using five recombinant human cytochrome P450 isoforms (1A2, 2D6, 3A4, 2C9, and 2C19) (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00631/suppl_file/jm9b00631_si_001.csv" class="ext-link">Table S3</a>, Supporting Information). For compounds <b>22</b> and <b>24</b>, the IC<sub>50</sub> values were higher than 10 μM, suggesting a low potential involved in drug–drug interactions. In contrast, compound <b>19</b> showed weak inhibition against 1A2 and 2C19, with IC<sub>50</sub> values of 8.75 and 9.91 μM, respectively; the other three isoforms had IC<sub>50</sub> values over 10 μM. Compound <b>22</b> was then processed into mouse in vivo pharmacokinetic (PK) studies, which demonstrated desirable results upon oral (PO) delivery, with a half-life of 3.06 h and bioavailability of 22.3% (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). Tissue distribution studies showed that lung had the highest compound concentration and kidney had the second highest compound concentration (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00631/suppl_file/jm9b00631_si_001.csv" class="ext-link">Figure S2</a>, Supporting Information). On the basis of its overall favorable profiles, compound <b>22</b> was thusly selected as a potential drug candidate for further in vivo profiling.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Pharmacokinetic Parameters for Intravenous (IV), Intraperitoneal (IP), and Oral (PO) Administration of <b>22</b> in C57BL/6 Mice</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">route</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>inf</sub> (h ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center"><i>F</i>%</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IV<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">1225</td><td class="colsep0 rowsep0" align="char" char=".">1.62</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IP<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">1243</td><td class="colsep0 rowsep0" align="char" char=".">1.19</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="char" char=".">766</td><td class="colsep0 rowsep0" align="left">20.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PO<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">1364</td><td class="colsep0 rowsep0" align="char" char=".">3.06</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="char" char=".">184</td><td class="colsep0 rowsep0" align="left">22.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">IV dose: 2 mg/kg.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">IP dose: 10 mg/kg.</p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">PO dose: 10 mg/kg. All administrated with 0.5% Methocel and 0.1% Tween-80 in citrate buffer, pH 3. Values were the mean values of male for mouse (<i>n</i> = 3).</p></div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> In Vivo Efficacy of Compound <b>22</b></h3><div class="NLM_p">In chronic inflammatory diseases, CatC has been linked with activation of neutrophil elastase (NE), cathepsin G (CatG) and proteinase 3 (PR3).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> These three serine proteases are major components of neutrophil granules, which are secreted and which cause both inflammation and destruction of extracellular matrices. Specifically, it has been found that CatC functions to peptidolytically remove N-terminal dipeptides from pro-NSPs during the promyelocyte stage of neutrophil maturation in bone marrow.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> Then, the activated NSPs (packaged in granules) in mature neutrophils are eventually released from bone marrow into the circulating blood. It has been reported that a continuous very high fractional inhibition of the CatC activity is required to effectively prevent the activation of NSPs in vivo.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a></div><div class="NLM_p">In vitro, <b>22</b> showed concentration-dependent inhibition of CatC in both THP1 and U937 cell-based assays, with IC<sub>50</sub> values of 2 and 3 nM, respectively. Subsequently, we tested whether the treatment of <b>22</b> could inhibit the activity of CatC and NSPs in vivo. First, the effect of oral administration of <b>22</b> on CatC inhibition was examined in mice. Within 15 min of oral administration of <b>22</b> at a dose of 20 mg/kg, the blood concentration of <b>22</b> was 200 ng/mL and CatC activity in blood was inhibited by 75%, and time-course activity studies showed statistically significant inhibition (80%) of CatC by <b>22</b> in blood lasting for 8 h post administration (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00631/suppl_file/jm9b00631_si_001.csv" class="ext-link">Figure S3</a>, Supporting Information). Next, the effect of compound <b>22</b> on the activation of NE, PR3, and CatG was assessed in vivo by oral administration of <b>22</b> twice daily to mice (6.7, 20, and 60 mg/kg) over a 6 day time course. In <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>, dose-dependent decreases of CatC activity were observed in both bone marrow and blood.</div><figure id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0006.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vivo profiling data (mice) of compound <b>22</b>. Compound <b>22</b> inhibited CatC and the activation of NE, PR3, and CatG in bone marrow and blood, and did so in a dose-dependent manner. Compound <b>22</b> was administered orally twice daily to naive mice (6.7, 20, and 60 mg/kg) for 6 days. The activity inhibition data of compound-treating groups were showed as percentage activity of the vehicle mean (set to 100% activity).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We also found that the activation of downstream NE, PR3, and CatG was also inhibited, in a dose-dependent manner, both in bone marrow and in blood (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Oral administration of compound <b>22</b> (60 mg/kg; twice daily) was tolerated, and we detected no difference in the white blood cell count (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00631/suppl_file/jm9b00631_si_001.csv" class="ext-link">Figure S4</a>, Supporting Information) between the vehicle-treated and 60 mg/kg treatment groups, thus suggesting that compound <b>22</b> might not exert direct effects on the maturation or release of neutrophil into the blood circulation. Collectively, these in vivo studies robustly confirmed that compound <b>22</b> can block CatC enzymatic activity and can, further, inhibit the activation of downstream NSPs (both in bone marrow and in blood samples). These results demonstrated that compound <b>22</b> could potentially be a therapeutic compound for the treatment of neutrophil-associated inflammatory diseases.</div><div class="NLM_p">Recently, Aghdassi et al. reported that deficiency of cathepsin C ameliorated severity of acute pancreatitis in mice.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Next, we examined the potential protective effect of compound <b>22</b> on the pancreas using a caerulein-induced acute pancreatitis mouse model. In this model, mice were orally administrated <b>22</b> or AZD5248 twice daily at 20 mg/kg for 6 days. On the 6th day, acute pancreatitis was induced via hourly intraperitoneal injections of caerulein. Compound <b>22</b> and AZD5248 both caused significant inhibition of CatC enzymatic activity in the pancreas and displayed a considerable pancreas-protecting effect based on assessment of photomicrographs of hematoxylin- and eosin (H&E)-stained pancreas sections (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). On the basis of its attractive performance, both in vitro and in vivo, we have initiated further druggability evaluations of compound <b>22</b> that are currently underway.</div><figure id="fig7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0007.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>22</b> reduced the severity of acute pancreatitis: (a) CatC activity in homogenates prepared from mice pancreas samples. Compound <b>22</b> and AZD5248 were administered orally twice daily at 20 mg/kg. The activity inhibition data of the compound-treated groups are shown as the percentage activity of a sham mean (set to 100% activity). Values are means ± standard error of the mean. Statistical significance was considered: <sup>##</sup><i>p</i> < 0.05 vs sham; ** <i>p</i> < 0.05 vs caelurein + vehicle group. (b) Pancreas histology representative photomicrographs. Hematoxylin and eosin staining of formalin-fixed sections of pancreas tissue. Scale bar: 50 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18802" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18802" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Starting from hit compound WZ4002 (a low micromolar CatC inhibitor), structure–activity relationship (SAR) investigations were performed guided by a plausible binding mode of WZ4002 within the CatC active site. These efforts ultimately led to the discovery of a novel series of CatC inhibitors with significant improvement in enzymatic/cellular potency, culminating finally in the identification of compound <b>22</b> as a highly potent and selective irreversible inhibitor of CatC. In vitro and in vivo profiling assays demonstrated that compound <b>22</b> is an extremely promising drug candidate, and further evaluations of compound <b>22</b> as a preclinical candidate are currently in progress.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75121" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75121" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Biology</h3><div class="NLM_p last">Recombinant human cathepsin C (1071-CY-010), cathepsin L (952-CY-010), Mca-RPKPVE-Nval-WRK (Dnp)-NH<sub>2</sub> (ES002), and Z-Leu-Arg-AMC (ES008) were purchased from R&D (Akron, OH). Recombinant human cathepsin B (10483-H08H) and cathepsin S (10487-H08H) were purchased from Sino Biological Inc. (Beijing, CN). Human THP1 cells and U937 cells were purchased from ATCC (Manassas, VA) and maintained in Roswell Park Memorial Institute (RPMI) 1640 culture medium. The medium was supplemented with 10% fetal bovine serum (12483-020) and 100 unit/mL penicillin–streptomycin (15140-122), which were bought from Life Technology (Beijing, CN). Human and mouse liver microsomes were purchased from BD Biosciences (Beijing, CN). Gly-Phe-AFC (SMAFC041) was bought from SM Biochemicals (Anaheim, CA). Cisbio HTRF KinEASE-TK kit (62TK0PEC) was purchased from Cisbio (Shanghai, CN). All other chemicals were purchased from Sigma-Aldrich (Shanghai, CN). The assay and cell culture plates were purchased from Corning (Shanghai, CN). C57BL/6 mice matched for gender and age were purchased from Vitalriver (Beijing, CN). All experiments on mice were conducted according to institutional and national animal regulations. Animal protocols were approved by the ethics committee of the National Institute of Biological Sciences. Mice were used at the age of 6–8 weeks.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> In Vitro CatC Enzyme Assay</h3><div class="NLM_p last">The CatC enzyme assay was performed on a black 384-well plate. First, rhCatC (440 nM) was activated by rhCatL (300 nM) in activation buffer (25 mM 2-(<i>N</i>-morpholino)ethanesulfonic acid (MES), 5 mM dithiothreitol (DTT), pH 6.0) at RT for 2 h and then activated rhCatC was diluted to 4.4 nM in assay buffer (25 mM MES, 50 mM NaCl, 5 mM DTT, 0.01% (v/v) Triton X-100, pH 6.0). Fourteen microliters of activated rhCatC and 1 μL of compound in 10% dimethyl sulfoxide (DMSO) or 10% DMSO were incubated at RT for 3 h, and 5 μL of the substrate (Gly-Phe-AFC) was added to the final concentration of 100 μM. After 60 min of reaction, the product of the reaction was measured in the EnSpire plate reader using Ex λ 400 nm and Em λ 505 nm for AFC. A standard irreversible CatC inhibitor AZD5248 by AstraZeneca was used as an inhibitor control in the assay.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> CatC Cell Assay</h3><div class="NLM_p last">The cell assay was carried out in a 96-well clear black plate. Thirty microliters of 1.0 × 10<sup>6</sup>/mL THP1 or U937 cells in medium were added to all wells. Then, 10 μL of 5% (v/v) DMSO positive controls or 10 μL of threefold serial diluted compound were dispensed into the appropriate well. The plate was preincubated at 37 °C for 4 h in a cell culture incubator, and then 10 μL of H-Gly-Phe-AFC (100 μM) was added to start the assay reaction. The plate was further incubated for 60 min at 37 °C and measured same as the above CatC enzyme assay.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> EGFR Kinase Assay</h3><div class="NLM_p last">The EGFR kinase assays were performed on a black 384-well plate using Cisbio HTRF KinEASE-TK kit. The assay buffer contained 50 mM <i>N</i>-(2-hydroxyethyl)piperazine-<i>N</i>′-ethanesulfonic acid (pH 7.0), 0.02% NaN<sub>3</sub>, 0.01% bovine serum albumin, 0.1 mM orthovanadate, 10 mM MgCl<sub>2</sub>, 2.5 mM DTT, and 6.25 nM SEB. EGFR kinases was first incubated with compounds for 2 h, respectively; then, adenosine 5′-triphosphate (ATP)/peptide substrate mixture was added to initiate the reaction. The final concentration EGFR WT was 0.1 nM. The final concentration of the biotin-labeled peptide substrate was 1.4 μM, and ATP was 20 μM for EGFR WT. After 30 min of reaction at RT, the detection reagents were added. The time-resolved fluorescence energy transfer signal was measured on PerkinElmer Envision using Ex λ 320 nm and Em λ 615/665 nm.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Data Analysis</h3><div class="NLM_p last">Data were analyzed using GraphPad Prism (GraphPad Software, Inc., San Diego, CA). The curves were fitted using a nonlinear regression model with a sigmoidal dose response.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Selectivity Profile of Cathepsin B/L/S</h3><div class="NLM_p last">Selectivity assay was conducted on a black 384-well plate. Briefly, compounds and recombinant human cathepsin enzymes were incubated at RT for 30 min followed by reaction with substrates for further 30 min, respectively. Z-Leu-Arg-AMC (as a substrate of cathepsin B and L) was measured by PerkinElmer Envision using Ex λ 380 nm and Em λ 460 nm. MCA-Arg-Pro-Lys-Pro-Val-Glu-NVAL-Trp-Arg-Lys(DNP)-NH<sub>2</sub> (as a substrate of cathepsin S) was measured at Ex λ 320 nm and Em λ 405 nm using Enspire plate reader. E-64, a natural inhibitor of cysteine proteases, was used as an inhibitor control in three assays.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Compounds Stability Test in Liver Microsomes Assays</h3><div class="NLM_p last">Compounds were incubated with human, rat or mouse liver microsomes and reduced nicotinamide adenine dinucleotide phosphate in 0.05 M phosphate buffer (pH = 7.4) at 37 °C for 0–60 min. The reaction was quenched, and the amount of the remaining compound was analyzed using liquid chromatography tandem mass spectrometry (LC–MS/MS).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Pharmacokinetics Study in Mice</h3><div class="NLM_p last">Following intravenous (IV), intraperitoneal (IP), or oral administration (PO) of <b>22</b> to C57BL/6 mice (<i>n</i> = 3), blood was sampled through eye puncture at various time points. Compound concentrations in the blood samples were analyzed by LC–MS/MS. Pharmacokinetic parameters were determined from individual animal data using noncompartmental analysis in phoenix 64 (winNonlin 6.3).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Mice in Vivo Study</h3><div class="NLM_p last">C57BL/6 mice (20–25 g) were randomly divided into four groups (<i>n</i> = 10) and kept at five animals per cage. Compound <b>22</b> was administered orally twice daily at 6.7, 20, and 60 mg/kg for 6 days. The matched vehicle controls (0.5% Methocel, 0.1% Tween-80 in 100 mM citrate buffer, pH 3) were also administered twice daily for 6 days. Mice were weighed and the dose adjusted accordingly on each day. Blood was sampled through eye puncture at 14 h intervals after the end of the administration. Then, mice were terminated and bone marrow cells were immediately extracted from femurs and tibias using ice cold RPMI 1640 medium. Blood cells and bone marrow cells were lysed according to the protocols previously described<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> with some modifications. Briefly, cell lysis buffer contained 50 mM Tris (pH 7.4), 750 mM NaCl, and 1% (v/v) Triton X-100, and cell lysates were mildly treated by ultrasonic treatment in ice. Following cell lysis, the supernatants were kept at −80 °C until NSPs’ activity analyses were carried out.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Analysis of Downstream NSPs Activities</h3><div class="NLM_p">The analysis was performed as previously described. Briefly, cell lysates were diluted according to protein concentration using different assay buffers.</div><div class="NLM_p last">The assay buffers used were 25 mM MES, 50 mM NaCl, 5 mM DTT, pH 6.0 for CatC, 50 mM Tris, 750 mM NaCl, pH 7.4 for NE and PR3 and 50 mM Tris, 750 mM NaCl, 5 mM ethylenediaminetetraacetic acid, pH 7.4 for CatG. Blood lysates were diluted 5-fold higher than bone marrow lysates. Lysates were added to 384-well plates together with DMSO control or protease inhibitors (inhibitor AZD5248 by AstraZeneca for CatC, avelestat for NE, sivelestat for PR3, cathepsin G inhibitor 1 for CatG). Synthetic peptide substrates (Gly-Phe-AFC (SM Biochemicals) for CatC, methoxysuccinyl-Ala-Ala-Pro-Val-AMC (Sigma) for NE, aminobenzoyl-Val-Ala-Asp-Cys-Ala-Asp-Gln-ethylenediamine 2,4-dinitrophenyl (Peptide Synthetics) for PR3, and <i>N</i>-succinyl-Ala-Ala-Pro-Phe-pNA (Sigma) for CatG) were added before plates were read at fluorescence or absorbance. Assay kinetics was monitored for up to 90 min. Data were analyzed using GraphPad Prism (GraphPad Software, Inc., San Diego, CA).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Induction of Pancreatitis</h3><div class="NLM_p last">The acute pancreatitis was induced by hourly intraperitoneal injections of caerulein (50 μg/(kg body weight)) for up to 8 h.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> C57BL/6 mice (20–25 g) were randomly divided into four groups (<i>n</i> = 5). Compound <b>22</b> and AZD5248 were administered orally twice daily at 20 mg/kg for 6 days. The matched vehicle controls (0.5% Methocel, 0.1% Tween-80 in 100 mM citrate buffer, pH 3) were also administered twice daily for 6 days. On the 6th day, mice were induced pancreatitis after compound administration, and after the last caerulein injection, mice were administered the compound. The sham-treated group was treated the same as vehicle controls except that saline was administered instead of caerulein. Mice were killed 1 h after the last caerulein injection. Tissue was harvested immediately after sacrificing the animals. A portion of pancreas samples was frozen in liquid nitrogen for preparation of homogenate. For histology, pancreas were fixed in 4.5% formalin for paraffin embedding and stained with hematoxylin and eosin. Serum samples were prepared and stored at −20 °C.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Molecule Docking</h3><div class="NLM_p last">Molecular docking was performed using MOE 2015.10 software. The cocrystal structure of CatC in complex with AZD5248 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CDE">4CDE</a>) was used for docking studies. The optimized structure of <b>22</b> was generated by MOE 2015.10. Before docking simulation, ligands and protein were prepared with the standard protocol using MOE 2015.10. <b>22</b> was inserted into the substrate-binding pocket of CatC to replace AZD5248. The complex of <b>22</b>-CatC was used for geometrical optimization. All docking calculations were performed using default settings.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Chemistry</h3><div class="NLM_p">The reagents and solvents for reactions were reagent-grade and used without further purification. Glass apparatus was used for reaction dewater, and deoxygenization was carried out under a nitrogen atmosphere at high temperature. Reactions sensitive to water and air rigorously followed water-free and oxygen-free reaction procedures, wherein reagents were added with an injection syringe. LC–mass spectrometry (MS) system: Waters 2545 (XBridge C18)/3100 mass detector. <sup>1</sup>H NMR spectra were recorded on a Varian 400 MHz spectrometer (Varian, Inc., Palo Alto, CA) at ambient temperature with tetramethylsilane as an internal standard. <sup>13</sup>C NMR spectra were recorded on a Varian 100 MHz spectrometer (with complete proton decoupling) at ambient temperature. Chemical shifts are reported in ppm. Data for <sup>1</sup>H NMR are reported as follows: chemical shift (δ) in ppm, multiplicity (s = singlet, bs = broad singlet, d = doublet, t = triplet, q = quartet, m = multiplet), coupling constants and integration. High-resolution mass spectra were obtained by Agilent Technologies 6540 UHD Accurate-Mass Q-TOF LC/MS (Santa Clara, CA). The samples were analyzed by high-performance liquid chromatography (HPLC)/MS on a Waters Auto Purification LC/MS system (3100 mass detector, 2545 binary gradient module, 2767 sample manager, and 2998 photodiode array detector), which was purchased from Waters (Milford, MA). The system was equipped with a Waters C<sub>18</sub> 5 μm SunFire separation column (150 × 4.6 mm<sup>2</sup>), equilibrated with HPLC grade water (solvent A) and HPLC grade acetonitrile (solvent B) with a flow rate of 0.3 mL/min. Thin-layer chromatography was carried out using HS-GF 254 silica plates; chromatographic purification was carried out using silica gel (Yan tai mou ping yuan bo jing xi silica gel plant). The purity of all final compounds was confirmed to be >95% by HPLC.</div><div id="sec4_13_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>N</i>-(5-((3-Chloro-6-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)pyridin-2-yl)oxy)-2-methylphenyl)acrylamide (<b>1</b>)</h4><div id="sec4_13_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> Step a: 3,6-Dichloro-2-(3-nitrophenoxy)pyridine (<b>36</b>)</h5><div class="NLM_p last">Potassium carbonate (1.52 g, 10.96 mmol) and 2,3,6-trichloropyridine (1.0 g, 5.48 mmol) were added to the solution of 3-nitrophenol (763 mg, 5.48 mmol) in anhydrous DMF (20 mL). The reaction mixture was heated to 100 °C for 4 h. The reaction mixture was filtered, and the filtrate was diluted with ethyl acetate and washed with brine three times. The organic layer was dried over anhydrous sodium sulfate and concentrated; the residue product was purified by silica gel chromatography to afford 1.02 g of a white solid (yield: 65%). <sup>1</sup>H NMR 400 MHz (CDCl<sub>3</sub>) δ 8.14–8.11 (m, 1H), 8.06 (t, <i>J</i> = 2.4 Hz, 1H), 7.75 (d, <i>J</i> = 8.0 Hz, 1H), 7.60 (t, <i>J</i> = 8.0 Hz, 1H), 7.55–7.52 (m, 1H), 7.08 (d, <i>J</i> = 8.0 Hz, 1H). LC–MS <i>m</i>/<i>z</i>: 285.02 (M + H)<sup>+</sup>.</div></div><div id="sec4_13_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> Step b: 5-Chloro-<i>N</i>-(2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)-6-(3-nitrophenoxy)pyridin-2-amine (<b>38a</b>)</h5><div class="NLM_p last">An anhydrous dioxane solution of 3,6-dichloro-2-(3-nitrophenoxy)pyridine (300 mg, 1.05 mmol), Pd(OAc)<sub>2</sub> (24 mg, 0.11 mmol), BINAP (98 mg, 0.16 mmol), cesium carbonate (515 mg, 1.58 mmol), and 2-methoxy-4-(4-methylpiperazin-1-yl)aniline (256 mg, 1.16 mmol) was added into a 20 mL microwave reaction vessel and capped. The reaction mixture was stirred for 1 h at 130 °C using a Biotage optimizer reactor. Water and ethyl acetate were added to the reaction solution and separated, and then the aqueous phase was extracted with ethyl acetate three times. The combined organic phase was washed with saturated brine, then dried over anhydrous sodium sulfate. The organic phase was filtered off and concentrated under reduced pressure. The obtained residue was purified by silica gel chromatography to afford 309 mg of a brown solid (yield: 62.6%). <sup>1</sup>H NMR 400 MHz (DMSO-<i>d</i><sub>6</sub>) δ 8.23 (s, 1H), 8.15–8.12 (m, 1H), 8.00 (t, <i>J</i> = 2.4 Hz, 1H), 7.73 (t, <i>J</i> = 8.4 Hz, 1H), 7.68–7.65 (m, 1H), 7.65 (d, <i>J</i> = 8.8 Hz, 1H), 7.07 (d, <i>J</i> = 8.8 Hz, 1H), 6.59 (d, <i>J</i> = 8.4 Hz, 1H), 6.50 (d, <i>J</i> = 2.4 Hz, 1H), 5.97 (dd, <i>J</i> = 2.4, 8.8 Hz, 1H), 3.74 (s, 3H), 3.00 (t, <i>J</i> = 4.8 Hz, 4H), 2.43 (t, <i>J</i> = 4.8 Hz, 4H), 2.21 (s, 3H). LC–MS <i>m</i>/<i>z</i>: 470.36 (M + H)<sup>+</sup>.</div></div><div id="sec4_13_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> Step c: 6-(3-Aminophenoxy)-5-chloro-<i>N</i>-(2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)pyridin-2-amine (<b>39a</b>)</h5><div class="NLM_p last">5-Chloro-<i>N</i>-(2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)-6-(3-nitrophenoxy)pyridin-2-amine (305 mg, 0.65 mmol) was dissolved in ethanol (2 mL) and THF (2 mL), and water (2 mL) was added. Iron powder (363 mg, 6.49 mmol) and ammonium chloride (344 mg, 6.49 mmol) were then added, and the resulting mixture was heated to 75 °C for 4 h The reaction mixture was cooled to RT and filtered through celite. The solvent was removed in vacuo, and the resulting residue was basified with saturated sodium bicarbonate and extracted with ethyl acetate three times. The combined organic phase was dried with anhydrous sodium sulfate, concentrated, and purified by silica gel chromatography with DCM–MeOH to afford 240 mg of a brown solid (yield: 83.9%). <sup>1</sup>H NMR 400 MHz (DMSO-<i>d</i><sub>6</sub>) δ 8.07 (s, 1H), 7.57 (d, <i>J</i> = 8.4 Hz, 1H), 7.41 (d, <i>J</i> = 8.8 Hz, 1H), 7.03 (t, <i>J</i> = 8.0 Hz, 1H), 6.54 (d, <i>J</i> = 2.4 Hz, 1H), 6.52 (d, <i>J</i> = 8.4 Hz, 1H), 6.42 (dd, <i>J</i> = 2.4, 8.0 Hz, 1H), 6.27 (t, <i>J</i> = 2.4 Hz, 1H), 6.23–6.17 (m, 1H), 5.21 (s, 2H), 3.77 (s, 3H), 3.04 (t, <i>J</i> = 4.8 Hz, 4H), 2.44 (t, <i>J</i> = 4.8 Hz, 4H), 2.22 (s, 3H). LC–MS <i>m</i>/<i>z</i>: 440.33 (M + H)<sup>+</sup>.</div></div><div id="sec4_13_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> Step d: <i>N</i>-(5-((3-Chloro-6-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)pyridin-2-yl)oxy)-2-methylphenyl)acrylamide (<b>1</b>)</h5><div class="NLM_p last">Acryloyl chloride (14 mg, 0.16 mmol) was added dropwise to a solution of 6-(3-aminophenoxy)-5-chloro-<i>N</i>-(2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)pyridin-2-amine (63 mg, 0.14 mmol) and triethylamine (30 μL, 0.21 mmol) in anhydrous DCM (2 mL) at 0 °C. The reaction mixture was stirred at 0 °C for 1 h. Water and DCM were added to the reaction solution, separated and then the aqueous phase was extracted with DCM twice. The combined organic phase was washed with brine, then dried over anhydrous sodium sulfate. The organic phase was filtered off and concentrated under reduced pressure. The obtained residue was dissolved in DCM (2 mL) and TFA (0.25 mL) was added and stirred at RT for 30 min to afford the TFA salt of the title compound. DCM and excess TFA were removed in vacuo; then, the residue was dissolved in MeOH and purified by reverse-phase HPLC eluting with acetonitrile/water (containing 0.15‰ TFA). Fractions containing the product were concentrated in vacuo to remove the solvent to give the title compound (TFA salt, 20 mg, 19.3%) as a gray solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.30 (s, 1H), 8.23 (s, 1H), 7.64 (d, <i>J</i> = 8.8 Hz, 1H), 7.61 (d, <i>J</i> = 8.4 Hz, 1H), 7.44 (t, <i>J</i> = 2.4 Hz, 1H), 7.40–7.35 (m, 2H), 6.86 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 6.64 (d, <i>J</i> = 8.4 Hz, 1H), 6.59 (d, <i>J</i> = 2.4 Hz, 1H), 6.42 (dd, <i>J</i> = 17.2, 10.0 Hz, 1H), 6.26 (dd, <i>J</i> = 17.2, 2.0 Hz, 1H), 6.07 (dd, <i>J</i> = 8.8, 2.8 Hz, 1H), 5.77 (dd, <i>J</i> = 10.0, 2.0 Hz, 1H), 3.78 (s, 3H), 3.68 (d, <i>J</i> = 13.6 Hz, 2H), 3.50 (d, <i>J</i> = 12.0 Hz, 2H), 3.17–3.08 (m, 2H), 2.86–2.80 (m, 5H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.29, 156.25, 154.13, 153.35, 150.03, 145.18, 140.24, 140.12, 131.72, 129.79, 127.28, 122.38, 120.87, 116.36, 115.50, 112.40, 106.91, 106.14, 103.18, 100.71, 55.67, 52.33, 46.31, 42.10. High-resolution mass spectrometry (HRMS) C<sub>26</sub>H<sub>28</sub>ClN<sub>5</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd mass, 494.1959; found, 494.1972.</div></div></div><div id="sec4_13_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>N</i>-(3-((3-Chloro-6-((4-(4-methylpiperazin-1-yl)phenyl)amino)pyridin-2-yl)oxy)phenyl)acrylamide (<b>2</b>)</h4><div class="NLM_p last">This compound was prepared according to the preparation of compound <b>1</b> using 4-(4-methylpiperazin-1-yl)aniline to replace 2-methoxy-4-(4-methylpiperazin-1-yl)aniline in step b to afford the title compound (TFA salt, 8 mg, 7%) as a brown solid. The title compound was purified by reverse-phase HPLC eluting with acetonitrile/water (containing 0.15‰ TFA). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.36 (s, 1H), 9.11 (s, 1H), 7.67 (d, <i>J</i> = 8.4 Hz, 1H), 7.65–7.63 (m, 1H), 7.49 (t, <i>J</i> = 2.4 Hz, 1H), 7.41 (t, <i>J</i> = 8.4 Hz, 1H), 7.14 (d, <i>J</i> = 8.8 Hz, 2H), 6.91–6.88 (m, 1H), 6.64 (d, <i>J</i> = 9.2 Hz, 2H), 6.47 (d, <i>J</i> = 8.4 Hz, 1H), 6.43 (dd, <i>J</i> = 16.8, 10.0 Hz, 1H), 6.26 (dd, <i>J</i> = 16.8, 2.0 Hz, 1H), 5.77 (dd, <i>J</i> = 10.0, 2.0 Hz, 1H), 3.57 (bs, 2H), 3.47 (bs, 2H), 3.12 (bs, 2H), 2.85 (s, 3H), 2.80 (bs, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.30, 156.59, 154.02, 152.78, 143.77, 140.30, 140.24, 134.19, 131.71, 129.86, 127.34, 118.94, 116.70, 116.52, 115.74, 112.80, 105.69, 102.96, 52.36, 46.46, 42.11. HRMS C<sub>25</sub>H<sub>27</sub>ClN<sub>5</sub>O<sub>2</sub> (M + H)<sup>+</sup> calcd mass, 464.1853; found, 464.1866.</div></div><div id="sec4_13_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-(3-((3-Chloro-6-((4-(piperazin-1-yl)phenyl)amino)pyridin-2-yl)oxy)phenyl)acrylamide (<b>3</b>)</h4><div class="NLM_p"><i>tert</i>-Butyl 4-(4-((6-(3-acrylamidophenoxy)-5-chloropyridin-2-yl)amino)phenyl)piperazine-1-carboxylate (<b>40d</b>) was prepared according to the preparation method of compound <b>1</b> using <i>tert</i>-butyl 4-(4-aminophenyl)piperazine-1-carboxylate to replace 2-methoxy-4-(4-methylpiperazin-1-yl) aniline in step b.</div><div class="NLM_p last"><i>tert</i>-Butyl 4-(4-((6-(3-acrylamidophenoxy)-5-chloropyridin-2-yl)amino)phenyl)piperazine-1-carboxylate (<b>40d</b>) was dissolved in DCM/TFA (2:1), and the mixture was stirred at RT for 2 h. The mixture was evaporated to dryness, dissolved in MeOH, and purified by reverse-phase HPLC eluting with acetonitrile/water (containing 0.15‰ TFA) to afford the title compound (TFA salt, 10 mg, 14.6% over the last two steps) as a gray solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.33 (s, 1H), 9.09 (s, 1H), 8.77 (bs, 1H), 7.66 (t, <i>J</i> = 8.8 Hz, 1H), 7.64 (t, <i>J</i> = 8.4 Hz, 1H), 7.50 (t, <i>J</i> = 2.4 Hz, 1H), 7.41 (t, <i>J</i> = 8.0 Hz, 1H), 7.14 (d, <i>J</i> = 8.4 Hz, 2H), 6.89 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 6.63 (d, <i>J</i> = 8.8 Hz, 2H), 6.47 (d, <i>J</i> = 8.8 Hz, 1H), 6.43 (dd, <i>J</i> = 16.8, 10.0 Hz, 1H), 6.26 (dd, <i>J</i> = 16.8, 2.0 Hz, 1H), 5.77 (dd, <i>J</i> = 10.0, 2.0 Hz, 1H), 3.21 (bs, 4H), 3.14 (d, <i>J</i> = 4.4 Hz, 4H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.32, 156.60, 154.02, 152.80, 144.32, 140.27, 134.20, 131.73, 129.81, 127.26, 118.96, 116.69, 116.59, 115.71, 112.83, 105.68, 102.94, 46.42, 42.79. HRMS C<sub>24</sub>H<sub>25</sub>ClN<sub>5</sub>O<sub>2</sub> (M + H)<sup>+</sup> calcd mass, 450.1697; found, 450.1704.</div></div><div id="sec4_13_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-(3-((3-Chloro-6-((4-morpholinophenyl)amino)pyridin-2-yl)oxy)phenyl)acrylamide (<b>4</b>)</h4><div class="NLM_p last">This compound was prepared according to the preparation of compound <b>1</b> using 4-morpholinoaniline to replace 2-methoxy-4-(4-methylpiperazin-1-yl)aniline in step b to afford the title compound (TFA salt, 20 mg, 16.7%) as a brown solid. The title compound was purified by reverse-phase HPLC eluting with acetonitrile/water (containing 0.15‰ TFA). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.31 (s, 1H), 9.09 (s, 1H), 7.67–7.61 (m, 2H), 7.54 (t, <i>J</i> = 2.4 Hz, 1H), 7.42 (t, <i>J</i> = 8.0 Hz, 1H), 7.13 (bs, 2H), 6.89 (dd, <i>J</i> = 2.4, 8.0 Hz, 1H), 6.67 (bs, 2H), 6.47 (s, 1H), 6.42 (dd, <i>J</i> = 16.8, 10.0 Hz, 1H), 6.25 (dd, <i>J</i> = 16.8, 2.0 Hz, 1H), 5.77 (dd, <i>J</i> = 10.0, 2.0 Hz, 1H), 3.73 (bs, 4H), 2.98 (bs, 4H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.26, 153.94, 140.25, 131.69, 129.85, 127.27, 118.89, 116.73, 115.69, 112.87, 65.84, 49.92. HRMS C<sub>24</sub>H<sub>24</sub>ClN<sub>4</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd mass, 451.1537; found, 451.1521.</div></div><div id="sec4_13_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i>-(3-((6-((3-(Aminomethyl)phenyl)amino)-3-chloropyridin-2-yl)oxy)phenyl)acrylamide (<b>5</b>)</h4><div class="NLM_p last">This compound was prepared according to the preparation of compound <b>3</b> using <i>tert</i>-butyl (3-aminobenzyl)carbamate to replace the <i>tert</i>-butyl 4-(4-aminophenyl)piperazine-1-carboxylate in step b to afford a brown solid (TFA salt, 13 mg, 18.4% over the last two steps). The title compound was purified by reverse-phase flash chromatography eluting with MeOH/water (containing 0.15‰ TFA). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.28 (s, 1H), 9.39 (s, 1H), 8.03 (s, 2H), 7.76 (d, <i>J</i> = 8.8 Hz, 1H), 7.58–7.54 (m, 2H), 7.43 (t, <i>J</i> = 8.4 Hz, 1H), 7.30–7.27 (m, 1H), 7.20 (t, <i>J</i> = 2.0 Hz, 1H), 7.00 (t, <i>J</i> = 8.0 Hz, 1H), 6.97–6.94 (m, 1H), 6.87 (d, <i>J</i> = 8.0 Hz, 1H), 6.60 (d, <i>J</i> = 8.4 Hz, 1H), 6.40 (dd, <i>J</i> = 16.8, 10.0 Hz, 1H), 6.24 (dd, <i>J</i> = 17.2, 2.0 Hz, 1H), 5.76 (dd, <i>J</i> = 10.0, 2.0 Hz, 1H), 3.74 (s, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.33, 156.57, 153.96, 152.45, 140.95, 140.60, 140.32, 134.13, 131.68, 129.83, 128.74, 127.31, 120.67, 118.07, 117.91, 116.88, 115.81, 112.68, 106.28, 104.20, 42.48. HRMS C<sub>21</sub>H<sub>20</sub>ClN<sub>4</sub>O<sub>2</sub> (M + H)<sup>+</sup> calcd mass, 395.1275; found, 395.1284.</div></div><div id="sec4_13_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>N</i>-(3-((6-((4-(2-Aminoethyl)phenyl)amino)-3-chloropyridin-2-yl)oxy)phenyl)acrylamide (<b>6</b>)</h4><div class="NLM_p last">This compound was prepared according to the preparation of compound <b>3</b> using <i>tert</i>-butyl (4-aminophenethyl)carbamate to replace <i>tert</i>-butyl 4-(4-aminophenyl)piperazine-1-carboxylate in step b to afford the title compound (TFA salt, 11 mg, 19.6% over the last two steps) as a brown solid. The product was purified by reverse-phase HPLC eluting with acetonitrile/water (containing 0.15‰ TFA). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.29 (s, 1H), 9.26 (s, 1H), 7.72 (d, <i>J</i> = 8.8 Hz, 1H), 7.72–7.70 (m, 2H), 7.64–7.61 (m, 1H), 7.51–7.50 (m, 1H), 7.42 (t, <i>J</i> = 8.4 Hz, 1H), 7.20 (d, <i>J</i> = 8.8 Hz, 1H), 7.21–7.18 (m, 1H), 6.93–6.90 (m, 1H), 6.85 (d, <i>J</i> = 8.4 Hz, 1H), 6.87–6.84 (m, 1H), 6.54 (d, <i>J</i> = 8.4 Hz, 1H), 6.41 (dd, <i>J</i> = 16.8, 10.0 Hz, 1H), 6.26 (dd, <i>J</i> = 17.2, 2.0 Hz, 1H), 5.77 (dd, <i>J</i> = 10.0, 2.0 Hz, 1H), 2.91 (bs, 2H), 2.67 (t, <i>J</i> = 8.0 Hz, 2H). HRMS C<sub>22</sub>H<sub>22</sub>ClN<sub>4</sub>O<sub>2</sub> (M + H)<sup>+</sup> calcd mass, 409.1431; found, 409.1437.</div></div><div id="sec4_13_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> <i>N</i>-(3-((3-Chloro-6-((4-(4-(cyclopropylmethyl)piperazin-1-yl)phenyl)amino)pyridin-2-yl)oxy)phenyl)acrylamide (<b>7</b>)</h4><div class="NLM_p last">Compound <b>3</b> (30 mg, 0.067 mmol) was dissolved in anhydrous DMF (2 mL); then, potassium carbonate (18 mg, 0.13 mmol) and (bromomethyl)cyclopropane (9 mg, 0.067 mmol) were added. The mixture was stirred at 70 °C for 4 h. Water and ethyl acetate were added to the reaction mixture, separated, and then the aqueous phase was extracted with ethyl acetate three times. The combined organic phase was washed with saturated brine, then dried over anhydrous sodium sulfate. The organic phase was filtered off and then concentrated under reduced pressure. The obtained residue was purified by reverse-phase HPLC eluting with acetonitrile/water (containing 0.15‰ TFA) to afford the title compound (TFA salt, 5 mg, 10.2%) as a gray solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.32 (s, 1H), 9.09 (s, 1H), 7.67 (d, <i>J</i> = 8.4 Hz, 1H), 7.67–7.64 (m, 1H), 7.47 (t, <i>J</i> = 2.0 Hz, 1H), 7.41 (t, <i>J</i> = 8.0 Hz, 1H), 7.14 (d, <i>J</i> = 9.2 Hz, 2H), 6.91–6.88 (m, 1H), 6.65 (d, <i>J</i> = 9.2 Hz, 2H), 6.47 (d, <i>J</i> = 8.8 Hz, 1H), 6.42 (dd, <i>J</i> = 17.2, 10.0 Hz, 1H), 6.26 (dd, <i>J</i> = 17.2, 2.0 Hz, 1H), 5.77 (dd, <i>J</i> = 10.0, 2.0 Hz, 1H), 3.60 (d, <i>J</i> = 11.6 Hz, 2H), 3.15–3.12 (m, 2H), 3.09–3.06 (m, 2H), 2.86 (t, <i>J</i> = 12.0 Hz, 2H), 1.12–1.06 (m, 1H), 0.70–0.65 (m, 2H), 0.41–0.37 (m, 2H). HRMS C<sub>28</sub>H<sub>31</sub>ClN<sub>5</sub>O<sub>2</sub> (M + H)<sup>+</sup> calcd mass, 504.2166; found, 504.2181.</div></div><div id="sec4_13_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>N</i>-(3-((3-Chloro-6-((4-(4-(cyclopentylmethyl)piperazin-1-yl)phenyl)amino)pyridin-2-yl)oxy)phenyl)acrylamide (<b>8</b>)</h4><div class="NLM_p last">This compound was prepared according to the preparation of compound <b>7</b> using (bromomethyl)cyclopentane to replace the (bromomethyl)cyclopropane in step f to afford the title compound (TFA salt, 7 mg, 12.7% over the last two steps) as a gray solid. The product was purified by reverse-phase HPLC eluting with acetonitrile/water (containing 0.15‰ TFA). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.32 (s, 1H), 9.09 (s, 1H), 7.67 (d, <i>J</i> = 8.4 Hz, 1H), 7.67–7.64 (m, 1H), 7.47 (t, <i>J</i> = 2.0 Hz, 1H), 7.41 (t, <i>J</i> = 8.0 Hz, 1H), 7.14 (d, <i>J</i> = 8.8 Hz, 2H), 6.91–6.88 (m, 1H), 6.64 (d, <i>J</i> = 8.8 Hz, 2H), 6.47 (d, <i>J</i> = 8.8 Hz, 1H), 6.43 (dd, <i>J</i> = 17.2, 10.4 Hz, 1H), 6.26 (dd, <i>J</i> = 17.2, 2.0 Hz, 1H), 5.77 (dd, <i>J</i> = 10.0, 2.0 Hz, 1H), 3.56 (d, <i>J</i> = 11.6 Hz, 2H), 3.15–3.07 (m, 4H), 2.91 (t, <i>J</i> = 11.6 Hz, 2H), 1.87–1.81 (m, 2H), 1.65–1.52 (m, 4H), 1.28–1.16 (m, 5H). HRMS C<sub>30</sub>H<sub>35</sub>ClN<sub>5</sub>O<sub>2</sub> (M + H)<sup>+</sup> calcd mass, 532.2479; found, 532.2522.</div></div><div id="sec4_13_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>N</i>-(3-((6-((2-Methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)pyridin-2-yl)oxy)phenyl)acrylamide (<b>9</b>)</h4><div class="NLM_p last">The title compound was obtained in the preparation of compound <b>14</b> as a brown solid (TFA salt, 16 mg). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.27 (s, 1H), 8.00 (s, 1H), 7.57–7.55 (m, 1H), 7.54–7.49 (m, 2H), 7.46–7.44 (m, 1H), 7.36 (t, <i>J</i> = 8.0 Hz, 1H), 6.84–6.81 (m, 1H), 6.62 (d, <i>J</i> = 2.8 Hz, 1H), 6.56 (d, <i>J</i> = 8.0 Hz, 1H), 6.42 (dd, <i>J</i> = 16.8, 10.0 Hz, 1H), 6.25 (dd, <i>J</i> = 16.8, 2.0 Hz, 1H), 6.21 (d, <i>J</i> = 8.0 Hz, 1H), 6.18 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 5.76 (dd, <i>J</i> = 10.0, 2.0 Hz, 1H), 3.79 (s, 3H), 3.70 (d, <i>J</i> = 13.2 Hz, 2H), 3.50 (d, <i>J</i> = 12.0 Hz, 2H), 3.18–3.09 (m, 2H), 2.87–2.82 (m, 5H). HRMS C<sub>26</sub>H<sub>30</sub>N<sub>5</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd mass, 460.2349; found, 460.2361.</div></div><div id="sec4_13_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>N</i>-(3-((6-((2-Methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-3-(trifluoromethyl)pyridin-2-yl)oxy)phenyl)acrylamide (<b>10</b>)</h4><div class="NLM_p last">This compound was prepared according to the preparation method of compound <b>1</b> using 2,6-dichloro-3-(trifluoromethyl)pyridine and 3-nitrophenol as the starting material. The product was purified by silica gel column chromatography eluting with DCM/MeOH as a yellow solid (20 mg, 35.9%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.32 (s, 1H), 7.96 (d, <i>J</i> = 8.4 Hz, 1H), 7.66–7.64 (m, 1H), 7.55 (t, <i>J</i> = 2.4 Hz, 1H), 7.46 (d, <i>J</i> = 2.0 Hz, 1H), 7.42 (t, <i>J</i> = 8.0 Hz, 1H), 7.33 (d, <i>J</i> = 8.8 Hz, 1H), 6.91–6.89 (m, 1H), 6.55 (d, <i>J</i> = 2.4 Hz, 1H), 6.46 (d, <i>J</i> = 8.8 Hz, 1H), 6.41 (dd, <i>J</i> = 16.8, 10.0 Hz, 1H), 6.25 (dd, <i>J</i> = 16.8, 2.0 Hz, 1H), 6.00 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 5.77 (dd, <i>J</i> = 10.0, 2.0 Hz, 1H), 3.80 (s, 3H), 3.01 (t, <i>J</i> = 4.8 Hz, 4H), 2.42 (t, <i>J</i> = 4.8 Hz, 4H), 2.21 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.65, 163.27, 153.34, 150.65, 149.14, 147.33, 140.44, 139.63, 131.68, 130.05, 127.28, 126.02, 123.33, 120.51, 120.22, 116.92, 116.05, 113.09, 106.29, 99.67, 98.42, 56.09, 54.65, 48.60, 45.82. HRMS C<sub>27</sub>H<sub>29</sub>F<sub>3</sub>N<sub>5</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd mass, 528.2222; found, 528.2232.</div></div><div id="sec4_13_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>N</i>-(3-((3-Cyano-6-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)pyridin-2-yl)oxy)phenyl)acrylamide (<b>11</b>)</h4><div class="NLM_p last">This compound was prepared according to the preparation method of compound <b>1</b> using 2,6-dichloronicotinonitrile and 3-nitrophenol as the starting material. The product was purified by silica gel column chromatography eluting with DCM/MeOH as a yellow solid (19 mg, 42.2%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.28 (s, 1H), 8.31 (s, 1H), 7.59–7.57 (m, 1H), 7.57 (d, <i>J</i> = 8.4 Hz, 1H), 7.50 (t, <i>J</i> = 2.4 Hz, 1H), 7.37 (t, <i>J</i> = 8.0 Hz, 1H), 7.29 (d, <i>J</i> = 9.2 Hz, 1H), 6.85–6.82 (m, 1H), 6.54 (d, <i>J</i> = 8.8 Hz, 1H), 6.51 (d, <i>J</i> = 2.4 Hz, 1H), 6.42 (dd, <i>J</i> = 16.8, 10.0 Hz, 1H), 6.25 (dd, <i>J</i> = 16.8, 2.0 Hz, 1H), 6.02 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 5.76 (dd, <i>J</i> = 10.0, 2.0 Hz, 1H), 3.75 (s, 3H), 3.00 (t, <i>J</i> = 4.8 Hz, 4H), 2.41 (t, <i>J</i> = 4.8 Hz, 4H), 2.21 (s, 3H). HRMS C<sub>27</sub>H<sub>29</sub>N<sub>6</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd mass, 485.2301; found, 485.2312.</div></div><div id="sec4_13_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>N</i>-(3-((3-Ethynyl-6-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)pyridin-2-yl)oxy)phenyl)acrylamide (<b>12</b>)</h4><div class="NLM_p">Step a: 3-Bromo-6-chloro-2-(3-nitrophenoxy)pyridine was prepared using 3-nitrophenol and 3-bromo-2,6-dichloropyridine as starting materials according to the method of step a mentioned in preparation of compound <b>1</b>.</div><div class="NLM_p">Step b: A flask containing 3-bromo-6-chloro-2-(3-nitrophenoxy)pyridine (275 mg, 0.83 mmol), Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (59 mg, 0.083 mmol) and CuI (16 mg, 0.083 mmol) was evacuated and back-filled with nitrogen three times. Then, sequentially, with stirring were added anhydrous dioxane (4 mL), triethylamine (126 mg, 1.25 mmol), and ethynyltrimethylsilane (98 mg, 1.00 mmol). The resulting solution was stirred at 70 °C for 4 h, before quenching with sat. ammonium chloride (aq). The mixture was diluted with ethyl acetate and washed with brine. The organic layers were dried over anhydrous sodium sulfate and concentrated in vacuo to afford the crude, which was purified by silica gel chromatography to afford the title product (224 mg, 77%). LC–MS <i>m</i>/<i>z</i>: 347.12 (M + H)<sup>+</sup>.</div><div class="NLM_p">Steps c and d: Same as the method in steps b and c mentioned in preparation of compound <b>1</b>.</div><div class="NLM_p">Step e: To a solution of intermediate 6-(3-aminophenoxy)-<i>N</i>-(2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)-5-((trimethylsilyl)ethynyl)pyridin-2-amine in THF was added a 1 M solution of TBAF in THF (10 equiv). The mixture was stirred at RT for 2 h. Water and ethyl acetate were added to the reaction solution and separated, and then the aqueous phase was extracted with ethyl acetate. The combined organic phase was washed with saturated brine, then dried over anhydrous sodium sulfate. The organic phase was filtered off and then concentrated under reduced pressure. The obtained residue was purified by silica column chromatography to afford 6-(3-aminophenoxy)-5-ethynyl-<i>N</i>-(2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)pyridin-2-amine. LC–MS <i>m</i>/<i>z</i>: 430.20 (M + H)<sup>+</sup>.</div><div class="NLM_p last">Step f: This method is the same as the method in step d mentioned in preparation of compound <b>1</b>. The product was purified by silica gel column chromatography eluting with DCM/MeOH as pale yellow solid (29 mg, 65.3%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.32 (s, 1H), 8.04 (d, <i>J</i> = 8.4 Hz, 1H), 7.89 (s, 1H), 7.61–7.58 (m, 1H), 7.56 (t, <i>J</i> = 2.0 Hz, 1H), 7.40 (t, <i>J</i> = 8.4 Hz, 1H), 7.26 (d, <i>J</i> = 8.8 Hz, 1H), 6.90–6.87 (m, 1H), 6.55 (d, <i>J</i> = 2.8 Hz, 1H), 6.42 (d, <i>J</i> = 8.4 Hz, 1H), 6.42 (dd, <i>J</i> = 16.8, 10.0 Hz, 1H), 6.25 (dd, <i>J</i> = 16.8, 2.0 Hz, 1H), 6.07 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 5.77 (dd, <i>J</i> = 10.0, 2.0 Hz, 1H), 3.79 (s, 3H), 3.03 (t, <i>J</i> = 4.8 Hz, 4H), 2.42 (t, <i>J</i> = 4.8 Hz, 4H), 2.22 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.78, 163.28, 155.56, 152.95, 150.36, 148.21, 145.59, 140.36, 131.68, 129.96, 127.29, 121.87, 119.37, 116.81, 116.76, 116.13, 112.89, 106.23, 99.61, 84.83, 55.85, 54.64, 48.48, 45.81. HRMS C<sub>28</sub>H<sub>30</sub>N<sub>5</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd mass, 484.2349; found, 484.2358.</div></div><div id="sec4_13_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>N</i>-(3-((3-(Dimethylamino)-6-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)pyridin-2-yl)oxy)phenyl)acrylamide (<b>13</b>)</h4><div class="NLM_p last">This compound was prepared according to the preparation of compound <b>22</b> using 3-bromo-2,6-dichloropyridine and 3-nitrophenol as starting materials, and in step b, dimethylamine was used to replace piperidine. The title compound was purified by silica gel column chromatography eluting with DCM/MeOH as a gray solid (14 mg, 46%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.24 (s, 1H), 7.57–7.54 (m, 1H), 7.50 (s, 1H), 7.46 (t, <i>J</i> = 2.4 Hz, 1H), 7.37–7.33 (m, 2H), 7.28 (d, <i>J</i> = 8.4 Hz, 1H), 6.82–6.79 (m, 1H), 6.56 (d, <i>J</i> = 8.4 Hz, 1H), 6.50 (d, <i>J</i> = 2.8 Hz, 1H), 6.41 (dd, <i>J</i> = 16.8, 10.0 Hz, 1H), 6.24 (dd, <i>J</i> = 16.8, 2.0 Hz, 1H), 6.02 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 6.75 (dd, <i>J</i> = 10.0, 2.0 Hz, 1H), 3.75 (s, 3H), 2.97 (t, <i>J</i> = 5.2 Hz, 4H), 2.69 (s, 6H), 2.43 (t, <i>J</i> = 5.2 Hz, 4H), 2.22 (s, 3H). HRMS C<sub>28</sub>H<sub>35</sub>N<sub>6</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd mass, 503.2771; found, 503.2770.</div></div><div id="sec4_13_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>N</i>-(3-((6-((2-Methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-3-(pyrrolidin-1-yl)pyridin-2-yl)oxy)phenyl)acrylamide (<b>14</b>)</h4><div class="NLM_p last">This compound was prepared according to the preparation of <b>22</b> using 3-bromo-2,6-dichloropyridine and 3-nitrophenol as starting materials, and in step b, pyrrolidine was used to replace piperidine. In step b, we obtained a mixture of 6-chloro-2-(3-nitrophenoxy)-3-(pyrrolidin-1-yl)pyridine and 2-chloro-6-(3-nitrophenoxy)pyridine, and in the next three steps, we used the mixture for reactions. In step e, the crude was purified by reverse-phase HPLC eluting with acetonitrile/water (containing 0.15‰ TFA) to afford <b>14</b> (TFA salt, 14 mg) as a brown solid and <b>9</b> (TFA salt, 16 mg) as a brown solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.32 (s, 1H), 9.88 (s, 1H), 7.57 (d, <i>J</i> = 8.4 Hz, 1H), 7.55–7.52 (m, 1H), 7.42–7.36 (m, 2H), 6.91–6.87 (m, 1H), 6.68–6.55 (m, 2H), 6.43 (dd, <i>J</i> = 16.8, 10.0 Hz, 1H), 6.25 (dd, <i>J</i> = 16.8, 2.0 Hz, 1H), 6.11–6.03 (m, 1H), 5.76 (dd, <i>J</i> = 10.0, 2.0 Hz, 1H), 3.79 (s, 3H), 3.66 (bs, 2H), 3.50 (d, <i>J</i> = 12.0 Hz, 2H), 3.12 (bs, 2H), 2.86 (s, 3H), 2.85 (bs, 2H), 2.05–1.97 (m, 4H). HRMS C<sub>30</sub>H<sub>37</sub>N<sub>6</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd mass, 529.2927; found, 529.2923.</div></div><div id="sec4_13_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>N</i>-(3-((6-((2-Methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-3-(piperidin-1-yl)pyridin-2-yl)oxy)phenyl)acrylamide (<b>15</b>)</h4><div class="NLM_p last">This compound was prepared according to the preparation of <b>22</b> using 3-bromo-2,6-dichloropyridine and 3-nitrophenol as starting materials. In step e, the crude was purified by reverse-phase HPLC eluting with acetonitrile/water (containing 0.15‰ TFA) to afford <b>15</b> (TFA salt, 18 mg, 16.4%) as a brown solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.35 (s, 1H), 9.91 (s, 1H), 7.58 (d, <i>J</i> = 8.4 Hz, 2H), 7.40 (t, <i>J</i> = 8.4 Hz, 1H), 7.34 (d, <i>J</i> = 8.4 Hz, 1H), 6.92 (d, <i>J</i> = 8.4 Hz, 1H), 6.63 (d, <i>J</i> = 8.4 Hz, 1H), 6.59 (s, 1H), 6.44 (dd, <i>J</i> = 16.8, 10.0 Hz, 1H), 6.26 (dd, <i>J</i> = 16.8, 2.0 Hz, 1H), 6.05 (d, <i>J</i> = 8.8 Hz, 1H), 5.77 (dd, <i>J</i> = 10.0, 2.0 Hz, 1H), 3.78 (s, 3H), 3.67 (d, <i>J</i> = 13.2 Hz, 2H), 3.51 (d, <i>J</i> = 12.0 Hz, 2H), 3.16–3.09 (m, 2H), 2.86 (s, 3H), 2.84–2.81 (m, 2H), 1.83 (bs, 4H), 1.58 (bs, 2H). HRMS C<sub>31</sub>H<sub>38</sub>N<sub>6</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd mass, 543.3084; found, 543.3133.</div></div><div id="sec4_13_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>N</i>-(3-((3-(Azepan-1-yl)-6-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)pyridin -2-yl)oxy)phenyl)acrylamide (<b>16</b>)</h4><div class="NLM_p last">This compound was prepared according to <a href="/doi/suppl/10.1021/acs.jmedchem.9b00631/suppl_file/jm9b00631_si_001.csv" class="ext-link">Scheme S1, Supporting Information</a>. In step d, the crude was purified by reverse-phase HPLC eluting with acetonitrile/water (containing 0.15‰ TFA) to afford <b>16</b> (TFA salt, 16 mg, 15.0%) as a brown solid. <sup>1</sup>H NMR (400 MHz, MeOD) δ 7.84 (s, 1H), 7.67 (d, <i>J</i> = 8.0 Hz, 1H), 7.40 (t, <i>J</i> = 8.4 Hz, 1H), 7.60 (s, 1H), 7.46 (t, <i>J</i> = 8.0 Hz, 1H), 7.01 (d, <i>J</i> = 8.4 Hz, 1H), 6.60 (bs, 1H), 8.44 (dd, <i>J</i> = 16.8, 9.6 Hz, 1H), 6.37 (dd, <i>J</i> = 16.8, 2.4 Hz, 1H), 6.13 (bs, 1H), 5.80 (dd, <i>J</i> = 9.6, 2.4 Hz, 1H), 3.83 (bs, 4H), 3.59 (d, <i>J</i> = 12.0 Hz, 2H), 3.25–3.19 (m, 2H), 2.97 (s, 3H), 2.13 (bs, 4H), 1.87 (bs, 4H). HRMS C<sub>32</sub>H<sub>41</sub>N<sub>6</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd mass, 557.3240; found, 557.3273.</div></div><div id="sec4_13_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>N</i>-(3-((6-((2-Methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-3-(pyrrolidin-1-yl)pyridin-2-yl)oxy)-2-methylphenyl)acrylamide (<b>17</b>)</h4><div class="NLM_p last">This compound was prepared according to the preparation of compound <b>22</b> using 3-bromo-2,6-dichloropyridine and 2-methyl-3-nitrophenol as starting materials, and in step b, pyrrolidine was used to replace piperidine to afford the title compound as a brown solid (TFA salt, 12 mg, 21.7%). The obtained residue was purified by reverse-phase flash chromatography eluting with MeOH/water (containing 0.15‰ TFA). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.98 (s, 1H), 9.62 (s, 1H), 7.60 (d, <i>J</i> = 8.0 Hz, 1H), 7.30–7.17 (m, 2H), 7.00–6.91 (m, 2H), 6.62 (dd, <i>J</i> = 16.8, 10.0 Hz, 1H), 6.28 (dd, <i>J</i> = 17.2, 2.0 Hz, 1H), 5.78 (dd, <i>J</i> = 10.0, 2.0 Hz, 1H), 3.78 (s, 3H), 3.51 (d, <i>J</i> = 11.6 Hz, 2H), 3.17–3.06 (m, 2H), 2.86 (s, 3H), 2.06 (s, 3H), 1.98 (bs, 4H). HRMS C<sub>31</sub>H<sub>39</sub>N<sub>6</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd mass, 543.3084; found, 543.3085.</div></div><div id="sec4_13_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>N</i>-(3-((6-((2-Methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-3-(pyrrolidin-1-yl)pyridin-2-yl)oxy)-4-methylphenyl)acrylamide (<b>18</b>)</h4><div class="NLM_p last">This compound was prepared according to the preparation method of compound <b>22</b> using 3-bromo-2,6-dichloropyridine and 2-methyl-5-nitrophenol as starting materials; in step b, pyrrolidine was used to replace piperidine to afford the title compound as a brown solid (TFA salt, 13 mg, 20.6%). The product was purified by reverse-phase HPLC eluting with acetonitrile/water (containing 0.15‰ TFA). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.19 (s, 1H), 9.64 (s, 1H), 7.57 (d, <i>J</i> = 8.0 Hz, 1H), 7.39–7.22 (m, 3H), 6.67–6.54 (m, 2H), 6.39 (dd, <i>J</i> = 16.8, 10.0 Hz, 1H), 6.23 (dd, <i>J</i> = 16.8, 2.0 Hz, 1H), 6.04–5.94 (m, 1H), 5.74 (dd, <i>J</i> = 10.0, 2.0 Hz, 1H), 3.77 (s, 3H), 3.51–3.48 (m, 4H), 3.11 (bs, 2H), 2.87–2.79 (m, 5H), 2.09 (s, 3H), 1.97 (bs, 4H). HRMS C<sub>31</sub>H<sub>38</sub>N<sub>6</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd mass, 543.3084; found, 543.3091.</div></div><div id="sec4_13_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>N</i>-(5-((6-((2-Methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-3-(pyrrolidin-1-yl)pyridin-2-yl)oxy)-2-methylphenyl)acrylamide (<b>19</b>)</h4><div class="NLM_p last">This compound was prepared according to the preparation of compound <b>22</b> using pyrrolidine to replace piperidine in step b to afford the title compound as a gray solid (25 mg, 50.4%). The title compound was purified by reverse-phase flash chromatography eluting with acetonitrile/water. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.46 (s, 1H), 7.37–7.33 (m, 2H), 7.22 (d, <i>J</i> = 8.4 Hz, 1H), 7.12 (d, <i>J</i> = 8.4 Hz, 1H), 6.80 (dd, <i>J</i> = 8.0, 2.4 Hz, 1H), 6.57 (dd, <i>J</i> = 16.8, 10.0 Hz, 1H), 6.54 (d, <i>J</i> = 8.8 Hz, 1H), 6.51 (d, <i>J</i> = 2.4 Hz, 1H), 6.22 (dd, <i>J</i> = 17.2, 2.0 Hz, 1H), 6.05 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 5.73 (dd, <i>J</i> = 10.0, 2.0 Hz, 1H), 3.76 (s, 3H), 3.17 (t, <i>J</i> = 6.4 Hz, 4H), 2.99 (t, <i>J</i> = 5.2 Hz, 4H), 2.43 (t, <i>J</i> = 5.2 Hz, 4H), 2.25 (s, 3H), 2.21 (s, 3H), 1.86–1.83 (m, 4H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.16, 153.10, 150.71, 149.04, 147.18, 145.64, 136.92, 131.75, 130.79, 127.01, 126.79, 125.96, 125.66, 123.41, 118.81, 117.32, 116.02, 106.90, 140.51, 100.43, 55.49, 54.81, 50.09, 49.19, 45.82, 24.18, 17.49. HRMS C<sub>31</sub>H<sub>39</sub>N<sub>6</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd mass, 543.3084; found, 543.3088.</div></div><div id="sec4_13_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>N</i>-(2-Methoxy-5-((6-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-3-(pyrrolidin-1-yl)pyridin-2-yl)oxy)phenyl)acrylamide (<b>20</b>)</h4><div class="NLM_p last">This compound was prepared according to the preparation of compound <b>22</b> using 3-bromo-2,6-dichloropyridine and 4-methoxy-3-nitrophenol as the starting material; in step b, pyrrolidine was used to replace the piperidine to afford the title compound as a gray solid (TFA salt, 8 mg, 11.4%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.64 (s, 1H), 9.48 (s, 1H), 8.08–8.03 (m, 1H), 7.45–7.38 (m, 1H), 7.12–7.08 (m, 1H), 6.90–6.85 (m, 1H), 6.75 (dd, <i>J</i> = 17.2, 10.0 Hz, 1H), 6.61–6.55 (m, 2H), 6.20 (dd, <i>J</i> = 17.2, 2.0 Hz, 1H), 6.08–6.03 (m, 1H), 5.72 (dd, <i>J</i> = 10.0, 2.0 Hz, 1H), 3.89 (s, 3H), 3.77 (s, 3H), 3.66 (bs, 4H), 3.49 (bs, 4H), 3.17–3.12 (m, 2H), 2.80–2.87 (m, 5H), 1.96 (bs, 4H). HRMS C<sub>31</sub>H<sub>39</sub>N<sub>6</sub>O<sub>4</sub> (M + H)<sup>+</sup> calcd mass, 559.3033; found, 559.3047.</div></div><div id="sec4_13_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>N</i>-(5-((3-(3-Hydroxypyrrolidin-1-yl)-6-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)pyridin-2-yl)oxy)-2-methylphenyl)acrylamide (<b>21</b>)</h4><div class="NLM_p">(±)-3-(<i>tert</i>-Butyldimethylsilyloxy)pyrrolidine hydrochloride was prepared following the reference: Tetrahedron, 2012, 68, 7295–7301.</div><div class="NLM_p"><i>N</i>-(5-((3-(3-((<i>tert</i>-Butyldimethylsilyl)oxy)pyrrolidin-1-yl)-6-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)pyridin-2-yl)oxy)-2-methylphenyl)acrylamide (<b>54a</b>) was prepared according to the preparation method of compound <b>22</b> using (±)-3-(<i>tert</i>-butyldimethylsilyloxy)pyrrolidine hydrochloride to replace piperidine in step b.</div><div class="NLM_p last">To a solution of <i>N</i>-(5-((3-(3-((<i>tert</i>-butyldimethylsilyl)oxy)pyrrolidin-1-yl)-6-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)pyridin-2-yl)oxy)-2-methylphenyl)acrylamide (<b>54a</b>) (1 equiv) in THF was added TBAF (1 M THF solution, 5 equiv) on an ice bath, which was stirred for 4 h at RT. Water was added to the reaction solution, which was then extracted with ethyl acetate three times. The extract was dried over anhydrous sodium sulfate, and the solvent was evaporated under reduced pressure. The obtained residue was purified by reverse-phase flash chromatography eluting with acetonitrile/water to give the title compound (68 mg, yield: 41.8% over the last two steps) as a brown solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.72 (s, 1H), 7.43 (d, <i>J</i> = 8.4 Hz, 1H), 7.20–7.18 (m, 2H), 7.04 (d, <i>J</i> = 8.4 Hz, 1H), 6.92 (d, <i>J</i> = 8.0 Hz, 1H), 6.49–6.48 (m, 2H), 6.42 (d, <i>J</i> = 8.4 Hz, 1H), 6.41–6.36 (m, 2H), 6.29–6.22 (m, 2H), 5.75–5.73 (m, 1H), 4.48–4.45 (m, 1H), 3.80 (s, 3H), 3.59–3.53 (m, 1H), 3.49–3.45 (m, 1H), 3.29–3.25 (m, 1H), 3.16–3.13 (m, 1H), 3.10 (t, <i>J</i> = 5.6 Hz, 4H), 2.59 (t, <i>J</i> = 5.2 Hz, 4H), 2.36 (s, 3H), 2.28 (s, 3H), 2.23–2.14 (m, 2H), 1.96–1.89 (m, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 163.80, 155.59, 153.58, 152.01, 149.20, 147.30, 146.00, 136.13, 131.11, 130.90, 127.78, 127.07, 126.83, 124.74, 118.46, 118.13, 116.03, 108.37, 103.59, 101.23, 71.05, 59.66, 55.63, 55.24, 50.48, 48.64, 46.11, 34.29, 17.46. HRMS C<sub>31</sub>H<sub>38</sub>N<sub>6</sub>O<sub>4</sub> (M + H)<sup>+</sup> calcd mass, 559.3033; found, 559.3017.</div></div><div id="sec4_13_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>N</i>-(5-((6-((2-Methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-3-(piperidin-1-yl) pyridin-2-yl)oxy)-2-methylphenyl)acrylamide (<b>22</b>)</h4><div id="sec4_13_22_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> Step a: 3-Bromo-6-chloro-2-(4-methyl-3-nitrophenoxy)pyridine (<b>47d</b>)</h5><div class="NLM_p last">Cesium carbonate (14.4 g, 44.07 mmol) and 3-bromo-2,6-dichloropyridine (5.0 g, 22.04 mmol) were added to the solution of 4-methyl-3-nitrophenol (3.4 g, 22.04 mmol) in anhydrous DMF (50 mL). The reaction mixture was heated to 90 °C for 8 h. The reaction mixture was filtered, and the filtrate was diluted with ethyl acetate and washed with brine three times. The organic layer was dried over anhydrous sodium sulfate and concentrated in vacuo, and the crude product was purified by silica gel chromatography to afford 5.31 g of a white solid (yield: 70%). <sup>1</sup>H NMR 400 MHz (DMSO-<i>d</i><sub>6</sub>) δ 8.26 (d, <i>J</i> = 8.0 Hz, 1H), 7.91 (d, <i>J</i> = 2.4 Hz, 1H), 7.60–7.53 (m, 2H), 7.27 (d, <i>J</i> = 8.0 Hz, 1H), 2.53 (s, 3H); LC–MS <i>m</i>/<i>z</i>: 343.03 (M + H)<sup>+</sup>.</div></div><div id="sec4_13_22_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> Step b: 6-Chloro-2-(4-methyl-3-nitrophenoxy)-3-(piperidin-1-yl)pyridine (<b>51b</b>)</h5><div class="NLM_p last">Piperidine (94 mg, 1.10 mmol) in anhydrous toluene (5 mL) was treated with 3-bromo-6-chloro-2-(4-methyl-3-nitrophenoxy)pyridine (345 mg, 1.00 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (95 mg, 0.10 mmol), BINAP (65 mg, 0.10 mmol), and cesium carbonate (491 mg, 1.51 mmol). The reaction mixture was heated to 100 °C overnight in the absence of light. The mixture was allowed to cool to ambient temperature, diluted with ethyl acetate, washed with brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel chromatography to provide the title compound (110 mg, 31%) as a brown oil. <sup>1</sup>H NMR 400 MHz (CDCl<sub>3</sub>) δ 7.79 (d, <i>J</i> = 2.0 Hz, 1H), 7.34–7.33 (m, 2H), 7.24–7.22 (m, 1H), 7.02 (d, <i>J</i> = 8.0 Hz, 1H), 3.05 (t, <i>J</i> = 4.2 Hz, 4H), 2.61 (s, 3H), 1.72–1.69 (m, 4H), 1.61–1.56 (m, 2H). LC–MS <i>m</i>/<i>z</i>: 348.28 (M + H)<sup>+</sup>.</div></div><div id="sec4_13_22_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> Step c: <i>N</i>-(2-Methoxy-4-(4-methylpiperazin-1-yl)phenyl)-6-(4-methyl-3-nitrophenoxy)-5-(piperidin-1-yl)pyridin-2-amine (<b>52b</b>)</h5><div class="NLM_p last">An anhydrous dioxane solution (2 mL) of 6-chloro-2-(4-methyl-3-nitrophenoxy)-3-(piperidin-1-yl)pyridine (100 mg, 0.29 mmol), Pd(OAc)<sub>2</sub> (6.5 mg, 0.029 mmol), BINAP (27 mg, 0.043 mmol), cesium carbonate (141 mg, 0.43 mmol), and 2-methoxy-4-(4-methylpiperazin-1-yl)aniline (70 mg, 0.32 mmol) was added into a 5 mL microwave reaction vessel and capped. The reaction mixture was reacted at 130 °C for 1 h using a Biotage optimizer reactor. Water and ethyl acetate were added to the reaction solution and separated, and then the aqueous phase was extracted with ethyl acetate two times. The combined organic phase was washed with saturated brine, then dried over anhydrous sodium sulfate. The organic phase was filtered off and then concentrated under reduced pressure. The obtained residue was purified by silica gel chromatography to afford a brown solid (69 mg, 45%). <sup>1</sup>H NMR 400 MHz (DMSO-<i>d</i><sub>6</sub>) δ 7.73 (d, <i>J</i> = 2.4 Hz, 1H), 7.61 (s, 1H), 7.54 (d, <i>J</i> = 8.8 Hz, 1H), 7.40 (dd, <i>J</i> = 8.4, 4.2 Hz, 1H), 7.31 (d, <i>J</i> = 8.4 Hz, 1H), 7.18 (d, <i>J</i> = 8.8 Hz, 1H), 6.56 (d, <i>J</i> = 8.4 Hz, 1H), 6.51 (d, <i>J</i> = 2.8 Hz, 1H), 5.98 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 3.75 (s, 3H), 3.01 (t, <i>J</i> = 5.2 Hz, 4H), 2.90 (t, <i>J</i> = 5.2 Hz, 4H), 2.55 (s, 3H), 2.44 (t, <i>J</i> = 4.8 Hz, 4H), 2.22 (s, 3H), 1.62–1.56 (m, 4H), 1.50–1.45 (m, 2H). LC–MS <i>m</i>/<i>z</i>: 533.42 (M + H)<sup>+</sup>.</div></div><div id="sec4_13_22_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> Step d: 6-(3-Amino-4-methylphenoxy)-<i>N</i>-(2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)-5(piperidin-1-yl)pyridin-2-amine (<b>53b</b>)</h5><div class="NLM_p last">Platinum(IV) oxide (6 mg) was added to the solution of <i>N</i>-(2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)-6-(4-methyl-3-nitrophenoxy)-5-(piperidin-1-yl)pyridin-2-amine (60 mg, 0.11 mmol) in MeOH/THF (2/2 mL). The reaction mixture was stirred at RT overnight under a hydrogen atmosphere. The reaction mixture was filtrated through celite and concentrated to afford the crude product, which was used without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.42 (s, 1H), 7.42 (d, <i>J</i> = 8.8 Hz, 1H), 7.21 (d, <i>J</i> = 8.4 Hz, 1H), 6.91 (d, <i>J</i> = 8.8 Hz, 1H), 6.51 (d, <i>J</i> = 2.8 Hz, 1H), 6.46 (d, <i>J</i> = 8.4 Hz, 1H), 6.33 (d, <i>J</i> = 2.4 Hz, 1H), 6.17 (dd, <i>J</i> = 2.4, 8.0 Hz, 1H), 6.04 (dd, <i>J</i> = 2.8, 8.8 Hz, 1H), 4.92 (s, 2H), 3.76 (s, 3H), 3.02 (t, <i>J</i> = 4.8 Hz, 4H), 2.90 (t, <i>J</i> = 4.8 Hz, 4H), 2.26 (s, 3H), 2.08 (s, 3H), 1.64–1.59 (m, 4H), 1.51–1.46 (m, 2H). LC–MS <i>m</i>/<i>z</i>: 503.32 (M + H)<sup>+</sup>.</div></div><div id="sec4_13_22_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> Step e: <i>N</i>-(5-((6-((2-Methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-3-(piperidin-1-yl)pyridin-2-yl)oxy)-2-methylphenyl)acrylamide (<b>22</b>)</h5><div class="NLM_p last">Acryloyl chloride (8 mg, 0.088 mmol) was added dropwise to a solution of 6-(3-amino-4-methylphenoxy)-<i>N</i>-(2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)-5(piperidin-1-yl)pyridin-2-amine (40 mg, 0.08 mmol) and TEA (17 μL, 0.12 mmol) in anhydrous DCM (2 mL) at 0 °C. The reaction mixture was stirred at 0 °C for 1 h. Water and DCM were added to the reaction solution and separated, and the aqueous phase was extracted with DCM twice. The combined organic phase was washed with saturated brine, then dried over anhydrous sodium sulfate. The organic phase was filtered off and then concentrated under reduced pressure. The obtained residue was dissolved in DCM (2 mL); TFA (0.25 mL) was added and stirred at RT for 30 min to afford the TFA salt of the title compound. DCM and excess TFA were removed in vacuo; then, the residue was dissolved in MeOH and purified by reverse-phase HPLC eluting with acetonitrile/water (containing 0.15‰ TFA). Fractions containing the product were concentrated in vacuo to remove the solvent to give the title compound (TFA salt, 15 mg, 24%) as a gray solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.71 (s, 1H), 7.39 (d, <i>J</i> = 8.8 Hz, 1H), 7.33–7.31 (m, 1H), 7.18 (d, <i>J</i> = 8.8 Hz, 1H), 7.17 (d, <i>J</i> = 8.4 Hz, 1H), 6.95 (d, <i>J</i> = 8.4 Hz, 1H), 6.45 (d, <i>J</i> = 2.8 Hz, 1H), 6.43 (s, 1H), 6.38–6.34 (m, 2H), 6.25 (dd, <i>J</i> = 16.8, 10.0 Hz, 1H), 6.19 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 5.69 (d, <i>J</i> = 10.0 Hz, 1H), 3.76 (s, 3H), 3.09 (t, <i>J</i> = 5.2 Hz, 4H), 2.96 (t, <i>J</i> = 5.2 Hz, 4H), 2.58 (t, <i>J</i> = 4.8 Hz, 4H), 2.34 (s, 3H), 2.27 (s, 3H), 1.72–1.68 (m, 4H), 1.54–1.48 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 163.46, 155.18, 153.47, 149.17, 148.86, 146.05, 136.11, 131.19, 130.73, 130.06, 129.13, 127.65, 124.68, 124.43, 119.07, 118.82, 116.63, 108.18, 102.66, 101.08, 55.59, 55.25, 52.58, 50.44, 46.11, 26.32, 24.32, 17.51. HRMS C<sub>32</sub>H<sub>40</sub>N<sub>6</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd mass, 557.3240; found, 557.3245.</div></div></div><div id="sec4_13_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> <i>N</i>-(5-((3-(3-Hydroxypiperidin-1-yl)-6-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)pyridin-2-yl)oxy)-2-methylphenyl)acrylamide (<b>23</b>)</h4><div class="NLM_p">(±)3-((<i>tert</i>-Butyldimethylsilyl)oxy)piperidine was prepared according to methods mentioned in preparation of (±)-3-(<i>tert</i>-butyldimethylsilyloxy)pyrrolidine hydrochloride in compound <b>21</b>.</div><div class="NLM_p last">Compound <b>23</b> was prepared according to the method of preparation of compound <b>21</b> using (±)3-((<i>tert</i>-butyldimethylsilyl)oxy)piperidine to replace (±)-3-(<i>tert</i>-butyldimethylsilyloxy)pyrrolidine in step b and purified by reverse-phase flash chromatography eluting with acetonitrile/water as a white solid (49 mg, 36.1% over the last two steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.79 (s, 1H), 7.44 (d, <i>J</i> = 8.8 Hz, 1H), 7.21–7.18 (m, 2H), 7.11 (s, 1H), 6.91 (d, <i>J</i> = 8.4 Hz, 1H), 6.49–6.47 (m, 2H), 6.42–6.37 (m, 2H), 6.30–6.23 (m, 2H), 5.75 (d, <i>J</i> = 10.0, 1H), 3.89–3.87 (m, 1H), 3.81 (s, 3H), 3.12 (bs, 4H), 3.04–3.01 (m, 3H), 2.87 (t, <i>J</i> = 10.4 Hz, 1H), 2.61 (t, <i>J</i> = 5.2 Hz, 4H), 2.37 (s, 3H), 2.31 (s, 3H), 1.93–1.87 (m, 1H), 1.72–1.58 (m, 4H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 163.59, 155.34, 153.55, 149.87, 149.60, 146.52, 136.17, 131.48, 131.16, 130.86, 128.28, 127.88, 124.43, 124.06, 119.48, 118.06, 115.81, 108.28, 102.99, 101.11, 66.18, 58.74, 55.67, 55.27, 52.11, 50.42, 46.15, 31.47, 21.97, 17.47. HRMS C<sub>32</sub>H<sub>40</sub>N<sub>6</sub>O<sub>4</sub> (M + H)<sup>+</sup> calcd mass, 573.3189; found, 573.3195.</div></div><div id="sec4_13_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> <i>N</i>-(5-((6-((2-Methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-3-morpholinopyridin-2-yl)oxy)-2-methylphenyl)acrylamide (<b>24</b>)</h4><div class="NLM_p last">This compound was prepared according to the preparation method of compound <b>22</b> using morpholine to replace piperidine in step b to afford the title compound as a gray solid (23 mg, 59.4%). The product was purified by silica gel column chromatography eluting with DCM/MeOH. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.46 (s, 1H), 7.53 (s, 1H), 7.39 (s, 1H), 7.32–7.23 (m, 3H), 6.83 (dd, <i>J</i> = 8.4, 2.8 Hz, 1H), 6.58 (dd, <i>J</i> = 17.6, 10.8 Hz, 1H), 6.53–6.51 (m, 2H), 6.21 (dd, <i>J</i> = 17.2, 2.0 Hz, 1H), 6.02 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 5.73 (dd, <i>J</i> = 10.4, 2.0 Hz, 1H), 3.75 (s, 3H), 3.70 (t, <i>J</i> = 4.8 Hz, 4H), 3.02 (bs, 4H), 2.95 (t, <i>J</i> = 4.8 Hz, 4H), 2.46 (bs, 4H), 2.27 (s, 3H), 2.24 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.19, 154.21, 152.47, 149.70, 149.41, 146.02, 136.93, 131.74, 130.78, 130.27, 126.83, 126.08, 122.71, 119.77, 118.20, 116.77, 106.74, 103.80, 100.32, 66.41, 55.50, 54.72, 50.98, 48.99, 45.71, 17.52. HRMS C<sub>31</sub>H<sub>38</sub>N<sub>6</sub>O<sub>4</sub> (M + H)<sup>+</sup> calcd mass, 559.3033; found, 559.3063.</div></div><div id="sec4_13_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> <i>N</i>-(5-((6-((2-Methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-3-(4-methylpiperazin-1-yl)pyridin-2-yl)oxy)-2-methylphenyl)acrylamide (<b>25</b>)</h4><div class="NLM_p last">This compound was prepared according to the preparation method of compound <b>22</b> using 1-methylpiperazine to replace piperidine in step b to afford the title compound as a brown solid (TFA salt, 18 mg, 19.4%). The product was purified by reverse-phase HPLC eluting with acetonitrile/water (containing 0.15‰ TFA). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.53 (s, 1H), 7.73 (s, 1H), 7.41–7.34 (m, 3H), 7.26 (d, <i>J</i> = 8.4 Hz, 1H), 6.86 (dd, <i>J</i> = 8.4, 2.8 Hz, 1H), 6.59–6.57 (m, 2H), 6.58 (dd, <i>J</i> = 17.2, 10.0 Hz, 1H), 6.22 (dd, <i>J</i> = 17.2, 2.0 Hz, 1H), 6.06 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 5.74 (dd, <i>J</i> = 10.4, 2.4 Hz, 1H), 3.77 (s, 3H), 3.67 (bs, 2H), 3.51–3.48 (m, 4H), 3.19–3.14 (m, 4H), 3.03–2.97 (m, 4H), 2.90–2.81 (m, 2H), 2.86 (s, 3H), 2.85 (s, 3H), 2.27 (s, 3H). HRMS C<sub>32</sub>H<sub>42</sub>N<sub>7</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd mass, 572.3349; found, 572.3361.</div></div><div id="sec4_13_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> <i>N</i>-(5-((6-((2-Methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-3-phenylpyridin-2-yl)oxy)-2-methylphenyl)acrylamide (<b>26</b>)</h4><div class="NLM_p">Step a: Tetrakistriphenylphosphine palladium (116 mg, 0.1 mmol), phenylboronic acid (146 mg, 1.2 mmol), and a 2 M sodium carbonate solution (1 mL) were sequentially added to a solution of 3-bromo-6-chloro-2-(4-methyl-3-nitrophenoxy)pyridine (<b>47d</b>) (344 mg, 1 mmol) in 1,2-dimethoxyethane (5 mL) in a nitrogen atmosphere, and the mixture was stirred at 80 °C for 8 h. Water was added to the reaction solution at RT, followed by extraction with ethyl acetate three times. The combined organic phase was washed with brine, dried over anhydrous sodium sulfate, and filtered. The solvent was then evaporated under reduced pressure. The resulting residue was purified by silica gel column chromatography to give the title product (304 mg, yield: 89%). 6-Chloro-2-(4-methyl-3-nitrophenoxy)-3-phenylpyridine (<b>51f</b>). LC–MS <i>m</i>/<i>z</i>: 341.23 (M + H)<sup>+</sup>.</div><div class="NLM_p">Steps b–d are the same as those in the method mentioned in preparation of compound <b>22</b>.</div><div class="NLM_p last">The product was purified by silica gel column chromatography eluting with DCM/MeOH as a gray solid (22 mg, 58.4%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.54 (s, 1H), 8.10 (s, 1H), 7.67–7.60 (m, 3H), 7.45–7.38 (m, 4H), 7.30–7.24 (m, 2H), 6.88 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 6.70 (d, <i>J</i> = 8.4 Hz, 1H), 6.62 (d, <i>J</i> = 2.4 Hz, 1H), 6.57 (dd, <i>J</i> = 16.8, 10.0 Hz, 1H), 6.22 (dd, <i>J</i> = 16.8, 2.0 Hz, 1H), 6.10 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 5.74 (dd, <i>J</i> = 10.0, 2.0 Hz, 1H), 3.80 (s, 3H), 3.72 (d, <i>J</i> = 12.8 Hz, 2H), 3.52 (d, <i>J</i> = 12.0 Hz, 2H), 3.19–3.11 (m, 2H), 2.90 (d, <i>J</i> = 12.0 Hz, 2H), 2.86 (s, 3H), 2.26 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.15, 158.30, 158.15, 157.98, 154.01, 152.53, 149.94, 144.89, 140.60, 137.00, 136.67, 131.72, 130.88, 128.45, 128.28, 126.87, 126.58, 126.38, 122.85, 120.87, 118.43, 116.97, 111.96, 107.14, 104.96, 100.89, 55.70, 52.41, 46.44, 42.11, 17.62. HRMS C<sub>33</sub>H<sub>35</sub>N<sub>5</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd mass, 550.2818; found, 550.2834.</div></div><div id="sec4_13_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> <i>N</i>-(2-Methyl-5-((6-((4-(4-methylpiperazin-1-yl)phenyl)amino)-3-(piperidin-1-yl)pyridin-2-yl)oxy)phenyl)acrylamide (<b>27</b>)</h4><div class="NLM_p last">This compound was prepared according to the preparation method of compound <b>22</b> using 4-(4-methylpiperazin-1-yl)aniline in step c. The product was purified by reverse-phase HPLC eluting with acetonitrile/water (containing 0.15‰ TFA) as a gray solid (TFA salt, 13 mg, 11.6%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.85 (s, 1H), 9.58 (s, 1H), 7.49 (s, 1H), 7.31 (d, <i>J</i> = 8.4 Hz, 1H), 7.12 (d, <i>J</i> = 8.4 Hz, 2H), 6.95 (d, <i>J</i> = 8.4 Hz, 1H), 6.64 (d, <i>J</i> = 8.8 Hz, 2H), 6.58 (dd, <i>J</i> = 16.8, 10.0 Hz, 1H), 6.46 (d, <i>J</i> = 8.4 Hz, 1H), 6.22 (dd, <i>J</i> = 16.8, 2.0 Hz, 1H), 5.75 (dd, <i>J</i> = 10.0, 2.0 Hz, 1H), 3.61 (d, <i>J</i> = 12.8 Hz, 2H), 3.51 (d, <i>J</i> = 12.0 Hz, 2H), 3.18–3.10 (m, 2H), 2.86–2.80 (m, 5H), 2.30 (s, 3H), 1.81 (bs, 4H), 1.57 (bs, 2H). HRMS C<sub>31</sub>H<sub>39</sub>N<sub>6</sub>O<sub>2</sub> (M + H)<sup>+</sup> calcd mass, 527.3134; found, 527.3146.</div></div><div id="sec4_13_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> <i>N</i>-(5-((6-((2-Methoxy-6-(4-methylpiperazin-1-yl)pyridin-3-yl)amino)-3-(piperidin-1-yl)pyridin-2-yl)oxy)-2-methylphenyl)acrylamide (<b>28</b>)</h4><div class="NLM_p">2-Methoxy-6-(4-methylpiperazin-1-yl)pyridin-3-amine (<b>55b</b>) was prepared following the patent: CN105218561, 2016.</div><div class="NLM_p last">Compound <b>28</b> was prepared according to the preparation method of <b>22</b> using 2-methoxy-6-(4-methylpiperazin-1-yl)pyridin-3-amine in step c. The product was purified by reverse-phase flash chromatography eluting with MeOH/water (containing 0.15‰ TFA) as a gray solid (TFA salt, 19 mg, 18.7%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.81 (d, <i>J</i> = 8.8 Hz, 1H), 7.66 (d, <i>J</i> = 8.4 Hz, 1H), 7.45 (d, <i>J</i> = 2.4 Hz, 1H), 7.35 (d, <i>J</i> = 8.4 Hz, 1H), 7.02 (dd, <i>J</i> = 8.0, 2.4 Hz, 1H), 6.57 (d, <i>J</i> = 8.0 Hz, 1H), 6.54 (dd, <i>J</i> = 16.8, 10.0 Hz, 1H), 6.36 (dd, <i>J</i> = 16.8, 1.6 Hz, 1H), 6.00 (d, <i>J</i> = 8.8 Hz, 1H), 5.80 (dd, <i>J</i> = 10.0, 1.6 Hz, 1H), 4.33 (bs, 2H), 3.90 (s, 3H), 3.72 (bs, 4H), 3.58 (bs, 2H), 3.13 (bs, 4H), 2.95 (s, 3H), 2.36 (s, 3H), 2.06 (bs, 4H), 1.79 (bs, 2H). HRMS C<sub>31</sub>H<sub>40</sub>N<sub>7</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd mass, 558.3193; found, 558.3222.</div></div><div id="sec4_13_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> <i>N</i>-(5-((6-((4-(4-Acetylpiperazin-1-yl)-2-methoxyphenyl)amino)-3-(piperidin-1-yl)pyridin-2-yl)oxy)-2-methylphenyl)acrylamide (<b>29</b>)</h4><div class="NLM_p last">This compound was prepared according to the preparation method of <b>22</b> using 1-(4-(4-amino-3-methoxyphenyl)piperazin-1-yl)ethan-1-one in step c. The product was purified by reverse-phase flash chromatography eluting MeOH/water (containing 0.15‰ TFA) as a gray solid (TFA salt, 25 mg, 31.6%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.51 (s, 1H), 7.58 (s, 1H), 7.30 (d, <i>J</i> = 8.4 Hz, 1H), 7.26–7.23 (m, 1H), 6.96 (s, 1H), 6.64–6.57 (m, 2H), 6.61 (dd, <i>J</i> = 16.8, 10.0 Hz, 1H), 6.23 (dd, <i>J</i> = 17.2, 2.0 Hz, 1H), 6.06 (d, <i>J</i> = 8.0 Hz, 1H), 5.76 (dd, <i>J</i> = 10.0, 2.0 Hz, 1H), 3.77 (s, 3H), 3.57–3.55 (m, 4H), 3.06–3.01 (m, 4H), 2.30 (s, 3H), 2.05 (s, 3H), 1.88 (bs, 4H), 1.53 (bs, 2H). HRMS C<sub>33</sub>H<sub>41</sub>N<sub>6</sub>O<sub>4</sub> (M + H)<sup>+</sup> calcd mass, 585.3189; found, 585.3220.</div></div><div id="sec4_13_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> <i>N</i>-(5-((6-((4-(4-(Dimethylamino)piperidin-1-yl)-2-methoxyphenyl)amino)-3-(piperidin-1-yl)pyridin-2-yl)oxy)-2-methylphenyl)acrylamide (<b>30</b>)</h4><div class="NLM_p">1-(4-Amino-3-methoxyphenyl)-<i>N</i>,<i>N</i>-dimethylpiperidin-4-amine (<b>55d</b>) was prepared following the patent: CN106905245, 2017.</div><div class="NLM_p last">Compound <b>30</b> was prepared according to the preparation method of <b>22</b> using 1-(4-amino-3-methoxyphenyl)-<i>N</i>,<i>N</i>-dimethylpiperidin-4-amine (<b>55d</b>) in step c to afford the title compound (TFA salt, 22 mg, 20.5%) as a gray solid. The product was purified by reverse-phase flash chromatography eluting with MeOH/water (containing 0.15‰ TFA). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.91 (s, 1H), 9.56 (s, 1H), 7.52 (s, 1H), 7.30 (d, <i>J</i> = 8.4 Hz, 1H), 7.26–7.24 (m, 1H), 6.95 (d, <i>J</i> = 8.4 Hz, 1H), 6.61 (dd, <i>J</i> = 17.2, 10.0 Hz, 1H), 6.61–6.57 (m, 2H), 6.23 (dd, <i>J</i> = 17.2, 2.0 Hz, 1H), 6.10 (d, <i>J</i> = 8.4 Hz, 1H), 5.76 (dd, <i>J</i> = 10.0, 2.0 Hz, 1H), 3.77 (s, 3H), 3.72–3.69 (m, 4H), 3.30–3.24 (m, 3H), 2.78 (s, 3H), 2.77 (s, 3H), 2.66 (bs, 2H), 2.30 (s, 3H), 2.09–2.06 (m, 2H), 1.86–1.73 (m, 6H), 1.55 (bs, 2H). HRMS C<sub>34</sub>H<sub>45</sub>N<sub>6</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd mass, 585.3553; found, 585.3608.</div></div><div id="sec4_13_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> <i>N</i>-(5-((6-((5-(4-(Dimethylamino)piperidin-1-yl)pyridin-2-yl)amino)-3-(piperidin-1-yl)pyridin-2-yl)oxy)-2-methylphenyl)acrylamide (<b>31</b>)</h4><div class="NLM_p">5-(4-(Dimethylamino)piperidin-1-yl)pyridin-2-amine (<b>55e</b>) was prepared following the reference: J. Med. Chem., 2017, 60, 1892–1915.</div><div class="NLM_p last">Compound <b>31</b> was prepared according to the preparation method of <b>22</b> using 5-(4-(dimethylamino)piperidin-1-yl)pyridin-2-amine (<b>55e</b>) in step c to afford the title compound (TFA salt, 32 mg, 14%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.79 (s, 1H), 9.76 (s, 1H), 7.72–7.64 (m, 2H), 7.46–7.45 (m, 1H), 7.43 (d, <i>J</i> = 8.4 Hz, 1H), 7.22 (d, <i>J</i> = 9.6 Hz, 1H), 7.04 (dd, <i>J</i> = 8.0, 2.4 Hz, 1H), 6.92 (d, <i>J</i> = 8.8 Hz, 1H), 6.55 (dd, <i>J</i> = 17.2, 10.0 Hz, 1H), 6.22 (dd, <i>J</i> = 17.2, 2.0 Hz, 1H), 5.77 (dd, <i>J</i> = 10.0, 2.0 Hz, 1H), 3.69 (d, <i>J</i> = 8.8 Hz, 2H), 3.34–3.27 (m, 1H), 3.14 (bs, 4H), 2.80 (s, 3H), 2.78 (s, 3H), 2.66 (t, <i>J</i> = 12.0 Hz, 2H), 2.31 (s, 3H), 2.07 (d, <i>J</i> = 12.0 Hz, 2H), 1.75–1.64 (m, 6H), 1.58 (bs, 2H). HRMS C<sub>34</sub>H<sub>45</sub>N<sub>6</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd mass, 556.3400; found, 556.3466.</div></div><div id="sec4_13_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> <i>N</i>-(5-((6-((2-Methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-3-(pyrrolidin-1-yl)pyridin-2-yl)oxy)-2-(trifluoromethyl)phenyl)acrylamide (<b>32</b>)</h4><div class="NLM_p">Step a: This is according to the method of step a mentioned in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. 3-Bromo-6-chloro-2-(3-nitro-4-(trifluoromethyl)phenoxy)pyridine (<b>59</b>), LC–MS <i>m</i>/<i>z</i>: 396.90 (M + H)<sup>+</sup>.</div><div class="NLM_p">Step b: This is according to the method of step c mentioned in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. 5-((3-Bromo-6-chloropyridin-2-yl)oxy)-2-(trifluoromethyl)aniline (<b>60</b>), LC–MS <i>m</i>/<i>z</i>: 367.08 (M + H)<sup>+</sup>.</div><div class="NLM_p">Step c: 5-((3-Bromo-6-chloropyridin-2-yl)oxy)-2-(trifluoromethyl)aniline (<b>60</b>) (284 mg, 0.77 mmol) was dissolved in THF (4 mL), (Boc)<sub>2</sub>O (387 mg, 1.78 mmol), and DMAP (9 mg, 0.077 mmol), and TEA (195 mg, 1.93 mmol) was added; the reaction mixture was stirred at RT overnight. The solvent was removed under reduced pressure, and the residue was partitioned between DCM and saturated aqueous sodium bicarbonate solution. The aqueous phase was extracted with DCM three times. The combined organic phase was dried over anhydrous sodium sulfate and concentrated in vacuo. The residue was purified by silica gel chromatography to afford the solid product (235 mg, yield: 65%). <i>tert</i>-Butyl (5-((3-bromo-6-chloropyridin-2-yl)oxy)-2-(trifluoromethyl)phenyl)carbamate (<b>61</b>), LC–MS <i>m</i>/<i>z</i>: 467.35 (M + H)<sup>+</sup>.</div><div class="NLM_p">Steps d and e: This is according to the method of steps b and c mentioned in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. 6-(3-Aminophenoxy)-<i>N</i>-(2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)-5-(pyrrolidin-1-yl)pyridin-2-amine (<b>63a</b>). LC–MS <i>m</i>/<i>z</i>: 643.02 (M + H)<sup>+</sup>.</div><div class="NLM_p">Step f: <i>tert</i>-Butyl(3-((6-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-3-(pyrrolidin-1-yl)pyridin-2-yl)oxy)phenyl)carbamate (<b>63a</b>) was dissolved in DCM/TFA (2:1); the reaction mixture was stirred at RT for 2 h. The solvent and excess TFA were removed in vacuo. The crude product was used for next transformation without further purification. 6-(3-Amino-4-(trifluoromethyl)phenoxy)-<i>N</i>-(2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)-5-(pyrrolidin-1-yl)pyridin-2-amine (<b>64a</b>). LC–MS <i>m</i>/<i>z</i>: 542.58 (M + H)<sup>+</sup>.</div><div class="NLM_p last">Step g: This is according to the method of step e mentioned in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. The crude product was purified by silica gel column chromatography eluting with DCM/MeOH to afford the product as a gray solid (16 mg, 29%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.76 (s, 1H), 7.75 (d, <i>J</i> = 8.8 Hz, 1H), 7.47 (s, 1H), 7.32 (d, <i>J</i> = 8.8 Hz, 1H), 7.26 (d, <i>J</i> = 2.4 Hz, 1H), 7.19 (d, <i>J</i> = 8.8 Hz, 1H), 7.10 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 6.62 (d, <i>J</i> = 8.4 Hz, 1H), 6.53 (d, <i>J</i> = 2.4 Hz, 1H), 6.54 (dd, <i>J</i> = 17.2, 10.4 Hz, 1H), 6.23 (dd, <i>J</i> = 17.2, 2.0 Hz, 1H), 6.10 (dd, <i>J</i> = 8.8, 2.8 Hz, 1H), 5.76 (dd, <i>J</i> = 10.4, 2.0 Hz, 1H), 3.76 (s, 3H), 3.16 (t, <i>J</i> = 6.4 Hz, 4H), 3.00 (t, <i>J</i> = 4.8 Hz, 4H), 2.42 (t, <i>J</i> = 4.8 Hz, 4H), 2.21 (s, 3H), 1.85–1.82 (m, 4H). HRMS C<sub>31</sub>H<sub>35</sub>F<sub>3</sub>N<sub>6</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd mass, 597.2801; found, 597.2819.</div></div><div id="sec4_13_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> <i>N</i>-(5-((6-((2-Methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-3-(piperidin-1-yl) pyridin-2-yl)oxy)-2-(trifluoromethyl)phenyl)acrylamide (<b>33</b>)</h4><div class="NLM_p last">This compound was prepared according to the preparation method of <b>32</b> using piperidine instead of pyrrolidine to afford the title compound. The product was purified by reverse-phase HPLC eluting with acetonitrile/water (containing 0.15‰ TFA) as a gray solid (TFA salt, 30 mg, 18.2% over the last two steps). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.82 (s, 1H), 9.64 (s, 1H), 7.79 (d, <i>J</i> = 8.8 Hz, 1H), 7.38–7.30 (m, 2H), 7.22 (s, 1H), 6.65 (d, <i>J</i> = 8.4 Hz, 1H), 6.62 (d, <i>J</i> = 2.4 Hz, 1H), 6.54 (dd, <i>J</i> = 17.2, 10.0 Hz, 1H), 6.23 (dd, <i>J</i> = 17.2, 2.0 Hz, 1H), 6.12 (d, <i>J</i> = 9.2 Hz, 1H), 5.78 (dd, <i>J</i> = 10.4, 2.0 Hz, 1H), 3.78 (s, 3H), 3.68 (d, <i>J</i> = 13.2 Hz, 2H), 3.52 (d, <i>J</i> = 12.0 Hz, 2H), 3.16–3.08 (m, 2H), 2.89–2.82 (m, 5H), 1.67 (bs, 4H), 1.51 (bs, 2H). HRMS C<sub>32</sub>H<sub>38</sub>F<sub>3</sub>N<sub>6</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd mass, 611.2957; found, 611.2964.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00631" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44867" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44867" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00631" class="ext-link">10.1021/acs.jmedchem.9b00631</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Summary of liver microsome stability data of the selected compounds; exploration of electrophilic warheads; cytochromes P450 (CYPs) inhibition and plasma protein binding study of the selected compounds; EGFR inhibitory activity of the selected compounds; tissue distribution of compound <b>22</b> in mouse (PO); some in vivo data of compound <b>22</b>; preparation and NMR data of compounds <b>65</b>–<b>72</b>; <sup>1</sup>H and <sup>13</sup>C NMR spectra of compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00631/suppl_file/jm9b00631_si_002.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00631/suppl_file/jm9b00631_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00631/suppl_file/jm9b00631_si_001.csv">jm9b00631_si_001.csv (3.3 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00631/suppl_file/jm9b00631_si_002.pdf">jm9b00631_si_002.pdf (1.53 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00631" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16208" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16208" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhiyuan Zhang</span> - <span class="hlFld-Affiliation affiliation">National Institute of Biological
Sciences (NIBS), 7 Science Park Road, ZGC Life Science Park, Beijing 102206, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2910-1986" title="Orcid link">http://orcid.org/0000-0002-2910-1986</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#740e1c151a130e1c1d0d01151a341a1d16075a15175a171a"><span class="__cf_email__" data-cfemail="6a10020b040d100203131f0b042a04030819440b09440904">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weijie Hou</span> - <span class="hlFld-Affiliation affiliation">National Institute of Biological
Sciences (NIBS), 7 Science Park Road, ZGC Life Science Park, Beijing 102206, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Huan Sun</span> - <span class="hlFld-Affiliation affiliation">National Institute of Biological
Sciences (NIBS), 7 Science Park Road, ZGC Life Science Park, Beijing 102206, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yongfen Ma</span> - <span class="hlFld-Affiliation affiliation">National Institute of Biological
Sciences (NIBS), 7 Science Park Road, ZGC Life Science Park, Beijing 102206, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chunyan Liu</span> - <span class="hlFld-Affiliation affiliation">National Institute of Biological
Sciences (NIBS), 7 Science Park Road, ZGC Life Science Park, Beijing 102206, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>W.H. and H.S. contributed equally to this work.</p><span class="author-information-subsection-header">Author Contributions</span><p>All authors have given approval to the final version of the manuscript. Z.Z. conceived the project; Z.Z. and W.H. designed, W.H. synthesized all of the compounds; H.S. designed and conducted the biochemical experiments in vitro and in vivo; H.S. tested liver microsomes stability and prepared compound formulations, Y.M. tested CYP inhibition, PPB, and pharmacokinetic parameters; H.S., C.L., and W.H. conducted mice experiments; W.H. and H.S. drafted the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>This work was supported by the National Major Scientific and Technological Special Project for “Significant New Drugs Development” during the 12th 5 year plan period 2013ZX0950910 from the Chinese Ministry of Science and Technology.</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e4954-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50236" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50236" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Kang Wang for the help with mice assays. We thank Li Li for the help with liver microsome stability test. We thank the metabolomics center and proteomics center for mass analysis.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">CatC</td><td class="NLM_def"><p class="first last">cathepsin C</p></td></tr><tr><td class="NLM_term">NSPs</td><td class="NLM_def"><p class="first last">neutrophil serine proteases</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">Compd</td><td class="NLM_def"><p class="first last">compound</p></td></tr><tr><td class="NLM_term">Enz</td><td class="NLM_def"><p class="first last">enzyme</p></td></tr><tr><td class="NLM_term">COPD</td><td class="NLM_def"><p class="first last">chronic obstructive pulmonary disease</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">WT</td><td class="NLM_def"><p class="first last">wild type</p></td></tr><tr><td class="NLM_term">RT</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">half-life</p></td></tr><tr><td class="NLM_term">Pd<sub>2</sub>(dba)<sub>3</sub></td><td class="NLM_def"><p class="first last">tris(dibenzylideneacetone)dipalladium(0)</p></td></tr><tr><td class="NLM_term">BINAP</td><td class="NLM_def"><p class="first last">(±)-2,2′-bis(diphenylphosphino)-1,1′-binaphthyl</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i84">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45434" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45434" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 36 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janjić, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Štern, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podobnik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamba, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahl, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauritzen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, B.</span></span> <span> </span><span class="NLM_article-title">Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">6570</span>– <span class="NLM_lpage">6582</span>, <span class="refDoi"> DOI: 10.1093/emboj/20.23.6570</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1093%2Femboj%2F20.23.6570" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=11726493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptVaqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=6570-6582&author=D.+Turkauthor=V.+Janji%C4%87author=I.+%C5%A0ternauthor=M.+Podobnikauthor=D.+Lambaauthor=S.+W.+Dahlauthor=C.+Lauritzenauthor=J.+Pedersenauthor=V.+Turkauthor=B.+Turk&title=Structure+of+human+dipeptidyl+peptidase+I+%28cathepsin+C%29%3A+exclusion+domain+added+to+an+endopeptidase+framework+creates+the+machine+for+activation+of+granular+serine+proteases&doi=10.1093%2Femboj%2F20.23.6570"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases</span></div><div class="casAuthors">Turk, Dusan; Janjic, Vojko; Stern, Igor; Podobnik, Marjetka; Lamba, Doriano; Dahl, Soren Weis; Lauritzen, Connie; Pedersen, John; Turk, Vito; Turk, Boris</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6570-6582</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase I (DPPI) or cathepsin C is the physiol. activator of groups of serine proteases from immune and inflammatory cells vital for defense of an organism.  The structure presented shows how an addnl. domain transforms the framework of a papain-like endopeptidase into a robust oligomeric protease-processing enzyme.  The tetrahedral arrangement of the active sites exposed to solvent allows approach of proteins in their native state; the massive body of the exclusion domain fastened within the tetrahedral framework excludes approach of a polypeptide chain apart from its termini; and the carboxylic group of Asp1 positions the N-terminal amino group of the substrate.  Based on a structural comparison and interactions within the active site cleft, it is suggested that the exclusion domain originates from a metallo-protease inhibitor.  The location of missense mutations, characterized in people suffering from Haim-Munk and Papillon-Lefevre syndromes, suggests how they disrupt the fold and function of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoHVah8XLwJrVg90H21EOLACvtfcHk0lhVyngNhqRDeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptVaqt7w%253D&md5=b505240f0ef236c26b0a6af99a90c63f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F20.23.6570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F20.23.6570%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DD.%26aulast%3DJanji%25C4%2587%26aufirst%3DV.%26aulast%3D%25C5%25A0tern%26aufirst%3DI.%26aulast%3DPodobnik%26aufirst%3DM.%26aulast%3DLamba%26aufirst%3DD.%26aulast%3DDahl%26aufirst%3DS.%2BW.%26aulast%3DLauritzen%26aufirst%3DC.%26aulast%3DPedersen%26aufirst%3DJ.%26aulast%3DTurk%26aufirst%3DV.%26aulast%3DTurk%26aufirst%3DB.%26atitle%3DStructure%2520of%2520human%2520dipeptidyl%2520peptidase%2520I%2520%2528cathepsin%2520C%2529%253A%2520exclusion%2520domain%2520added%2520to%2520an%2520endopeptidase%2520framework%2520creates%2520the%2520machine%2520for%2520activation%2520of%2520granular%2520serine%2520proteases%26jtitle%3DEMBO%2520J.%26date%3D2001%26volume%3D20%26spage%3D6570%26epage%3D6582%26doi%3D10.1093%2Femboj%2F20.23.6570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fonović, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, B.</span></span> <span> </span><span class="NLM_article-title">Cysteine cathepsins and extracellular matrix degradation</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1840</i></span>,  <span class="NLM_fpage">2560</span>– <span class="NLM_lpage">2570</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2014.03.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1016%2Fj.bbagen.2014.03.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=24680817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmt1WqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1840&publication_year=2014&pages=2560-2570&author=M.+Fonovi%C4%87author=B.+Turk&title=Cysteine+cathepsins+and+extracellular+matrix+degradation&doi=10.1016%2Fj.bbagen.2014.03.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cysteine cathepsins and extracellular matrix degradation</span></div><div class="casAuthors">Fonovic, Marko; Turk, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1840</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2560-2570</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Cysteine cathepsins are normally found in the lysosomes where they are involved in intracellular protein turnover.  Their ability to degrade the components of the extracellular matrix in vitro was first reported more than 25 years ago.  However, cathepsins were for a long time not considered to be among the major players in ECM degrdn. in vivo.  During the last decade it has, however, become evident that abundant secretion of cysteine cathepsins into extracellular milieu is accompanying numerous physiol. and disease conditions, enabling the cathepsins to degrade extracellular proteins.  In this review we will focus on cysteine cathepsins and their extracellular functions linked with ECM degrdn., including regulation of their activity, which is often enhanced by acidification of the extracellular microenvironment, such as found in the bone resorption lacunae or tumor microenvironment.  We will further discuss the ECM substrates of cathepsins with a focus on collagen and elastin, including the importance of that for pathologies.  Finally, we will overview the current status of cathepsin inhibitors in clin. development for treatment of ECM-linked diseases, in particular osteoporosis.  Cysteine cathepsins are among the major proteases involved in ECM remodeling, and their role is not limited to degrdn. only.  Deregulation of their activity is linked with numerous ECM-linked diseases and they are now validated targets in a no. of them.  Cathepsins S and K are the most attractive targets, esp. cathepsin K as a major therapeutic target for osteoporosis with drugs targeting it in advanced clin. trials.  Due to their major role in ECM remodeling cysteine cathepsins have emerged as an important group of therapeutic targets for a no. of ECM-related diseases, including, osteoporosis, cancer and cardiovascular diseases.  This article is part of a Special Issue entitled Matrix-mediated cell behavior and properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3SBbdcbnoELVg90H21EOLACvtfcHk0lhVyngNhqRDeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmt1WqsLs%253D&md5=16b74089dd830919e624133cbc7d0421</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2014.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2014.03.017%26sid%3Dliteratum%253Aachs%26aulast%3DFonovi%25C4%2587%26aufirst%3DM.%26aulast%3DTurk%26aufirst%3DB.%26atitle%3DCysteine%2520cathepsins%2520and%2520extracellular%2520matrix%2520degradation%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2014%26volume%3D1840%26spage%3D2560%26epage%3D2570%26doi%3D10.1016%2Fj.bbagen.2014.03.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, B.</span></span> <span> </span><span class="NLM_article-title">The future of cysteine cathepsins in disease management</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">873</span>– <span class="NLM_lpage">898</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2017.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1016%2Fj.tips.2017.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=28668224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCht7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=873-898&author=L.+Kramerauthor=D.+Turkauthor=B.+Turk&title=The+future+of+cysteine+cathepsins+in+disease+management&doi=10.1016%2Fj.tips.2017.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The Future of Cysteine Cathepsins in Disease Management</span></div><div class="casAuthors">Kramer, Lovro; Turk, Dusan; Turk, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">873-898</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Since the discovery of the key role of cathepsin K in bone resorption, cysteine cathepsins have been investigated by pharmaceutical companies as drug targets.  The first clin. results from targeting cathepsins by activity-based probes and substrates are paving the way for the next generation of mol. diagnostic imaging, whereas the majority of antibody-drug conjugates currently in clin. trials depend on activation by cathepsins.  Finally, cathepsins have emerged as suitable vehicles for targeted drug delivery.  It is therefore timely to review the future of cathepsins in drug discovery.  We focus here on inflammation-assocd. diseases because dysregulation of the immune system accompanied by elevated cathepsin activity is a common feature of these conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpygt3-Q-qJ3bVg90H21EOLACvtfcHk0ljKNSxDFNgIjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCht7bI&md5=acf27aa07e741a6da38e866d4fe3f292</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2017.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2017.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DL.%26aulast%3DTurk%26aufirst%3DD.%26aulast%3DTurk%26aufirst%3DB.%26atitle%3DThe%2520future%2520of%2520cysteine%2520cathepsins%2520in%2520disease%2520management%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2017%26volume%3D38%26spage%3D873%26epage%3D898%26doi%3D10.1016%2Fj.tips.2017.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adkison, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raptis, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, C. T. N.</span></span> <span> </span><span class="NLM_article-title">Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">371</span>, <span class="refDoi"> DOI: 10.1172/JCI0213462</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1172%2FJCI0213462" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=11827996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtV2isLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=363-371&author=A.+M.+Adkisonauthor=S.+Z.+Raptisauthor=D.+G.+Kelleyauthor=C.+T.+N.+Pham&title=Dipeptidyl+peptidase+I+activates+neutrophil-derived+serine+proteases+and+regulates+the+development+of+acute+experimental+arthritis&doi=10.1172%2FJCI0213462"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis</span></div><div class="casAuthors">Adkison, April M.; Raptis, Sofia Z.; Kelley, Diane G.; Pham, Christine T. N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">363-371</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Leukocyte recruitment in inflammation is crit. for host defense, but excessive accumulation of inflammatory cells can lead to tissue damage.  Neutrophil-derived serine proteases (cathepsin G [CG], neutrophil elastase [NE], and proteinase 3 [PR3]) are expressed specifically in mature neutrophils and are thought to play an important role in inflammation.  To investigate the role of these proteases in inflammation, we generated a mouse deficient in dipeptidyl peptidase I (DPPI) and established that DPPI is required for the full activation of CG, NE, and PR3.  Although DPPI-/- mice have normal in vitro neutrophil chemotaxis and in vivo neutrophil accumulation during sterile peritonitis, they are protected against acute arthritis induced by passive transfer of monoclonal antibodies against type II collagen.  Specifically, there is no accumulation of neutrophils in the joints of DPPI-/- mice.  This protective effect correlates with the inactivation of neutrophil-derived serine proteases, since NE-/- × CG-/- mice are equally resistant to arthritis induction by anti-collagen antibodies.  In addn., protease-deficient mice have decreased response to zymosan- and immune complex-mediated inflammation in the s.c. air pouch.  This defect is accompanied by a decrease in local prodn. of TNF-α and IL-1β.  These results implicate DPPI and polymorphonuclear neutrophil-derived serine proteases in the regulation of cytokine prodn. at sites of inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe4N4iJlOG8bVg90H21EOLACvtfcHk0ljKNSxDFNgIjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtV2isLc%253D&md5=66adb9a264a0ed93597d6c36305d6375</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1172%2FJCI0213462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI0213462%26sid%3Dliteratum%253Aachs%26aulast%3DAdkison%26aufirst%3DA.%2BM.%26aulast%3DRaptis%26aufirst%3DS.%2BZ.%26aulast%3DKelley%26aufirst%3DD.%2BG.%26aulast%3DPham%26aufirst%3DC.%2BT.%2BN.%26atitle%3DDipeptidyl%2520peptidase%2520I%2520activates%2520neutrophil-derived%2520serine%2520proteases%2520and%2520regulates%2520the%2520development%2520of%2520acute%2520experimental%2520arthritis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2002%26volume%3D109%26spage%3D363%26epage%3D371%26doi%3D10.1172%2FJCI0213462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, C. T. N.</span></span> <span> </span><span class="NLM_article-title">Dipeptidyl peptidase I regulates the development of collagen-induced arthritis</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2553</span>– <span class="NLM_lpage">2558</span>, <span class="refDoi"> DOI: 10.1002/art.21192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1002%2Fart.21192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=16059912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpslGhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=2553-2558&author=Y.+Huauthor=C.+T.+N.+Pham&title=Dipeptidyl+peptidase+I+regulates+the+development+of+collagen-induced+arthritis&doi=10.1002%2Fart.21192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase I regulates the development of collagen-induced arthritis</span></div><div class="casAuthors">Hu, Ying; Pham, Christine T. N.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2553-2558</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: To examine the role of dipeptidyl peptidase I (DPPI), a widely expressed lysosomal cysteine protease, in the development of collagen-induced arthritis (CIA) in mice.  Methods: Wild-type (WT) and DPPI-deficient (DPPI-/-) mice backcrossed to DBA/1J mice for 10 generations were immunized with bovine type II collagen (CII), and disease susceptibility and severity were assessed over time.  Collagen-specific B cell and T cell responses and the prodn. of proinflammatory cytokines (tumor necrosis factor α, interleukin-1, and interleukin-6) were measured.  In addn., adoptive transfer of splenocytes from WT, CII-sensitized mice was performed to evaluate the specific role of DPPI-/- T lymphocytes.  Results: The majority of DPPI-/- mice were resistant to CIA induction, although clin. disease (i.e., evidence of inflammation and bone erosions) did develop in a small no. of DPPI-/- mice.  The protection against disease development was not attributable to a defect in the B and T cell response to collagen immunization, because both anticollagen antibody prodn. and T cell proliferation in response to CII were normal.  Release of the proinflammatory cytokines was largely unaffected in CII-stimulated DPPI-/- splenocytes.  In addn., when cells isolated from the joints of DPPI-/- mice were stimulated in vitro, they had no intrinsic defect in their ability to release inflammatory cytokines.  Last, adoptive transfer of splenocytes from WT, CII-immunized mice into naive WT and DPPI-/- mice led to development of arthritis in WT mice but not in DPPI-/- mice.  Conclusion: These results indicate that DPPI regulates a crit. step in the development of CIA that is independent of T cell and B cell functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6W442OlyjAbVg90H21EOLACvtfcHk0ljKNSxDFNgIjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpslGhtL8%253D&md5=3529b07eceea274133a690492acfe207</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fart.21192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.21192%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DPham%26aufirst%3DC.%2BT.%2BN.%26atitle%3DDipeptidyl%2520peptidase%2520I%2520regulates%2520the%2520development%2520of%2520collagen-induced%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2005%26volume%3D52%26spage%3D2553%26epage%3D2558%26doi%3D10.1002%2Fart.21192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mallen-St.
Clair, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, C. T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalta, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caughey, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolters, P. J.</span></span> <span> </span><span class="NLM_article-title">Mast cell dipeptidyl peptidase I mediates survival from sepsis</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">628</span>– <span class="NLM_lpage">634</span>, <span class="refDoi"> DOI: 10.1172/JCI200419062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1172%2FJCI200419062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=14966572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFKhtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2004&pages=628-634&author=J.+Mallen-St.%0AClairauthor=C.+T.+N.+Phamauthor=S.+A.+Villaltaauthor=G.+H.+Caugheyauthor=P.+J.+Wolters&title=Mast+cell+dipeptidyl+peptidase+I+mediates+survival+from+sepsis&doi=10.1172%2FJCI200419062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Mast cell dipeptidyl peptidase I mediates survival from sepsis</span></div><div class="casAuthors">Mallen-St. Clair, Jon; Pham, Christine T. N.; Villalta, S. Armando; Caughey, George H.; Wolters, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">628-634</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Sepsis is a common, life-threatening disease for which there is little treatment.  The cysteine protease dipeptidyl peptidase I (DPPI) activates granule-assocd. serine proteases, several of which play important roles in host responses to bacterial infection.  To examine DPPI's role in sepsis, we compared DPPI-/- and DPPI+/+ mice using the cecal ligation and puncture (CLP) model of septic peritonitis, finding that DPPI-/- mice are far more likely to survive sepsis.  Outcomes of CLP in mice lacking mast cell DPPI reveal that the absence of DPPI in mast cells, rather than in other cell types, is responsible for the survival advantage.  Among several cytokines surveyed in peritoneal fluid and serum, IL-6 is highly and differentially expressed in DPPI-/- mice compared with DPPI+/+ mice.  Remarkably, deleting IL-6 expression in DPPI-/- mice eliminates the survival advantage.  The increase in IL-6 in septic DPPI-/- mice, which appears to protect these mice from death, may be related to reduced DPPI-mediated activation of mast cell tryptase and other peptidases, which we show cleave IL-6 in vitro.  These results indicate that mast cell DPPI harms the septic host and that DPPI is a novel potential therapeutic target for treatment of sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7pmJzuL2jpbVg90H21EOLACvtfcHk0lgeTl5DWa1Wbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFKhtrw%253D&md5=1c26daef798e0df4ccb7406e5f609279</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1172%2FJCI200419062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI200419062%26sid%3Dliteratum%253Aachs%26aulast%3DMallen-St.%2BClair%26aufirst%3DJ.%26aulast%3DPham%26aufirst%3DC.%2BT.%2BN.%26aulast%3DVillalta%26aufirst%3DS.%2BA.%26aulast%3DCaughey%26aufirst%3DG.%2BH.%26aulast%3DWolters%26aufirst%3DP.%2BJ.%26atitle%3DMast%2520cell%2520dipeptidyl%2520peptidase%2520I%2520mediates%2520survival%2520from%2520sepsis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2004%26volume%3D113%26spage%3D628%26epage%3D634%26doi%3D10.1172%2FJCI200419062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, C. T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luft, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettritz, R.</span></span> <span> </span><span class="NLM_article-title">Neutrophil serine proteases promote IL-1β generation and injury in necrotizing crescentic glomerulonephritis</span>. <i>J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">470</span>– <span class="NLM_lpage">482</span>, <span class="refDoi"> DOI: 10.1681/ASN.2010080892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1681%2FASN.2010080892" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=22241891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1Omtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=470-482&author=A.+Schreiberauthor=C.+T.+N.+Phamauthor=Y.+Huauthor=W.+Schneiderauthor=F.+C.+Luftauthor=R.+Kettritz&title=Neutrophil+serine+proteases+promote+IL-1%CE%B2+generation+and+injury+in+necrotizing+crescentic+glomerulonephritis&doi=10.1681%2FASN.2010080892"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Neutrophil serine proteases promote IL-1β generation and injury in necrotizing crescentic glomerulonephritis</span></div><div class="casAuthors">Schreiber, Adrian; Pham, Christine T. N.; Hu, Ying; Schneider, Wolfgang; Luft, Friedrich C.; Kettritz, Ralph</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">470-482</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">The pathogenesis of anti-neutrophil cytoplasmic antibody (ANCA)-assocd. necrotizing crescentic GN (NCGN) is incompletely understood.  Dipeptidyl peptidase I (DPPI) is a cysteine protease required for the activation of neutrophil serine proteases (NSPs) cathepsin G, neutrophil elastase, and proteinase 3, which are enzymes that modulate inflammation.  We used a mouse model of anti-myeloperoxidase (MPO) antibody-induced NCGN to det. whether active NSPs contribute to its pathogenesis.  MPO-deficient animals immunized with murine MPO, irradiated, and transplanted with wild-type bone marrow developed NCGN.  In contrast, transplantation with bone marrow that lacked DPPI or lacked both neutrophil elastase and proteinase 3 protected mice from NCGN induced by anti-MPO antibody.  The kidneys of mice reconstituted with DPPI-deficient bone marrow generated significantly less IL-1β than did those of mice reconstituted with wild-type bone marrow; similarly, in vitro, DPPI-deficient monocytes produced significantly less IL-1β in response to anti-MPO antibody than did wild-type monocytes.  This redn. in IL-1β was NSP dependent; exogenous addn. of PR3 restored IL-β prodn. in DPPI-deficient monocytes.  Last, the IL-1 receptor antagonist anakinra protected animals against anti-MPO antibody-induced NCGN (16.7% ± 6.0% vs. 2.4% ± 1.7% crescents), suggesting that IL-1β is a crit. inflammatory mediator in this model.  These data suggest that the development of anti-MPO antibody-induced NCGN requires NSP-dependent IL-1β generation and that these processes may provide therapeutic targets for ANCA-mediated diseases in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4kBPXPLIUObVg90H21EOLACvtfcHk0lgeTl5DWa1Wbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1Omtrs%253D&md5=035520a00b3f4670e458c3589534a05f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1681%2FASN.2010080892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2010080892%26sid%3Dliteratum%253Aachs%26aulast%3DSchreiber%26aufirst%3DA.%26aulast%3DPham%26aufirst%3DC.%2BT.%2BN.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DSchneider%26aufirst%3DW.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DKettritz%26aufirst%3DR.%26atitle%3DNeutrophil%2520serine%2520proteases%2520promote%2520IL-1%25CE%25B2%2520generation%2520and%2520injury%2520in%2520necrotizing%2520crescentic%2520glomerulonephritis%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2012%26volume%3D23%26spage%3D470%26epage%3D482%26doi%3D10.1681%2FASN.2010080892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, P. J.</span></span> <span> </span><span class="NLM_article-title">Cellular and molecular mechanisms of chronic obstructive pulmonary disease</span>. <i>Clin. Chest Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1016/j.ccm.2013.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1016%2Fj.ccm.2013.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=24507838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A280%3ADC%252BC2crmsVKhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=71-86&author=P.+J.+Barnes&title=Cellular+and+molecular+mechanisms+of+chronic+obstructive+pulmonary+disease&doi=10.1016%2Fj.ccm.2013.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular and molecular mechanisms of chronic obstructive pulmonary disease</span></div><div class="casAuthors">Barnes Peter J</div><div class="citationInfo"><span class="NLM_cas:title">Clinics in chest medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chronic obstructive pulmonary disease is associated with chronic inflammation affecting predominantly lung parenchyma and peripheral airways and results in largely irreversible and progressive airflow limitation.  This inflammation is characterized by increased numbers of alveolar macrophages, neutrophils, and T lymphocytes, which are recruited from the circulation.  Oxidative stress plays a key role in driving this inflammation.  The pulmonary inflammation may enhance the development and growth of lung cancer.  The peripheral inflammation extends into the circulation, resulting in systemic inflammation with the same inflammatory proteins.  Systemic inflammation may worsen comorbidities.  Treatment of pulmonary inflammation may therefore have beneficial effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQWZ0g10qbTewHqQV89nF-2fW6udTcc2ea7r03iAYcQObntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crmsVKhtg%253D%253D&md5=76c97406be7f91550a7cdac0cfaf3b9b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.ccm.2013.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccm.2013.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DP.%2BJ.%26atitle%3DCellular%2520and%2520molecular%2520mechanisms%2520of%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DClin.%2520Chest%2520Med.%26date%3D2014%26volume%3D35%26spage%3D71%26epage%3D86%26doi%3D10.1016%2Fj.ccm.2013.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><a href="http://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death" class="extLink">http://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death</a> (accessed May 5, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.who.int%2Fnews-room%2Ffact-sheets%2Fdetail%2Fthe-top-10-causes-of-death+%28accessed+May+5%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamon, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legowska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hervé, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallet-Choisy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand-Adam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderlynden, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demonte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si-Tahar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuzé-Vourc’h, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalmanach, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenne, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korkmaz, B.</span></span> <span> </span><span class="NLM_article-title">Neutrophilic cathepsin C is maturated by a multi-step proteolytic process and secreted by activated cells during inflammatory lung diseases</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">8486</span>– <span class="NLM_lpage">8499</span>, <span class="refDoi"> DOI: 10.1074/jbc.M115.707109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1074%2Fjbc.M115.707109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=26884336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVyitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=8486-8499&author=Y.+Hamonauthor=M.+Legowskaauthor=V.+Herv%C3%A9author=S.+Dallet-Choisyauthor=S.+Marchand-Adamauthor=L.+Vanderlyndenauthor=M.+Demonteauthor=R.+Williamsauthor=C.+J.+Scottauthor=M.+Si-Taharauthor=N.+Heuz%C3%A9-Vourc%E2%80%99hauthor=G.+Lalmanachauthor=D.+E.+Jenneauthor=A.+Lesnerauthor=F.+Gauthierauthor=B.+Korkmaz&title=Neutrophilic+cathepsin+C+is+maturated+by+a+multi-step+proteolytic+process+and+secreted+by+activated+cells+during+inflammatory+lung+diseases&doi=10.1074%2Fjbc.M115.707109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Neutrophilic Cathepsin C Is Maturated by a Multistep Proteolytic Process and Secreted by Activated Cells during Inflammatory Lung Diseases</span></div><div class="casAuthors">Hamon, Yveline; Legowska, Monika; Herve, Virginie; Dallet-Choisy, Sandrine; Marchand-Adam, Sylvain; Vanderlynden, Lise; Demonte, Michele; Williams, Rich; Scott, Christopher J.; Si-Tahar, Mustapha; Heuze-Vourc'h, Nathalie; Lalmanach, Gilles; Jenne, Dieter E.; Lesner, Adam; Gauthier, Francis; Korkmaz, Brice</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">8486-8499</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The cysteine protease cathepsin C (CatC) activates granule-assocd. proinflammatory serine proteases in hematopoietic precursor cells.  Its early inhibition in the bone marrow is regarded as a new therapeutic strategy for treating proteolysis-driven chronic inflammatory diseases, but its complete inhibition is elusive in vivo.  Controlling the activity of CatC may be achieved by directly inhibiting its activity with a specific inhibitor or/and by preventing its maturation.  We have investigated immunochem. and kinetically the occurrence of CatC and its proform in human hematopoietic precursor cells and in differentiated mature immune cells in lung secretions.  The maturation of proCatC obeys a multistep mechanism that can be entirely managed by CatS in neutrophilic precursor cells.  CatS inhibition by a cell-permeable inhibitor abrogated the release of the heavy and light chains from proCatC and blocked ∼80% of CatC activity.  Under these conditions the activity of neutrophil serine proteases, however, was not abolished in precursor cell cultures.  In patients with neutrophilic lung inflammation, mature CatC is found in large amts. in sputa.  It is secreted by activated neutrophils as confirmed through lipopolysaccharide administration in a nonhuman primate model.  CatS inhibitors currently in clin. trials are expected to decrease the activity of neutrophilic CatC without affecting those of elastase-like serine proteases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3pYa55IgDPLVg90H21EOLACvtfcHk0lht7KQVGIe5qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVyitrc%253D&md5=e910fbabdfe80c79544fafd7332c6fdc</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.707109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.707109%26sid%3Dliteratum%253Aachs%26aulast%3DHamon%26aufirst%3DY.%26aulast%3DLegowska%26aufirst%3DM.%26aulast%3DHerv%25C3%25A9%26aufirst%3DV.%26aulast%3DDallet-Choisy%26aufirst%3DS.%26aulast%3DMarchand-Adam%26aufirst%3DS.%26aulast%3DVanderlynden%26aufirst%3DL.%26aulast%3DDemonte%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DScott%26aufirst%3DC.%2BJ.%26aulast%3DSi-Tahar%26aufirst%3DM.%26aulast%3DHeuz%25C3%25A9-Vourc%25E2%2580%2599h%26aufirst%3DN.%26aulast%3DLalmanach%26aufirst%3DG.%26aulast%3DJenne%26aufirst%3DD.%2BE.%26aulast%3DLesner%26aufirst%3DA.%26aulast%3DGauthier%26aufirst%3DF.%26aulast%3DKorkmaz%26aufirst%3DB.%26atitle%3DNeutrophilic%2520cathepsin%2520C%2520is%2520maturated%2520by%2520a%2520multi-step%2520proteolytic%2520process%2520and%2520secreted%2520by%2520activated%2520cells%2520during%2520inflammatory%2520lung%2520diseases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D8486%26epage%3D8499%26doi%3D10.1074%2Fjbc.M115.707109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korkmaz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caughey, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapple, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirschfeld, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenne, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettritz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalmanach, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamort, A.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauritzen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Łȩgowska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand-Adam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKaig, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seren, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thakker, N. S.</span></span> <span> </span><span class="NLM_article-title">Therapeutic targeting of cathepsin C: from pathophysiology to treatment</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>190</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2018.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1016%2Fj.pharmthera.2018.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=29842917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A280%3ADC%252BC1Mbhtlyhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2018&pages=202-236&author=B.+Korkmazauthor=G.+H.+Caugheyauthor=I.+Chappleauthor=F.+Gauthierauthor=J.+Hirschfeldauthor=D.+E.+Jenneauthor=R.+Kettritzauthor=G.+Lalmanachauthor=A.-S.+Lamortauthor=C.+Lauritzenauthor=M.+%C5%81%C8%A9gowskaauthor=A.+Lesnerauthor=S.+Marchand-Adamauthor=S.+J.+McKaigauthor=C.+Mossauthor=J.+Pedersenauthor=H.+Robertsauthor=A.+Schreiberauthor=S.+Serenauthor=N.+S.+Thakker&title=Therapeutic+targeting+of+cathepsin+C%3A+from+pathophysiology+to+treatment&doi=10.1016%2Fj.pharmthera.2018.05.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of cathepsin C: from pathophysiology to treatment</span></div><div class="casAuthors">Korkmaz Brice; Caughey George H; Chapple Iain; Hirschfeld Josefine; Roberts Helen; Gauthier Francis; Lalmanach Gilles; Marchand-Adam Sylvain; Seren Seda; Jenne Dieter E; Lamort Anne-Sophie; Kettritz Ralph; Schreiber Adrian; Lauritzen Conni; Pedersen John; L gowska Monika; Lesner Adam; McKaig Sarah J; Moss Celia; Thakker Nalin S</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">202-236</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cathepsin C (CatC) is a highly conserved tetrameric lysosomal cysteine dipeptidyl aminopeptidase.  The best characterized physiological function of CatC is the activation of pro-inflammatory granule-associated serine proteases.  These proteases are synthesized as inactive zymogens containing an N-terminal pro-dipeptide, which maintains the zymogen in its inactive conformation and prevents premature activation, which is potentially toxic to the cell.  The activation of serine protease zymogens occurs through cleavage of the N-terminal dipeptide by CatC during cell maturation in the bone marrow.  In vivo data suggest that pharmacological inhibition of pro-inflammatory serine proteases would suppress or attenuate deleterious effects mediated by these proteases in inflammatory/auto-immune disorders.  The pathological deficiency in CatC is associated with Papillon-Lefevre syndrome (PLS).  The patients however do not present marked immunodeficiency despite the absence of active serine proteases in immune defense cells.  Hence, the transitory pharmacological blockade of CatC activity in the precursor cells of the bone marrow may represent an attractive therapeutic strategy to regulate activity of serine proteases in inflammatory and immunologic conditions.  A variety of CatC inhibitors have been developed both by pharmaceutical companies and academic investigators, some of which are currently being employed and evaluated in preclinical/clinical trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRS91OmpXGfGcNIRw0GKUoEfW6udTcc2ebW9x-Eo3iPfLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mbhtlyhsw%253D%253D&md5=e4d3a57b7b445195d109159c40897ff8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2018.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2018.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DKorkmaz%26aufirst%3DB.%26aulast%3DCaughey%26aufirst%3DG.%2BH.%26aulast%3DChapple%26aufirst%3DI.%26aulast%3DGauthier%26aufirst%3DF.%26aulast%3DHirschfeld%26aufirst%3DJ.%26aulast%3DJenne%26aufirst%3DD.%2BE.%26aulast%3DKettritz%26aufirst%3DR.%26aulast%3DLalmanach%26aufirst%3DG.%26aulast%3DLamort%26aufirst%3DA.-S.%26aulast%3DLauritzen%26aufirst%3DC.%26aulast%3D%25C5%2581%25C8%25A9gowska%26aufirst%3DM.%26aulast%3DLesner%26aufirst%3DA.%26aulast%3DMarchand-Adam%26aufirst%3DS.%26aulast%3DMcKaig%26aufirst%3DS.%2BJ.%26aulast%3DMoss%26aufirst%3DC.%26aulast%3DPedersen%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DH.%26aulast%3DSchreiber%26aufirst%3DA.%26aulast%3DSeren%26aufirst%3DS.%26aulast%3DThakker%26aufirst%3DN.%2BS.%26atitle%3DTherapeutic%2520targeting%2520of%2520cathepsin%2520C%253A%2520from%2520pathophysiology%2520to%2520treatment%26jtitle%3DPharmacol.%2520Ther.%26date%3D2018%26volume%3D190%26spage%3D202%26epage%3D236%26doi%3D10.1016%2Fj.pharmthera.2018.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Podolin, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognese, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpenter, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wixted, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kou, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capper-Spudich, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McQueney, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Booth-Genthe, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palovich, M. R.</span></span> <span> </span><span class="NLM_article-title">Cathepsin C inhibition: a novel approach for the treatment of chronic respiratory diseases</span>. <i>Am. J. Respir. Crit. Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>187</i></span>,  <span class="NLM_fpage">A1500</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2013&pages=A1500&author=P.+L.+Podolinauthor=B.+J.+Bologneseauthor=J.+P.+Foleyauthor=D.+C.+Carpenterauthor=G.+A.+Loganauthor=W.+E.+Wixtedauthor=J.+P.+Kouauthor=E.+A.+Capper-Spudichauthor=M.+S.+McQueneyauthor=C.+L.+Booth-Gentheauthor=M.+R.+Palovich&title=Cathepsin+C+inhibition%3A+a+novel+approach+for+the+treatment+of+chronic+respiratory+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPodolin%26aufirst%3DP.%2BL.%26aulast%3DBolognese%26aufirst%3DB.%2BJ.%26aulast%3DFoley%26aufirst%3DJ.%2BP.%26aulast%3DCarpenter%26aufirst%3DD.%2BC.%26aulast%3DLogan%26aufirst%3DG.%2BA.%26aulast%3DWixted%26aufirst%3DW.%2BE.%26aulast%3DKou%26aufirst%3DJ.%2BP.%26aulast%3DCapper-Spudich%26aufirst%3DE.%2BA.%26aulast%3DMcQueney%26aufirst%3DM.%2BS.%26aulast%3DBooth-Genthe%26aufirst%3DC.%2BL.%26aulast%3DPalovich%26aufirst%3DM.%2BR.%26atitle%3DCathepsin%2520C%2520inhibition%253A%2520a%2520novel%2520approach%2520for%2520the%2520treatment%2520of%2520chronic%2520respiratory%2520diseases%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2013%26volume%3D187%26spage%3DA1500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kam, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudig, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. C.</span></span> <span> </span><span class="NLM_article-title">Dipeptidyl peptidase I: importance of progranzyme activation sequences, other dipeptide sequences, and the N-terminal amino group of synthetic substrates for enzyme activity</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>403</i></span>,  <span class="NLM_fpage">160</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1016/S0003-9861(02)00217-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1016%2FS0003-9861%2802%2900217-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=12139965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFKgu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=403&publication_year=2002&pages=160-170&author=T.+V.+Tranauthor=K.+A.+Ellisauthor=C.-M.+Kamauthor=D.+Hudigauthor=J.+C.+Powers&title=Dipeptidyl+peptidase+I%3A+importance+of+progranzyme+activation+sequences%2C+other+dipeptide+sequences%2C+and+the+N-terminal+amino+group+of+synthetic+substrates+for+enzyme+activity&doi=10.1016%2FS0003-9861%2802%2900217-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase I: importance of progranzyme activation sequences, other dipeptide sequences, and the N-terminal amino group of synthetic substrates for enzyme activity</span></div><div class="casAuthors">Tran, Tinh V.; Ellis, Karen A.; Kam, Chih-Min; Hudig, Dorothy; Powers, James C.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">403</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">160-170</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">The broadly reactive cysteine protease dipeptidyl peptidase I (DPPI, cathepsin C) is thought to activate all progranzymes (zymogens of lymphocyte serine proteases) to form mature granzymes.  We synthesized dipeptide 7-amino-4-methylcoumarin (AMC) substrates contg. progranzyme activation sequences and showed that they were efficiently hydrolyzed by DPPI.  However, DPPI will not hydrolyze Ile-Ile-AMC, the N-terminal dipeptide sequence found in mature granzymes.  Introduction of the nonphysiol. homophenylalanine (Hph) residue at P1 resulted in the best substrate Ala-Hph-AMC for DPPI (kcat/Km=9,000,000 M-1 s-1).  The charged N-terminal amino group of the substrate was essential and replacement of the NH2 group with OH or NH(CH3) in Gly-Phe-AMC reduced the kcat/Km value by two to three orders of magnitude.  A hydrazide azaglycine analog, NH2NHCO-Phe-AMC, was not hydrolyzed at pH 5.5, but underwent slow hydrolysis at lower pHs where the amino group is partially protonated.  DPPI also failed to hydrolyze NH2COCH2-Phe-AMC, where the NH2 group is unprotonated.  The results reported in this paper should be useful in the design of better DPPI inhibitors to block granzyme maturation and granzyme-dependent apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp70G9oGB-iibVg90H21EOLACvtfcHk0lh19t4RxlGwtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFKgu70%253D&md5=6d9e37195921419eebfd0839dcfe5f9d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0003-9861%2802%2900217-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0003-9861%252802%252900217-5%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DT.%2BV.%26aulast%3DEllis%26aufirst%3DK.%2BA.%26aulast%3DKam%26aufirst%3DC.-M.%26aulast%3DHudig%26aufirst%3DD.%26aulast%3DPowers%26aufirst%3DJ.%2BC.%26atitle%3DDipeptidyl%2520peptidase%2520I%253A%2520importance%2520of%2520progranzyme%2520activation%2520sequences%252C%2520other%2520dipeptide%2520sequences%252C%2520and%2520the%2520N-terminal%2520amino%2520group%2520of%2520synthetic%2520substrates%2520for%2520enzyme%2520activity%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2002%26volume%3D403%26spage%3D160%26epage%3D170%26doi%3D10.1016%2FS0003-9861%2802%2900217-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laine, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busch-Petersen, J.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of cathepsin C (dipeptidyl peptidase I)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1517/13543771003657172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1517%2F13543771003657172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=20205619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslamuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=497-506&author=D.+I.+Laineauthor=J.+Busch-Petersen&title=Inhibitors+of+cathepsin+C+%28dipeptidyl+peptidase+I%29&doi=10.1517%2F13543771003657172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of cathepsin C (dipeptidyl peptidase I)</span></div><div class="casAuthors">Laine, Dramane I.; Busch-Petersen, Jakob</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">497-506</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance to the field: Cathepsin C (dipeptidyl peptidase I) plays a key role in the activation of several degradative enzymes linked to tissue destruction in inflammatory diseases.  Thus, cathepsin C inhibitors could potentially be effective therapeutics for the treatment of such diseases as chronic obstructive pulmonary disease and cystic fibrosis.  Areas covered in this review: Although this article focuses on cathepsin C inhibitor patents, the journal literature concerning small mol. inhibitors of the enzyme is also covered comprehensively (1981 - 2009).  What the reader will gain: It is our aim to give the reader a complete overview of the cathepsin C inhibitor chemotypes that have been disclosed to date.  In addn., key biol. data have been included for both irreversible and reversible inhibitors.  Take home message: All known cathepsin C inhibitors are believed to have a covalent interaction with the Cys-234 residue of the enzyme.  The electrophilic and sometimes peptidic nature of these mols. is assocd. with poor metabolic stability and is also a potential safety concern.  Thus, overcoming developability issues is a serious hurdle for these compds. and there can be little doubt that this is the principal reason why no cathepsin C inhibitors appear to have reached clin. development so far.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdwKOpSi2hZ7Vg90H21EOLACvtfcHk0lg4XPTaMZCz-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslamuro%253D&md5=f53116f8e20d29cc8eb8ed5643a30625</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1517%2F13543771003657172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543771003657172%26sid%3Dliteratum%253Aachs%26aulast%3DLaine%26aufirst%3DD.%2BI.%26aulast%3DBusch-Petersen%26aufirst%3DJ.%26atitle%3DInhibitors%2520of%2520cathepsin%2520C%2520%2528dipeptidyl%2520peptidase%2520I%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D497%26epage%3D506%26doi%3D10.1517%2F13543771003657172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Green, G. D. J.</span>; <span class="NLM_string-name">Shaw, E.</span></span> <span> </span><span class="NLM_article-title">Peptidyl diazomethyl ketones are specific inactivators of thiol proteinases</span>.  <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1981</span> <span class="NLM_fpage">1923</span>– <span class="NLM_lpage">1928</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=7007374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADyaL3MXhsFantbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1981&pages=1923-1928&author=G.+D.+J.+Green&author=E.+Shaw&title=Peptidyl+diazomethyl+ketones+are+specific+inactivators+of+thiol+proteinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidyl diazomethyl ketones are specific inactivators of thiol proteinases</span></div><div class="casAuthors">Green, George D. J.; Shaw, Elliott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1923-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Peptidyl diazomethyl ketones are specific inactivators of thiol proteinases, being unreactive toward other classes of proteinases.  Variation of the peptide portion of the reagents has provided affinity labels for the selective inactivation of the thiol endopeptidases, cathepsin B, streptococcal proteinase, and clostripain, and for the aminodipeptidase, cathepsin C.  Comparison of rates of inactivation of cathepsin B and streptococcal proteinase revealed a similarity in specificity, both enzymes showing a preference for a phenylalanine residue in the penultimate position of the peptide portion of the reagent.  Reagents not satisfying the specificity of a particular thiol proteinase either did not inactivate or did so only very slowly.  In some cases, the reagents bound to the enzyme in a manner unproductive for alkylation but productive for substrate behavior leading to destruction of the inhibitor by cleavage of the peptide portion.  Thus, benzyloxycarbonyl-Phe-Gly-Phe diazomethyl ketone was rapidly cleaved by cathepsin B into benzyloxycarbonyl-Phe-Gly and phenylalanine diazomethyl ketone.  Clostripain, an enzyme of trypsin-like specificity, was selectively inactivated by benzyloxycarbonyllysine diazomethyl ketone at micromolar concns., but was inactivated extremely slowly by 2.5 × 10-4M benzyloxycarbonyl-Phe-Ala diazomethyl ketone, a very effective inactivator of cathepsin B.  Cathepsin C, a thiol aminodipeptidase, was inactivated by Gly-Phe diazomethyl ketone in the range of 10-7 to 10-8M.  By comparison, peptidyl diazomethyl ketones with blocked N-terminals were considerably less effective.  Peptidyl diazomethyl ketones are unreactive with such thiols, as mercaptoethanol and glutathione.  This property and the lack of reactivity toward other classes of proteinases suggest the usefulness of this class of inhibitors as diagnostic reagents for both in vitro and in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOZmm7XqRtDrVg90H21EOLACvtfcHk0lg4XPTaMZCz-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXhsFantbY%253D&md5=2c019d5fb8e8c9adb42942f42877ad76</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DG.%2BD.%2BJ.%26atitle%3DPeptidyl%2520diazomethyl%2520ketones%2520are%2520specific%2520inactivators%2520of%2520thiol%2520proteinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1981%26spage%3D1923%26epage%3D1928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korver, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kam, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudig, D.</span></span> <span> </span><span class="NLM_article-title">Dipeptide vinyl sulfones suitable for intracellular inhibition of dipeptidyl peptidase I</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1016/S0162-3109(00)00267-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1016%2FS0162-3109%2800%2900267-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=11367515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtlWnsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=21-32&author=G.+E.+Korverauthor=C.-M.+Kamauthor=J.+C.+Powersauthor=D.+Hudig&title=Dipeptide+vinyl+sulfones+suitable+for+intracellular+inhibition+of+dipeptidyl+peptidase+I&doi=10.1016%2FS0162-3109%2800%2900267-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptide vinyl sulfones suitable for intracellular inhibition of dipeptidyl peptidase I</span></div><div class="casAuthors">Korver, Gretchen E.; Kam, Chih-Min; Powers, James C.; Hudig, Dorothy</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-32</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">In granules of hematopoietic cells, dipeptidyl peptidase I (DPPI) processes inactive proenzymes into active enzymes, e.g., lymphocyte progranzyme A.  Our goal was to develop irreversible inhibitors of intracellular DPPI.  First, we identified inhibitors with aq. stability.  Then we detd. which inhibitors were nontoxic, could enter cells and inactivate intracellular DPPI.  We screened nine dipeptide vinyl sulfone (VS) inhibitors (kobs/[I] > 72 M-1 s-1) and found six that were nontoxic.  Four affected intracellular DPPI at < 25 μM.  These compds. contained only uncharged amino acid residues; the two less reactive compds. contained charged Glu residues.  The best one, Leu-Phe-VS-CH3, inactivated DPPI in cells with an ID50 of ∼ 5 μM.  This inhibitor was not the best inhibitor of purified DPPI.  Longer aq. stabilities were important predictors of cellular efficacy.  Leu-Phe-VS-CH3 had a half life of 97 min at the pH of the extracellular medium (7.5) and 1302 min at pH 5.5 (the intracellular environment of DPPI).  This VS had no direct effect on granzyme activities.  In contrast, the diazomethyl ketone inhibitor Gly-Phe-CHN2 inhibited chymase activity.  Several good intracellular DPPI VS inhibitors lacked reactivity with cathepsins B, H and L.  In conclusion, we have identified DPPI inhibitors suitable for cellular applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcFqtyilH1S7Vg90H21EOLACvtfcHk0lg4XPTaMZCz-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtlWnsLY%253D&md5=e774a7937e958f7c11989e5bd6fb4abb</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0162-3109%2800%2900267-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0162-3109%252800%252900267-8%26sid%3Dliteratum%253Aachs%26aulast%3DKorver%26aufirst%3DG.%2BE.%26aulast%3DKam%26aufirst%3DC.-M.%26aulast%3DPowers%26aufirst%3DJ.%2BC.%26aulast%3DHudig%26aufirst%3DD.%26atitle%3DDipeptide%2520vinyl%2520sulfones%2520suitable%2520for%2520intracellular%2520inhibition%2520of%2520dipeptidyl%2520peptidase%2520I%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2001%26volume%3D1%26spage%3D21%26epage%3D32%26doi%3D10.1016%2FS0162-3109%2800%2900267-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kam, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Götz, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koot, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuire, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiele, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudig, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. C.</span></span> <span> </span><span class="NLM_article-title">Design and evaluation of inhibitors for dipeptidyl peptidase I (Cathepsin C)</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>427</i></span>,  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2004.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1016%2Fj.abb.2004.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=15196986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvVClt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2004&pages=123-134&author=C.-M.+Kamauthor=M.+G.+G%C3%B6tzauthor=G.+Kootauthor=M.+McGuireauthor=D.+Thieleauthor=D.+Hudigauthor=J.+C.+Powers&title=Design+and+evaluation+of+inhibitors+for+dipeptidyl+peptidase+I+%28Cathepsin+C%29&doi=10.1016%2Fj.abb.2004.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Design and evaluation of inhibitors for dipeptidyl peptidase I (Cathepsin C)</span></div><div class="casAuthors">Kam, Chih-Min; Gotz, Marion G.; Koot, Gretchen; McGuire, Michael; Thiele, Dwain; Hudig, Dorothy; Powers, James C.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">427</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-134</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase I (DPPI, cathepsin C) is a lysosomal cysteine protease that can activate zymogens of several different serine proteases by one step or sequential removal of dipeptides from the N-termini of the pro-protease protein substrates.  To find DPPI inhibitors more suitable for cellular applications than diazomethyl ketones, we synthesized three types of inhibitors: dipeptide acyloxymethyl ketones, fluoromethyl ketones, and vinyl sulfones (VS).  The acyloxymethyl ketones inhibited DPPI slowly and are moderate inhibitors of cellular DPPI.  The fluoromethyl ketones were potent, but the inhibited DPPI regained activity quickly.  The dipeptide vinyl sulfones were effective inhibitors for DPPI, but they also inhibited cathepsins B, H, and L weakly.  The best inhibitor, Ala-Hph-VS-Ph, had a k2/KI of 2,000,000 M-1 s-1.  The vinyl sulfones also inhibited intracellular DPPI, and for this application the more stable inhibitors exhibit better potency.  We conclude that vinyl sulfones are promising inhibitors to study the intracellular functions of DPPI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2ecoE_aDnEbVg90H21EOLACvtfcHk0lghTWRrXbUFzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvVClt7o%253D&md5=6fb8dd13f10c90b704d0b323ab2ae163</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2004.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2004.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKam%26aufirst%3DC.-M.%26aulast%3DG%25C3%25B6tz%26aufirst%3DM.%2BG.%26aulast%3DKoot%26aufirst%3DG.%26aulast%3DMcGuire%26aufirst%3DM.%26aulast%3DThiele%26aufirst%3DD.%26aulast%3DHudig%26aufirst%3DD.%26aulast%3DPowers%26aufirst%3DJ.%2BC.%26atitle%3DDesign%2520and%2520evaluation%2520of%2520inhibitors%2520for%2520dipeptidyl%2520peptidase%2520I%2520%2528Cathepsin%2520C%2529%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2004%26volume%3D427%26spage%3D123%26epage%3D134%26doi%3D10.1016%2Fj.abb.2004.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lainé, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palovich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCleland, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petitjean, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delhom, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevins, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDevitt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Midgett, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kmett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umbrecht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettoun, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel cyanamide-based inhibitors of cathepsin C</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">142</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1021/ml100212k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100212k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2rsL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=142-147&author=D.+Lain%C3%A9author=M.+Palovichauthor=B.+McClelandauthor=E.+Petitjeanauthor=I.+Delhomauthor=H.+Xieauthor=J.+Dengauthor=G.+Linauthor=R.+Davisauthor=A.+Jolitauthor=N.+Nevinsauthor=B.+Zhaoauthor=J.+Villaauthor=J.+Schneckauthor=P.+McDevittauthor=R.+Midgettauthor=C.+Kmettauthor=S.+Umbrechtauthor=B.+Peckauthor=A.+B.+Davisauthor=D.+Bettoun&title=Discovery+of+novel+cyanamide-based+inhibitors+of+cathepsin+C&doi=10.1021%2Fml100212k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel cyanamide-based inhibitors of cathepsin C</span></div><div class="casAuthors">Laine, Dramane; Palovich, Michael; McCleland, Brent; Petitjean, Emilie; Delhom, Isabelle; Xie, Haibo; Deng, Jianghe; Lin, Guoliang; Davis, Roderick; Jolit, Anais; Nevins, Neysa; Zhao, Baoguang; Villa, Jim; Schneck, Jessica; McDevitt, Patrick; Midgett, Robert; Kmett, Casey; Umbrecht, Sandra; Peck, Brian; Davis, Alicia Bacon; Bettoun, David</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">142-147</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of potent and selective cyanamide-based inhibitors of the cysteine protease cathepsin C is detailed.  Optimization of the template with regard to plasma stability led to the identification of (2S,4R)-1-cyano-2-methyl-4-(2,5-dibromophenylsulfonylamino)pyrrolidine (I), a potent cathepsin C inhibitor with excellent selectivity over other cathepsins and potent in vivo activity in a cigarette smoke mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnAQabB_znSrVg90H21EOLACvtfcHk0lghTWRrXbUFzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2rsL%252FK&md5=5b8478f6abc28e4d273eb9aa7c93aeb1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fml100212k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100212k%26sid%3Dliteratum%253Aachs%26aulast%3DLain%25C3%25A9%26aufirst%3DD.%26aulast%3DPalovich%26aufirst%3DM.%26aulast%3DMcCleland%26aufirst%3DB.%26aulast%3DPetitjean%26aufirst%3DE.%26aulast%3DDelhom%26aufirst%3DI.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DG.%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DJolit%26aufirst%3DA.%26aulast%3DNevins%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DVilla%26aufirst%3DJ.%26aulast%3DSchneck%26aufirst%3DJ.%26aulast%3DMcDevitt%26aufirst%3DP.%26aulast%3DMidgett%26aufirst%3DR.%26aulast%3DKmett%26aufirst%3DC.%26aulast%3DUmbrecht%26aufirst%3DS.%26aulast%3DPeck%26aufirst%3DB.%26aulast%3DDavis%26aufirst%3DA.%2BB.%26aulast%3DBettoun%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520novel%2520cyanamide-based%2520inhibitors%2520of%2520cathepsin%2520C%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D142%26epage%3D147%26doi%3D10.1021%2Fml100212k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Furber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiden, A.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mete, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millichip, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinchin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luckhurst, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cage, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanganee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chohan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oreffo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchinson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debreczeni, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breed, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wissler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edman, K.</span></span> <span> </span><span class="NLM_article-title">Cathepsin C inhibitors: property optimization and identification of a clinical candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2357</span>– <span class="NLM_lpage">2367</span>, <span class="refDoi"> DOI: 10.1021/jm401705g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401705g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVehsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2357-2367&author=M.+Furberauthor=A.-K.+Tidenauthor=P.+Gardinerauthor=A.+Meteauthor=R.+Fordauthor=I.+Millichipauthor=L.+Steinauthor=A.+Matherauthor=E.+Kinchinauthor=C.+Luckhurstauthor=S.+Barberauthor=P.+Cageauthor=H.+Sanganeeauthor=R.+Austinauthor=K.+Chohanauthor=R.+Beriauthor=B.+Thongauthor=A.+Wallaceauthor=V.+Oreffoauthor=R.+Hutchinsonauthor=S.+Harperauthor=J.+Debreczeniauthor=J.+Breedauthor=L.+Wisslerauthor=K.+Edman&title=Cathepsin+C+inhibitors%3A+property+optimization+and+identification+of+a+clinical+candidate&doi=10.1021%2Fjm401705g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin C Inhibitors: Property Optimization and Identification of a Clinical Candidate</span></div><div class="casAuthors">Furber, Mark; Tiden, Anna-Karin; Gardiner, Philip; Mete, Antonio; Ford, Rhonan; Millichip, Ian; Stein, Linda; Mather, Andrew; Kinchin, Elizabeth; Luckhurst, Christopher; Barber, Simon; Cage, Peter; Sanganee, Hitesh; Austin, Rupert; Chohan, Kamaldeep; Beri, Raj; Thong, Bob; Wallace, Alan; Oreffo, Victor; Hutchinson, Ray; Harper, Steve; Debreczeni, Judit; Breed, Jason; Wissler, Lisa; Edman, Karl</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2357-2367</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A lead generation and optimization program delivered the highly selective and potent CatC inhibitor 10 as an in vivo tool compd. and potential development candidate.  Structural studies were undertaken to generate SAR understanding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMrzoFYqcSSrVg90H21EOLACvtfcHk0ljQie5bgtgT2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVehsLg%253D&md5=35e3eca5dc118251ba5e3e39219c6f60</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm401705g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401705g%26sid%3Dliteratum%253Aachs%26aulast%3DFurber%26aufirst%3DM.%26aulast%3DTiden%26aufirst%3DA.-K.%26aulast%3DGardiner%26aufirst%3DP.%26aulast%3DMete%26aufirst%3DA.%26aulast%3DFord%26aufirst%3DR.%26aulast%3DMillichip%26aufirst%3DI.%26aulast%3DStein%26aufirst%3DL.%26aulast%3DMather%26aufirst%3DA.%26aulast%3DKinchin%26aufirst%3DE.%26aulast%3DLuckhurst%26aufirst%3DC.%26aulast%3DBarber%26aufirst%3DS.%26aulast%3DCage%26aufirst%3DP.%26aulast%3DSanganee%26aufirst%3DH.%26aulast%3DAustin%26aufirst%3DR.%26aulast%3DChohan%26aufirst%3DK.%26aulast%3DBeri%26aufirst%3DR.%26aulast%3DThong%26aufirst%3DB.%26aulast%3DWallace%26aufirst%3DA.%26aulast%3DOreffo%26aufirst%3DV.%26aulast%3DHutchinson%26aufirst%3DR.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DDebreczeni%26aufirst%3DJ.%26aulast%3DBreed%26aufirst%3DJ.%26aulast%3DWissler%26aufirst%3DL.%26aulast%3DEdman%26aufirst%3DK.%26atitle%3DCathepsin%2520C%2520inhibitors%253A%2520property%2520optimization%2520and%2520identification%2520of%2520a%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2357%26epage%3D2367%26doi%3D10.1021%2Fjm401705g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lönn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Käck, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Poël, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swallow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wikell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenvall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johannesson, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of second generation reversible covalent DPP1 inhibitors leading to an oxazepane amidoacetonitrile based clinical candidate (AZD7986)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9457</span>– <span class="NLM_lpage">9472</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01127</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01127" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1SmtLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9457-9472&author=K.+Doyleauthor=H.+L%C3%B6nnauthor=H.+K%C3%A4ckauthor=A.+Van+de+Po%C3%ABlauthor=S.+Swallowauthor=P.+Gardinerauthor=S.+Connollyauthor=J.+Rootauthor=C.+Wikellauthor=G.+Dahlauthor=K.+Stenvallauthor=P.+Johannesson&title=Discovery+of+second+generation+reversible+covalent+DPP1+inhibitors+leading+to+an+oxazepane+amidoacetonitrile+based+clinical+candidate+%28AZD7986%29&doi=10.1021%2Facs.jmedchem.6b01127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986)</span></div><div class="casAuthors">Doyle, Kevin; Lonn, Hans; Kack, Helena; Van de Poel, Amanda; Swallow, Steve; Gardiner, Philip; Connolly, Stephen; Root, James; Wikell, Cecilia; Dahl, Goran; Stenvall, Kristina; Johannesson, Petra</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9457-9472</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of second generation DPP1 inhibitors free from aorta binding liabilities found for earlier compd. series was discovered.  This work culminated in the identification of compd. 30 (AZD7986) as a highly potent, reversible, and selective clin. candidate for COPD, with predicted human PK properties suitable for once daily human dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouJ_YtbyrmtbVg90H21EOLACvtfcHk0ljQie5bgtgT2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1SmtLbF&md5=73daf54da4a47b7b11db53e0b5a98e50</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01127%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DK.%26aulast%3DL%25C3%25B6nn%26aufirst%3DH.%26aulast%3DK%25C3%25A4ck%26aufirst%3DH.%26aulast%3DVan%2Bde%2BPo%25C3%25ABl%26aufirst%3DA.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DGardiner%26aufirst%3DP.%26aulast%3DConnolly%26aufirst%3DS.%26aulast%3DRoot%26aufirst%3DJ.%26aulast%3DWikell%26aufirst%3DC.%26aulast%3DDahl%26aufirst%3DG.%26aulast%3DStenvall%26aufirst%3DK.%26aulast%3DJohannesson%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520second%2520generation%2520reversible%2520covalent%2520DPP1%2520inhibitors%2520leading%2520to%2520an%2520oxazepane%2520amidoacetonitrile%2520based%2520clinical%2520candidate%2520%2528AZD7986%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9457%26epage%3D9472%26doi%3D10.1021%2Facs.jmedchem.6b01127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamboni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Methot, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ethier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Percival, M. D.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of dipeptidyl nitriles as potent, selective, and reversible inhibitors of cathepsin C</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">5392</span>– <span class="NLM_lpage">5396</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.07.114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1016%2Fj.bmcl.2009.07.114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=19665376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVeqsLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5392-5396&author=D.+Guayauthor=C.+Beaulieuauthor=T.+J.+Reddyauthor=R.+Zamboniauthor=N.+Methotauthor=J.+Rubinauthor=D.+Ethierauthor=M.+D.+Percival&title=Design+and+synthesis+of+dipeptidyl+nitriles+as+potent%2C+selective%2C+and+reversible+inhibitors+of+cathepsin+C&doi=10.1016%2Fj.bmcl.2009.07.114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of dipeptidyl nitriles as potent, selective, and reversible inhibitors of cathepsin C</span></div><div class="casAuthors">Guay, Daniel; Beaulieu, Christian; Jagadeeswar Reddy, T.; Zamboni, Robert; Methot, Nathalie; Rubin, Joel; Ethier, Diane; David Percival, M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5392-5396</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of dipeptide nitriles with a thienyl alanine in P2 were identified as potent and selective cathepsin C inhibitors.  Incorporation of a substituted cyclopropyl moiety in P1 effectively protects these derivs. against hydrolase activity in whole blood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3YY4UjyYe67Vg90H21EOLACvtfcHk0ljeqDcLsBoHHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVeqsLrI&md5=5e3a92361de2c537def8770271494de4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.07.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.07.114%26sid%3Dliteratum%253Aachs%26aulast%3DGuay%26aufirst%3DD.%26aulast%3DBeaulieu%26aufirst%3DC.%26aulast%3DReddy%26aufirst%3DT.%2BJ.%26aulast%3DZamboni%26aufirst%3DR.%26aulast%3DMethot%26aufirst%3DN.%26aulast%3DRubin%26aufirst%3DJ.%26aulast%3DEthier%26aufirst%3DD.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520dipeptidyl%2520nitriles%2520as%2520potent%252C%2520selective%252C%2520and%2520reversible%2520inhibitors%2520of%2520cathepsin%2520C%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5392%26epage%3D5396%26doi%3D10.1016%2Fj.bmcl.2009.07.114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Percival, M. D.</span></span> <span> </span><span class="NLM_article-title">Therapeutic utility and medicinal chemistry of cathepsin C inhibitors</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">708</span>– <span class="NLM_lpage">716</span>, <span class="refDoi"> DOI: 10.2174/156802610791113469</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.2174%2F156802610791113469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=20337582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsF2ksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=708-716&author=D.+Guayauthor=C.+Beaulieuauthor=M.+D.+Percival&title=Therapeutic+utility+and+medicinal+chemistry+of+cathepsin+C+inhibitors&doi=10.2174%2F156802610791113469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic utility and medicinal chemistry of cathepsin C inhibitors</span></div><div class="casAuthors">Guay, Daniel; Beaulieu, Christian; Percival, M. David</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">708-716</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The lysosomal cysteine protease cathepsin C (Cat C), also known as dipeptidyl peptidase 1, activates a no. of granule-assocd. serine proteases with pro-inflammatory and immune functions by removal of their inhibitory N-terminal dipeptides.  Thus, Cat C is a therapeutic target for the treatment of a no. of inflammatory and autoimmune diseases.  Cathepsin C null mice and humans with Cat C loss of function mutations (Papillon-Lefevre syndrome) show deficiencies in disease-relevant proteases including neutrophil elastase, cathepsin G, chymases and granzymes and the Cat C mice are protected in a no. of disease models.  Several methodologies have been recently reported for assessing the effects of Cat C inhibitors on serine protease activities in cellular assays and prolonged treatment of rats with a reversible, selective Cat C inhibitor reduced the activity of three leukocyte serine proteases.  Nearly all potent and selective Cat C inhibitors described are based on the preferred dipeptide substrates bearing either irreversible (e.g. diazomethylketone, acyloxymethyl ketone, o-acyl hydroxamic acid and vinyl sulfone) or reversible (e.g. semicarbazide, nitrile and cyanamide) electrophilic warheads.  While potent and highly selective, the best inhibitors described to date still have poor stability and/or rodent pharmacokinetics, likely resulting from their peptidic nature.  The lack of selective compds. with appropriate rodent pharmacokinetic properties has hampered the assessment of the effects of Cat C inhibitors on the activation of disease-relevant proteases in vivo and the full evaluation of the therapeutic utility of Cat C inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp9SHPfL5KVrVg90H21EOLACvtfcHk0ljeqDcLsBoHHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsF2ksbc%253D&md5=ff226a5ad4f7967ac5791ae2baf05d71</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F156802610791113469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610791113469%26sid%3Dliteratum%253Aachs%26aulast%3DGuay%26aufirst%3DD.%26aulast%3DBeaulieu%26aufirst%3DC.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DTherapeutic%2520utility%2520and%2520medicinal%2520chemistry%2520of%2520cathepsin%2520C%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D708%26epage%3D716%26doi%3D10.2174%2F156802610791113469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallow, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyce, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpenter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churchill, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heslop, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazaar, A. L.</span></span> <span> </span><span class="NLM_article-title">Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK2793660)</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">2813</span>– <span class="NLM_lpage">2820</span>, <span class="refDoi"> DOI: 10.1111/bcp.13398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1111%2Fbcp.13398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=28800383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvV2ns7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2017&pages=2813-2820&author=B.+E.+Millerauthor=R.+J.+Mayerauthor=N.+Goyalauthor=J.+Balauthor=N.+Dallowauthor=M.+Boyceauthor=D.+Carpenterauthor=A.+Churchillauthor=T.+Heslopauthor=A.+L.+Lazaar&title=Epithelial+desquamation+observed+in+a+phase+I+study+of+an+oral+cathepsin+C+inhibitor+%28GSK2793660%29&doi=10.1111%2Fbcp.13398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK2793660)</span></div><div class="casAuthors">Miller, Bruce E.; Mayer, Ruth J.; Goyal, Navin; Bal, Joanne; Dallow, Nigel; Boyce, Malcolm; Carpenter, Donald; Churchill, Alison; Heslop, Teresa; Lazaar, Aili L.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2813-2820</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">1365-2125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aims : Cathepsin C (CTSC) is necessary for the activation of several serine proteases including neutrophil elastase (NE), cathepsin G and proteinase 3.  GSK2793660 is an oral, irreversible inhibitor of CTSC that is hypothesized to provide an alternative route to achieve NE inhibition and was tested in a Phase I study.  Methods : Single escalating oral doses of GSK2793660 from 0.5 to 20 mg or placebo were administered in a randomized crossover design to healthy male subjects; a sep. cohort received once daily doses of 12 mg or placebo for 21 days.  Data were collected on safety, pharmacokinetics, CTSC enzyme inhibition and blood biomarkers.  Results : Single, oral doses of GSK2793660 were able to dose-dependently inhibit whole blood CTSC activity.  Once daily dosing of 12 mg GSK2793660 for 21 days achieved ≥90% inhibition (95% CI: 56, 130) of CTSC within 3 h on day 1.  Only modest redns. of whole blood enzyme activity of approx. 20% were obsd. for NE, cathepsin G and proteinase 3.  Seven of 10 subjects receiving repeat doses of GSK2793660 manifested epidermal desquamation on palmar and plantar surfaces beginning 7-10 days after dosing commencement.  There were no other clin. important safety findings.  Conclusions : GSK2793660 inhibited CTSC activity but not the activity of downstream neutrophil serine proteases.  The palmar-plantar epidermal desquamation suggests a previously unidentified role for CTSC or one of its target proteins in the maintenance and integrity of the epidermis at these sites, with some similarities to the phenotype of CTSC-deficient humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgzbhfHPivxrVg90H21EOLACvtfcHk0ljeqDcLsBoHHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvV2ns7zM&md5=7adcac6bc9dc5a24bffda1afd89e1f88</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1111%2Fbcp.13398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcp.13398%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DB.%2BE.%26aulast%3DMayer%26aufirst%3DR.%2BJ.%26aulast%3DGoyal%26aufirst%3DN.%26aulast%3DBal%26aufirst%3DJ.%26aulast%3DDallow%26aufirst%3DN.%26aulast%3DBoyce%26aufirst%3DM.%26aulast%3DCarpenter%26aufirst%3DD.%26aulast%3DChurchill%26aufirst%3DA.%26aulast%3DHeslop%26aufirst%3DT.%26aulast%3DLazaar%26aufirst%3DA.%2BL.%26atitle%3DEpithelial%2520desquamation%2520observed%2520in%2520a%2520phase%2520I%2520study%2520of%2520an%2520oral%2520cathepsin%2520C%2520inhibitor%2520%2528GSK2793660%2529%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2017%26volume%3D83%26spage%3D2813%26epage%3D2820%26doi%3D10.1111%2Fbcp.13398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palovich, M.</span>; <span class="NLM_string-name">Bolognese, B.</span>; <span class="NLM_string-name">Booth-Genthe, C.</span>; <span class="NLM_string-name">Churchill, A.</span>; <span class="NLM_string-name">Foley, J.
P.</span>; <span class="NLM_string-name">Goyal, N.</span>; <span class="NLM_string-name">Landis, P.</span>; <span class="NLM_string-name">Logan, G.</span>; <span class="NLM_string-name">Long, E.,  III</span>; <span class="NLM_string-name">Mayer, R.
J.</span>; <span class="NLM_string-name">Miller, B.</span>; <span class="NLM_string-name">Neipp, C.</span>; <span class="NLM_string-name">Podolin, P. L.</span>; <span class="NLM_string-name">Umbrecht, S. T.</span></span> In  <i>Inhibitors of Cathepsin C: Not Your Typical Small Oral Molecules</i>, Presented at RSC/SCI Symposium on Proteinase Inhibitor Design, Basel, Switzerland April 13, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+Palovich&author=B.+Bolognese&author=C.+Booth-Genthe&author=A.+Churchill&author=J.%0AP.+Foley&author=N.+Goyal&author=P.+Landis&author=G.+Logan&author=E.+Long&author=R.%0AJ.+Mayer&author=B.+Miller&author=C.+Neipp&author=P.+L.+Podolin&author=S.+T.+Umbrecht&title=Inhibitors+of+Cathepsin+C%3A+Not+Your+Typical+Small+Oral+Molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DPalovich%26aufirst%3DM.%26jtitle%3DInhibitors%2520of%2520Cathepsin%2520C%253A%2520Not%2520Your%2520Typical%2520Small%2520Oral%2520Molecules%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><a href="https://clinicaltrials.gov/ct2/show/NCT02058407" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02058407</a> (accessed May 5, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02058407+%28accessed+May+5%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palmér, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mäenpää, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jauhiainen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prothon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chialda, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forte, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egelrud, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenvall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, P.</span></span> <span> </span><span class="NLM_article-title">Dipeptidyl peptidase 1 inhibitor AZD7986 induces a sustained, exposure-dependent reduction in neutrophil elastase activity in healthy subjects</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">1155</span>– <span class="NLM_lpage">1164</span>, <span class="refDoi"> DOI: 10.1002/cpt.1053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1002%2Fcpt.1053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=29484635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1Sgtr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2018&pages=1155-1164&author=R.+Palm%C3%A9rauthor=J.+M%C3%A4enp%C3%A4%C3%A4author=A.+Jauhiainenauthor=B.+Larssonauthor=J.+Moauthor=M.+Russellauthor=J.+Rootauthor=S.+Prothonauthor=L.+Chialdaauthor=P.+Forteauthor=T.+Egelrudauthor=K.+Stenvallauthor=P.+Gardiner&title=Dipeptidyl+peptidase+1+inhibitor+AZD7986+induces+a+sustained%2C+exposure-dependent+reduction+in+neutrophil+elastase+activity+in+healthy+subjects&doi=10.1002%2Fcpt.1053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl Peptidase 1 Inhibitor AZD7986 Induces a Sustained, Exposure-Dependent Reduction in Neutrophil Elastase Activity in Healthy Subjects</span></div><div class="casAuthors">Palmer, Robert; Maeenpaeae, Jukka; Jauhiainen, Alexandra; Larsson, Bengt; Mo, John; Russell, Muir; Root, James; Prothon, Susanne; Chialda, Ligia; Forte, Pablo; Egelrud, Torbjoern; Stenvall, Kristina; Gardiner, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1155-1164</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Neutrophil serine proteases (NSPs), such as neutrophil elastase (NE), are activated by dipeptidyl peptidase 1 (DPP1) during neutrophil maturation.  High NSP levels can be detrimental, particularly in lung tissue, and inhibition of NSPs is therefore an interesting therapeutic opportunity in multiple lung diseases, including chronic obstructive pulmonary disease (COPD) and bronchiectasis.  We conducted a randomized, placebo-controlled, first-in-human study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple oral doses of the DPP1 inhibitor AZD7986 in healthy subjects.  Pharmacokinetic and pharmacodynamic data were analyzed using nonlinear mixed effects modeling and showed that AZD7986 inhibits whole blood NE activity in an exposure-dependent, indirect manner-consistent with in vitro and preclin. predictions.  Several dose-dependent, possibly DPP1-related, nonserious skin findings were obsd., but these were not considered to prevent further clin. development.  Overall, the study results provided confidence to progress AZD7986 to phase II and supported selection of a clin. relevant dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNNpZU5DYCmrVg90H21EOLACvtfcHk0lgEi90QPq6kHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1Sgtr3I&md5=be63909f3c5374982b0cdbf7ca8e5202</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fcpt.1053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpt.1053%26sid%3Dliteratum%253Aachs%26aulast%3DPalm%25C3%25A9r%26aufirst%3DR.%26aulast%3DM%25C3%25A4enp%25C3%25A4%25C3%25A4%26aufirst%3DJ.%26aulast%3DJauhiainen%26aufirst%3DA.%26aulast%3DLarsson%26aufirst%3DB.%26aulast%3DMo%26aufirst%3DJ.%26aulast%3DRussell%26aufirst%3DM.%26aulast%3DRoot%26aufirst%3DJ.%26aulast%3DProthon%26aufirst%3DS.%26aulast%3DChialda%26aufirst%3DL.%26aulast%3DForte%26aufirst%3DP.%26aulast%3DEgelrud%26aufirst%3DT.%26aulast%3DStenvall%26aufirst%3DK.%26aulast%3DGardiner%26aufirst%3DP.%26atitle%3DDipeptidyl%2520peptidase%25201%2520inhibitor%2520AZD7986%2520induces%2520a%2520sustained%252C%2520exposure-dependent%2520reduction%2520in%2520neutrophil%2520elastase%2520activity%2520in%2520healthy%2520subjects%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2018%26volume%3D104%26spage%3D1155%26epage%3D1164%26doi%3D10.1002%2Fcpt.1053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><a href="https://clinicaltrials.gov/ct2/show/NCT03218917" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03218917</a> (accessed May
5, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03218917+%28accessed+May%0A5%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span> <span> </span><span class="NLM_article-title">Focusing on probe-modified peptides: a quick and effective method for target identification</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">10225</span>– <span class="NLM_lpage">10228</span>, <span class="refDoi"> DOI: 10.1039/C6CC04030F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1039%2FC6CC04030F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=27443632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFOgsr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2016&pages=10225-10228&author=H.+Sunauthor=Y.+Renauthor=W.+Houauthor=L.+Liauthor=F.+Zengauthor=S.+Liauthor=Y.+Maauthor=X.+Liuauthor=S.+Chenauthor=Z.+Zhang&title=Focusing+on+probe-modified+peptides%3A+a+quick+and+effective+method+for+target+identification&doi=10.1039%2FC6CC04030F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Focusing on probe-modified peptides: a quick and effective method for target identification</span></div><div class="casAuthors">Sun, Huan; Ren, Yan; Hou, Weijie; Li, Lin; Zeng, Fanqi; Li, Sisi; Ma, Yongfen; Liu, Xiao; Chen, She; Zhang, Zhiyuan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">67</span>),
    <span class="NLM_cas:pages">10225-10228</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A new and efficient method focusing on probe-modified peptides was developed to identify the target protein and modification site of a hit compd. or a drug.  This method exhibited high click conjugation efficiency and few false-pos. results.  The modification site further facilitated target validation, biol. mechanism study and new indications exploration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLd8P3vyX8OrVg90H21EOLACvtfcHk0lgEi90QPq6kHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFOgsr7K&md5=c717532da42e1b100162c02baadb23b3</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1039%2FC6CC04030F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6CC04030F%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DHou%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DZeng%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DZ.%26atitle%3DFocusing%2520on%2520probe-modified%2520peptides%253A%2520a%2520quick%2520and%2520effective%2520method%2520for%2520target%2520identification%26jtitle%3DChem.%2520Commun.%26date%3D2016%26volume%3D52%26spage%3D10225%26epage%3D10228%26doi%3D10.1039%2FC6CC04030F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bragg, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brocklehurst, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickling, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFaul, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swallow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tugwood, J.</span></span> <span> </span><span class="NLM_article-title">Aortic binding of AZD5248: mechanistic insight and reactivity assays to support lead optimzation</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1991</span>– <span class="NLM_lpage">1999</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.5b00236</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.5b00236" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVOnsrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2015&pages=1991-1999&author=R.+A.+Braggauthor=S.+Brocklehurstauthor=F.+Gustafssonauthor=J.+Goodmanauthor=K.+Hicklingauthor=P.+A.+MacFaulauthor=S.+Swallowauthor=J.+Tugwood&title=Aortic+binding+of+AZD5248%3A+mechanistic+insight+and+reactivity+assays+to+support+lead+optimzation&doi=10.1021%2Facs.chemrestox.5b00236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Aortic Binding of AZD5248: Mechanistic Insight and Reactivity Assays To Support Lead Optimization</span></div><div class="casAuthors">Bragg, Ryan A.; Brocklehurst, Simon; Gustafsson, Frida; Goodman, James; Hickling, Kevin; MacFaul, Philip A.; Swallow, Steve; Tugwood, Jonathan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1991-1999</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The oral dipeptidyl peptidase 1 (DPP1) inhibitor AZD5248 showed aortic binding in a rat quant. whole-body autoradiog. (QWBA) study, and its development was terminated prior to human dosing.  A mechanistic hypothesis for this finding was established invoking reactivity with aldehydes involved in the crosslinking of elastin, a major component of aortic tissue.  This was tested by developing a simple aldehyde chem. reactivity assay and a novel in vitro competitive covalent binding assay.  Results obtained with AZD5248, literature compds., and close analogs of AZD5248 support the mechanistic hypothesis and provide validation for the use of these assays in a two tier screening approach to support lead optimization.  The strengths and limitations of these assays are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVsQOf7qsJOLVg90H21EOLACvtfcHk0lhzdq7PbMb9sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVOnsrbO&md5=d9e73a25a1a8153121ba1e29e65819dc</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.5b00236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.5b00236%26sid%3Dliteratum%253Aachs%26aulast%3DBragg%26aufirst%3DR.%2BA.%26aulast%3DBrocklehurst%26aufirst%3DS.%26aulast%3DGustafsson%26aufirst%3DF.%26aulast%3DGoodman%26aufirst%3DJ.%26aulast%3DHickling%26aufirst%3DK.%26aulast%3DMacFaul%26aufirst%3DP.%2BA.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DTugwood%26aufirst%3DJ.%26atitle%3DAortic%2520binding%2520of%2520AZD5248%253A%2520mechanistic%2520insight%2520and%2520reactivity%2520assays%2520to%2520support%2520lead%2520optimzation%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2015%26volume%3D28%26spage%3D1991%26epage%3D1999%26doi%3D10.1021%2Facs.chemrestox.5b00236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ercan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capelletti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortot, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chirieac, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacob, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padera, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eck, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jänne, P. A.</span></span> <span> </span><span class="NLM_article-title">Novel mutant-selective EGFR kinase inhibitors against EGFR T790M</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>462</i></span>,  <span class="NLM_fpage">1070</span>, <span class="refDoi"> DOI: 10.1038/nature08622</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1038%2Fnature08622" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=20033049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1SktbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=462&publication_year=2009&pages=1070&author=W.+Zhouauthor=D.+Ercanauthor=L.+Chenauthor=C.-H.+Yunauthor=D.+Liauthor=M.+Capellettiauthor=A.+B.+Cortotauthor=L.+Chirieacauthor=R.+E.+Iacobauthor=R.+Paderaauthor=J.+R.+Engenauthor=K.-K.+Wongauthor=M.+J.+Eckauthor=N.+S.+Grayauthor=P.+A.+J%C3%A4nne&title=Novel+mutant-selective+EGFR+kinase+inhibitors+against+EGFR+T790M&doi=10.1038%2Fnature08622"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Novel mutant-selective EGFR kinase inhibitors against EGFR T790M</span></div><div class="casAuthors">Zhou, Wenjun; Ercan, Dalia; Chen, Liang; Yun, Cai-Hong; Li, Danan; Capelletti, Marzia; Cortot, Alexis B.; Chirieac, Lucian; Iacob, Roxana E.; Padera, Robert; Engen, John R.; Wong, Kwok-Kin; Eck, Michael J.; Gray, Nathanael S.; Janne, Pasi A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">462</span>
        (<span class="NLM_cas:issue">7276</span>),
    <span class="NLM_cas:pages">1070-1074</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The clin. efficacy of epidermal growth factor receptor (EGFR) kinase inhibitors in EGFR-mutant non-small-cell lung cancer (NSCLC) is limited by the development of drug-resistance mutations, including the gatekeeper T790M mutation.  Strategies targeting EGFR T790M with irreversible inhibitors have had limited success and are assocd. with toxicity due to concurrent inhibition of wild-type EGFR.  All current EGFR inhibitors possess a structurally related quinazoline-based core scaffold and were identified as ATP-competitive inhibitors of wild-type EGFR.  Here we identify a covalent pyrimidine EGFR inhibitor by screening an irreversible kinase inhibitor library specifically against EGFR T790M.  These agents are 30- to 100-fold more potent against EGFR T790M, and up to 100-fold less potent against wild-type EGFR, than quinazoline-based EGFR inhibitors in vitro.  They are also effective in murine models of lung cancer driven by EGFR T790M.  Co-crystn. studies reveal a structural basis for the increased potency and mutant selectivity of these agents.  These mutant-selective irreversible EGFR kinase inhibitors may be clin. more effective and better tolerated than quinazoline-based inhibitors.  Our findings demonstrate that functional pharmacol. screens against clin. important mutant kinases represent a powerful strategy to identify new classes of mutant-selective kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcksZlIe-1bbVg90H21EOLACvtfcHk0lhzdq7PbMb9sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1SktbvI&md5=9b5d41a2be401c67a4b9f04a41cf1725</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnature08622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08622%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DErcan%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DYun%26aufirst%3DC.-H.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DCapelletti%26aufirst%3DM.%26aulast%3DCortot%26aufirst%3DA.%2BB.%26aulast%3DChirieac%26aufirst%3DL.%26aulast%3DIacob%26aufirst%3DR.%2BE.%26aulast%3DPadera%26aufirst%3DR.%26aulast%3DEngen%26aufirst%3DJ.%2BR.%26aulast%3DWong%26aufirst%3DK.-K.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DJ%25C3%25A4nne%26aufirst%3DP.%2BA.%26atitle%3DNovel%2520mutant-selective%2520EGFR%2520kinase%2520inhibitors%2520against%2520EGFR%2520T790M%26jtitle%3DNature%26date%3D2009%26volume%3D462%26spage%3D1070%26doi%3D10.1038%2Fnature08622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGuire, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipsky, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiele, D. L.</span></span> <span> </span><span class="NLM_article-title">Generation of active myeloid and lymphoid granule serine proteases requires processing by the granule thiol protease dipeptidyl peptidase I</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>268</i></span>,  <span class="NLM_fpage">2458</span>– <span class="NLM_lpage">2467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=8428921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADyaK3sXhvV2qsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1993&pages=2458-2467&author=M.+J.+McGuireauthor=P.+E.+Lipskyauthor=D.+L.+Thiele&title=Generation+of+active+myeloid+and+lymphoid+granule+serine+proteases+requires+processing+by+the+granule+thiol+protease+dipeptidyl+peptidase+I"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of active myeloid and lymphoid granule serine proteases requires processing by the granule thiol protease dipeptidyl peptidase I</span></div><div class="casAuthors">McGuire, Michael J.; Lipsky, Peter E.; Thiele, Dwain L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2458-67</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The proenzyme activation peptides predicted from cDNAs encoding each of the granule serine proteases synthesized by cytotoxic lymphocytes and myeloid and mast cells are composed of 2 residues.  The mechanism by which these amino-terminal dipeptides are cleaved to generate the active enzymes has not been elucidated.  The comparable distribution of dipeptidyl peptidase I (DPPI) and serine proteases and the ability of DPPI to hydrolyze relevant dipeptide sequences suggested a role for DPPI in the processing and activation of granule serine proteases.  This study demonstrates that inhibition of DPPI activity is assocd. with impairment of the generation of granule serine protease activity in CD8(+) T cells, lymphokine-activated killer cells, P815 mastocytoma cells, and U-937 myeloid cells.  Inhibition of DPPI resulted in impairment of the generation of cathepsin G enzymic activity without redn. in the amt. of immunoreactive cathepsin G product.  In U-937 cells pulsed with [3H]isoleucine, inhibition of DPPI activity was assocd. with the accumulation of the inactive proenzyme form of cathepsin G bearing an amino-terminal dipeptide extension to the isoleucine residue that normally occupies the amino terminus of the enzymically active protein.  These results indicate that DPPI plays a requisite role in the post-translational processing and activation of members of the family of granule serine proteases expressed in bone marrow-derived effector cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps2BbXeqrD2LVg90H21EOLACvtfcHk0lhzdq7PbMb9sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhvV2qsr8%253D&md5=afa6355e3bad7fcc44b678f4e30294e8</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuire%26aufirst%3DM.%2BJ.%26aulast%3DLipsky%26aufirst%3DP.%2BE.%26aulast%3DThiele%26aufirst%3DD.%2BL.%26atitle%3DGeneration%2520of%2520active%2520myeloid%2520and%2520lymphoid%2520granule%2520serine%2520proteases%2520requires%2520processing%2520by%2520the%2520granule%2520thiol%2520protease%2520dipeptidyl%2520peptidase%2520I%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1993%26volume%3D268%26spage%3D2458%26epage%3D2467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fouret, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">du Bois, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernaudin, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrans, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crystal, R. G.</span></span> <span> </span><span class="NLM_article-title">Expression of the neutrophil elastase gene during human bone marrow cell differentiation</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">833</span>– <span class="NLM_lpage">845</span>, <span class="refDoi"> DOI: 10.1084/jem.169.3.833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1084%2Fjem.169.3.833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=2538548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADyaL1MXhsFalsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=1989&pages=833-845&author=P.+Fouretauthor=R.+M.+du+Boisauthor=J.+F.+Bernaudinauthor=H.+Takahashiauthor=V.+J.+Ferransauthor=R.+G.+Crystal&title=Expression+of+the+neutrophil+elastase+gene+during+human+bone+marrow+cell+differentiation&doi=10.1084%2Fjem.169.3.833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of the neutrophil elastase gene during human bone marrow cell differentiation</span></div><div class="casAuthors">Fouret, Pierre; Du Bois, Roland M.; Bernaudin, Jean Francois; Takahashi, Hideki; Ferrans, Victor J.; Crystal, Ronald G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">833-45</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    </div><div class="casAbstract">Neutrophil elastase, a potent serine protease carried and released by activated neutrophils, is not synthesized by neutrophils, but by their bone marrow precursor cells.  Using in situ hybridization with 35S-labeled antisense and sense neutrophil elastase cRNA probes, the present study demonstrates that expression of the neutrophil elastase gene is tightly controlled in bone marrow precursors and occurs during a very limited stage of differentiation of the neutrophil myeloid series, almost entirely at the promyelocyte stage.  Neutrophil elastase mRNA transcript levels are detectable to a limited extent in blasts, increase markedly in the promyelocyte stage, and then disappear as promyelocytes further differentiate.  Control probes specific for myeloperoxidase, lactoferrin, and β-globin mRNA transcripts, resp., demonstrated contrasting gene expression.  Myeloperoxidase mRNA transcripts were also found almost exclusively at the promyelocyte stage, but myeloperoxidase mRNA levels disappeared earlier than do neutrophil elastase mRNA levels, suggesting that expression of these genes may be differently controlled.  In comparison, lactoferrin mRNA transcripts were detected late in the neutrophil lineage, while β-globin mRNA was detected only in cells of the erythroid lineage.  The expression of the neutrophil elastase gene is likely under very tight control, and is likely different than that for other constituents of the neutrophil granules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmsy1yMlUtfrVg90H21EOLACvtfcHk0lj8OdEU_H-M-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhsFalsbs%253D&md5=bd01714bb0290a0bdcfae6d5841bfbcd</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1084%2Fjem.169.3.833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.169.3.833%26sid%3Dliteratum%253Aachs%26aulast%3DFouret%26aufirst%3DP.%26aulast%3Ddu%2BBois%26aufirst%3DR.%2BM.%26aulast%3DBernaudin%26aufirst%3DJ.%2BF.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DFerrans%26aufirst%3DV.%2BJ.%26aulast%3DCrystal%26aufirst%3DR.%2BG.%26atitle%3DExpression%2520of%2520the%2520neutrophil%2520elastase%2520gene%2520during%2520human%2520bone%2520marrow%2520cell%2520differentiation%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1989%26volume%3D169%26spage%3D833%26epage%3D845%26doi%3D10.1084%2Fjem.169.3.833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Méthot, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ethier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Normandin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riendeau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Percival, M. D.</span></span> <span> </span><span class="NLM_article-title">In vivo inhibition of serine protease processing requires a high fractional inhibition of cathepsin C</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">1857</span>– <span class="NLM_lpage">1865</span>, <span class="refDoi"> DOI: 10.1124/mol.108.045682</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1124%2Fmol.108.045682" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=18326050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BD1cXms1emsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=1857-1865&author=N.+M%C3%A9thotauthor=D.+Guayauthor=J.+Rubinauthor=D.+Ethierauthor=K.+Ortegaauthor=S.+Wongauthor=D.+Normandinauthor=C.+Beaulieuauthor=T.+J.+Reddyauthor=D.+Riendeauauthor=M.+D.+Percival&title=In+vivo+inhibition+of+serine+protease+processing+requires+a+high+fractional+inhibition+of+cathepsin+C&doi=10.1124%2Fmol.108.045682"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo inhibition of serine protease processing requires a high fractional inhibition of cathepsin C</span></div><div class="casAuthors">Methot, Nathalie; Guay, Daniel; Rubin, Joel; Ethier, Diane; Ortega, Karen; Wong, Simon; Normandin, Denis; Beaulieu, Christian; Reddy, T. Jagadeeswar; Riendeau, Denis; Percival, M. David</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1857-1865</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Inhibition of cathepsin C, a dipeptidyl peptidase that activates many serine proteases, represents an attractive therapeutic strategy for inflammatory diseases with a high neutrophil burden.  We recently showed the feasibility of blocking the activation of neutrophil elastase, cathepsin G, and proteinase-3 with a single cathepsin C selective inhibitor in cultured cells.  Here we measured the fractional inhibition of cathepsin C that is required for blockade of downstream serine protease processing, in cell-based assays and in vivo.  Using a radiolabeled active site probe and U937 cells, a 50% redn. of cathepsin G processing required ∼50% of cathepsin C active sites to be occupied by an inhibitor.  In EcoM-G cells, inhibition of 50% of neutrophil elastase activity required ∼80% occupancy.  Both of these serine proteases were fully inhibited at full cathepsin C active site occupancy, whereas granzyme B processing in TALL-104 cells was partially inhibited, despite complete occupancy.  In vivo, leukocytes from cathepsin C+/- mice exhibited comparable levels of neutrophil elastase activity to wild-type animals, even though their cathepsin C activity was reduced by half.  The long-term administration of a cathepsin C inhibitor to rats, at doses that resulted in the nearly complete blockade of cathepsin C active sites in bone marrow, caused significant redns. of neutrophil elastase, cathepsin G and proteinase-3 activities.  Our results demonstrate that the inhibition of cathepsin C leads to a decrease of activity of multiple serine proteases involved in inflammation but also suggest that high fractional inhibition is necessary to reach therapeutically significant effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHl78T2oKjDLVg90H21EOLACvtfcHk0lj8OdEU_H-M-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXms1emsL0%253D&md5=17bfbce4f3e3cbc7be59ad3a8f86b715</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fmol.108.045682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.108.045682%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A9thot%26aufirst%3DN.%26aulast%3DGuay%26aufirst%3DD.%26aulast%3DRubin%26aufirst%3DJ.%26aulast%3DEthier%26aufirst%3DD.%26aulast%3DOrtega%26aufirst%3DK.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DNormandin%26aufirst%3DD.%26aulast%3DBeaulieu%26aufirst%3DC.%26aulast%3DReddy%26aufirst%3DT.%2BJ.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DIn%2520vivo%2520inhibition%2520of%2520serine%2520protease%2520processing%2520requires%2520a%2520high%2520fractional%2520inhibition%2520of%2520cathepsin%2520C%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D73%26spage%3D1857%26epage%3D1865%26doi%3D10.1124%2Fmol.108.045682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Méthot, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ethier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riendeau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Percival, M. D.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the activation of multiple serine proteases with a cathepsin C inhibitor requires sustained exposure to prevent pro-enzyme processing</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">20836</span>– <span class="NLM_lpage">20846</span>, <span class="refDoi"> DOI: 10.1074/jbc.M702615200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1074%2Fjbc.M702615200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=17535802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BD2sXns1ygurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=20836-20846&author=N.+M%C3%A9thotauthor=J.+Rubinauthor=D.+Guayauthor=C.+Beaulieuauthor=D.+Ethierauthor=T.+J.+Reddyauthor=D.+Riendeauauthor=M.+D.+Percival&title=Inhibition+of+the+activation+of+multiple+serine+proteases+with+a+cathepsin+C+inhibitor+requires+sustained+exposure+to+prevent+pro-enzyme+processing&doi=10.1074%2Fjbc.M702615200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the Activation of Multiple Serine Proteases with a Cathepsin C Inhibitor Requires Sustained Exposure to Prevent Pro-enzyme Processing</span></div><div class="casAuthors">Methot, Nathalie; Rubin, Joel; Guay, Daniel; Beaulieu, Christian; Ethier, Diane; Reddy, T. Jagadeeswar; Riendeau, Denis; Percival, M. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">20836-20846</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cathepsin C is a cysteine protease required for the activation of several pro-inflammatory serine proteases and, as such, is of interest as a therapeutic target.  In cathepsin C-deficient mice and humans, the N-terminal processing and activation of neutrophil elastase, cathepsin G, and proteinase-3 is abolished and is accompanied by a redn. of protein levels.  Pharmacol., the consequence of cathepsin C inhibition on the activation of these serine proteases has not been described, due to the lack of stable and non-toxic inhibitors and the absence of appropriate exptl. cell systems.  Using novel reversible peptide nitrile inhibitors of cathepsin C, and cell-based assays with U937 and EcoM-G cells, we detd. the effects of pharmacol. inhibition of cathepsin C on serine protease activity.  We show that indirect and complete inhibition of neutrophil elastase, cathepsin G, and proteinase-3 is achievable in intact cells with selective and non-cytotoxic cathepsin C inhibitors, at concns. ∼10-fold higher than those required to inhibit purified cathepsin C. The concn. of inhibitor needed to block processing of these three serine proteases was similar, regardless of the cell system used.  Importantly, cathepsin C inhibition must be sustained to maintain serine protease inhibition, because removal of the reversible inhibitors resulted in the activation of pro-enzymes in intact cells.  These findings demonstrate that near complete inhibition of multiple serine proteases can be achieved with cathepsin C inhibitors and that cathepsin C inhibition represents a viable but challenging approach for the treatment of neutrophil-based inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs7l1PM7ZKMLVg90H21EOLACvtfcHk0lj8OdEU_H-M-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXns1ygurg%253D&md5=7ab97011a54f10a476313eead154feb2</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M702615200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M702615200%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A9thot%26aufirst%3DN.%26aulast%3DRubin%26aufirst%3DJ.%26aulast%3DGuay%26aufirst%3DD.%26aulast%3DBeaulieu%26aufirst%3DC.%26aulast%3DEthier%26aufirst%3DD.%26aulast%3DReddy%26aufirst%3DT.%2BJ.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DInhibition%2520of%2520the%2520activation%2520of%2520multiple%2520serine%2520proteases%2520with%2520a%2520cathepsin%2520C%2520inhibitor%2520requires%2520sustained%2520exposure%2520to%2520prevent%2520pro-enzyme%2520processing%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D20836%26epage%3D20846%26doi%3D10.1074%2Fjbc.M702615200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">John, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aschenbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krüger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sendler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, F. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayerle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerch, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aghdassi, A. A.</span></span> <span> </span><span class="NLM_article-title">Deficiency of cathepsin C ameliorates severity of acute pancreatitis by reduction of neutrophil elastase activation and cleavage of E-cadherin</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>294</i></span>,  <span class="NLM_fpage">697</span>– <span class="NLM_lpage">707</span>, <span class="refDoi"> DOI: 10.1074/jbc.RA118.004376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1074%2Fjbc.RA118.004376" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=30455353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1Cis74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2019&pages=697-707&author=D.+S.+Johnauthor=J.+Aschenbachauthor=B.+Kr%C3%BCgerauthor=M.+Sendlerauthor=F.+U.+Weissauthor=J.+Mayerleauthor=M.+M.+Lerchauthor=A.+A.+Aghdassi&title=Deficiency+of+cathepsin+C+ameliorates+severity+of+acute+pancreatitis+by+reduction+of+neutrophil+elastase+activation+and+cleavage+of+E-cadherin&doi=10.1074%2Fjbc.RA118.004376"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Deficiency of cathepsin C ameliorates severity of acute pancreatitis by reduction of neutrophil elastase activation and cleavage of E-cadherin</span></div><div class="casAuthors">John, Daniel S.; Aschenbach, Julia; Krueger, Burkhard; Sendler, Matthias; Weiss, F. Ulrich; Mayerle, Julia; Lerch, Markus M.; Aghdassi, Ali A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">697-707</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Acute pancreatitis is characterized by premature intracellular protease activation and infiltration of inflammatory cells, mainly neutrophil granulocytes and macrophages, into the organ.  The lysosomal proteases cathepsin B, D, and L have been identified as regulators of early zymogen activation and thus modulators of the severity of pancreatitis.  Cathepsin C (CTSC, syn. dipeptidly-peptidase I) is a widely expressed, exo-cystein-protease involved in the proteolytic processing of various other lysosomal enzymes.  We have studied its role in pancreatitis.  We used CTSC-deleted mice and their WT littermates in two exptl. models of pancreatitis.  The mild model involved eight hourly caerulein injections and the severe model partial duct ligation.  Isolated pancreatic acini and spleen-derived leukocytes were used for ex vivo expts.  CTSC is expressed in the pancreas and in inflammatory cells.  CTSC deletion reduced the severity of pancreatitis (more prominently in the milder model) without directly affecting intra-acinar cell trypsin activation in vitro.  The absence of CTSC reduced infiltration of neutrophil granulocytes impaired their capacity for cleaving E-cadherin in adherens junctions between acinar cells and reduced the activity of neutrophil serine proteases polymorphonuclear (neutrophil) elastase, cathepsin G, and proteinase 3, but not neutrophil motility.  Macrophage invasion was not dependent on the presence of CTSC.  CTSC is a regulator and activator of various lysosomal enzymes such as cathepsin B, D, and L.  Its loss mitigates the severity of pancreatitis not by reducing intra-acinar cell zymogen activation but by reducing infiltration of neutrophil granulocytes into the pancreas.  In this context one of its key roles is that of an activator of neutrophil elastase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEC_CF7_vU7bVg90H21EOLACvtfcHk0lgUx_mZmkHFPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1Cis74%253D&md5=4eef871380c4ecd99fb4c437f9181076</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA118.004376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA118.004376%26sid%3Dliteratum%253Aachs%26aulast%3DJohn%26aufirst%3DD.%2BS.%26aulast%3DAschenbach%26aufirst%3DJ.%26aulast%3DKr%25C3%25BCger%26aufirst%3DB.%26aulast%3DSendler%26aufirst%3DM.%26aulast%3DWeiss%26aufirst%3DF.%2BU.%26aulast%3DMayerle%26aufirst%3DJ.%26aulast%3DLerch%26aufirst%3DM.%2BM.%26aulast%3DAghdassi%26aufirst%3DA.%2BA.%26atitle%3DDeficiency%2520of%2520cathepsin%2520C%2520ameliorates%2520severity%2520of%2520acute%2520pancreatitis%2520by%2520reduction%2520of%2520neutrophil%2520elastase%2520activation%2520and%2520cleavage%2520of%2520E-cadherin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2019%26volume%3D294%26spage%3D697%26epage%3D707%26doi%3D10.1074%2Fjbc.RA118.004376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lerch, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lutz, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidenbach, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller-Pillasch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gress, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leser, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adler, G.</span></span> <span> </span><span class="NLM_article-title">Dissociation and reassembly of adherens junctions during experimental acute pancreatitis</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">1355</span>– <span class="NLM_lpage">1366</span>, <span class="refDoi"> DOI: 10.1053/gast.1997.v113.pm9322531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1053%2Fgast.1997.v113.pm9322531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=9322531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A280%3ADyaK2svmtlygsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1997&pages=1355-1366&author=M.+M.+Lerchauthor=M.+P.+Lutzauthor=H.+Weidenbachauthor=F.+Muller-Pillaschauthor=T.+M.+Gressauthor=J.+Leserauthor=G.+Adler&title=Dissociation+and+reassembly+of+adherens+junctions+during+experimental+acute+pancreatitis&doi=10.1053%2Fgast.1997.v113.pm9322531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Dissociation and reassembly of adherens junctions during experimental acute pancreatitis</span></div><div class="casAuthors">Lerch M M; Lutz M P; Weidenbach H; Muller-Pillasch F; Gress T M; Leser J; Adler G</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1355-66</span>
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    </div><div class="casAbstract">BACKGROUND & AIMS:  The initial pathophysiological events that characterize acute pancreatitis include the formation of pancreatic edema.  An interstitial accumulation of fluid, however, is incompatible with the presence of intact intercellular junctions between acinar cells.  This study examined the major components of adherens junctions, E-cadherin, alpha-catenin, beta-catenin, and actin, during the initial phase of experimental pancreatitis.  METHODS:  Pancreatitis was induced in rats by 10 micrograms.kg-1.h-1 intravenous cerulein for up to 12 hours.  Adherens junction proteins were localized by immunocytochemistry for fluorescence microscopy or electron microscopy, their expression was studied by slot blot analysis, and their association was investigated by immunoprecipitation and Western blot.  RESULTS:  During a rapid increase of E-cadherin-encoding RNA, E-cadherin protein declined only moderately and, unlike its cytoskeletal binding partner actin, was not proteolytically cleaved during pancreatitis.  Morphologically, E-cadherin and beta-catenin were localized at the basolateral cell membrane from where they rapidly dissociated early in pancreatitis and to where they slowly relocalized during the subsequent course.  E-cadherin/beta-catenin complexes disintegrated and reassembled completely in parallel on immunoprecipitation experiments.  CONCLUSIONS:  The dissociation of adherens junctions and the internalization, relocalization, and reassembly of their major components seem to represent the critical biochemical event at cell-cell contacts during edema formation and resolution in acute pancreatitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQf1kHxgdNWNw20zIbnCCI3fW6udTcc2eb_j5XR8ERY8Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2svmtlygsg%253D%253D&md5=616ebc3f037b6f9fa3ac811ee5bb2d12</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1053%2Fgast.1997.v113.pm9322531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fgast.1997.v113.pm9322531%26sid%3Dliteratum%253Aachs%26aulast%3DLerch%26aufirst%3DM.%2BM.%26aulast%3DLutz%26aufirst%3DM.%2BP.%26aulast%3DWeidenbach%26aufirst%3DH.%26aulast%3DMuller-Pillasch%26aufirst%3DF.%26aulast%3DGress%26aufirst%3DT.%2BM.%26aulast%3DLeser%26aufirst%3DJ.%26aulast%3DAdler%26aufirst%3DG.%26atitle%3DDissociation%2520and%2520reassembly%2520of%2520adherens%2520junctions%2520during%2520experimental%2520acute%2520pancreatitis%26jtitle%3DGastroenterology%26date%3D1997%26volume%3D113%26spage%3D1355%26epage%3D1366%26doi%3D10.1053%2Fgast.1997.v113.pm9322531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 4 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Chen</span>, <span class="hlFld-ContribAuthor ">Rong  Huang</span>, <span class="hlFld-ContribAuthor ">Xing-Han  Yun</span>, <span class="hlFld-ContribAuthor ">Tian-Hui  Hao</span>, <span class="hlFld-ContribAuthor ">Sheng-Jiao  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-component cascade reaction of 3-formylchromones: highly selective synthesis of 4,5-dihydro-[4,5′-bipyrimidin]-6(1
              H
              )-one derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2021,</strong> <em>42 </em><a href="https://doi.org/10.1039/D1CC02437J" title="DOI URL">https://doi.org/10.1039/D1CC02437J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1CC02437J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1CC02437J%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DMulti-component%252Bcascade%252Breaction%252Bof%252B3-formylchromones%25253A%252Bhighly%252Bselective%252Bsynthesis%252Bof%252B4%25252C5-dihydro-%25255B4%25252C5%2525E2%252580%2525B2-bipyrimidin%25255D-6%2525281%252BH%252B%252529-one%252Bderivatives%26aulast%3DChen%26aufirst%3DLi%26date%3D2021%26date%3D2021%26volume%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eman A. Abd  El-Meguid</span>, <span class="hlFld-ContribAuthor ">Eman M. Mohi  El-Deen</span>, <span class="hlFld-ContribAuthor ">Manal A.  Nael</span>, <span class="hlFld-ContribAuthor ">Manal M.  Anwar</span>. </span><span class="cited-content_cbyCitation_article-title">Novel benzimidazole derivatives as anti-cervical cancer agents of potential multi-targeting kinase inhibitory activity. </span><span class="cited-content_cbyCitation_journal-name">Arabian Journal of Chemistry</span><span> <strong>2020,</strong> <em>13 </em>
                                    (12)
                                     , 9179-9195. <a href="https://doi.org/10.1016/j.arabjc.2020.10.041" title="DOI URL">https://doi.org/10.1016/j.arabjc.2020.10.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.arabjc.2020.10.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.arabjc.2020.10.041%26sid%3Dliteratum%253Aachs%26jtitle%3DArabian%2520Journal%2520of%2520Chemistry%26atitle%3DNovel%252Bbenzimidazole%252Bderivatives%252Bas%252Banti-cervical%252Bcancer%252Bagents%252Bof%252Bpotential%252Bmulti-targeting%252Bkinase%252Binhibitory%252Bactivity%26aulast%3DEl-Meguid%26aufirst%3DEman%2BA.%2BAbd%26date%3D2020%26volume%3D13%26issue%3D12%26spage%3D9179%26epage%3D9195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongdong  Zhang</span>, <span class="hlFld-ContribAuthor ">Yanhong  Shi</span>, <span class="hlFld-ContribAuthor ">Rui  Xu</span>, <span class="hlFld-ContribAuthor ">Kang  Du</span>, <span class="hlFld-ContribAuthor ">Fujiang  Guo</span>, <span class="hlFld-ContribAuthor ">Kaixian  Chen</span>, <span class="hlFld-ContribAuthor ">Yiming  Li</span>, <span class="hlFld-ContribAuthor ">Rui  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Alkaloid Enantiomers from the Roots of Isatis indigotica. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (17)
                                     , 3140. <a href="https://doi.org/10.3390/molecules24173140" title="DOI URL">https://doi.org/10.3390/molecules24173140</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24173140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24173140%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAlkaloid%252BEnantiomers%252Bfrom%252Bthe%252BRoots%252Bof%252BIsatis%252Bindigotica%26aulast%3DZhang%26aufirst%3DDongdong%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D17%26spage%3D3140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinjie  Ning</span>, <span class="hlFld-ContribAuthor ">Juncheng  Luo</span>, <span class="hlFld-ContribAuthor ">Gengqiang  Ling</span>, <span class="hlFld-ContribAuthor ">Xiaochun  Zhong</span>, <span class="hlFld-ContribAuthor ">Shoulian  Zheng</span>, <span class="hlFld-ContribAuthor ">Jian  Guo</span>, <span class="hlFld-ContribAuthor ">Qingchang  Liu</span>, <span class="hlFld-ContribAuthor ">Binchu  Xu</span>, <span class="hlFld-ContribAuthor ">Xinjie  Ning</span>, <span class="hlFld-ContribAuthor ">Juncheng  Luo</span>, <span class="hlFld-ContribAuthor ">Gengqiang  Ling</span>, <span class="hlFld-ContribAuthor ">Xiaochun  Zhong</span>, <span class="hlFld-ContribAuthor ">Shoulian  Zheng</span>, <span class="hlFld-ContribAuthor ">Jian  Guo</span>, <span class="hlFld-ContribAuthor ">Qingchang  Liu</span>, <span class="hlFld-ContribAuthor ">Binchu  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Role of CTSC in Glioblastoma Based on Oncomine and TCGA Database. </span><span class="cited-content_cbyCitation_journal-name">Trends Journal of Sciences Research</span><span> <strong>2019,</strong> <em>4 </em>
                                    (3)
                                     , 121-126. <a href="https://doi.org/10.31586/Cancer.0403.05" title="DOI URL">https://doi.org/10.31586/Cancer.0403.05</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.31586/Cancer.0403.05&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.31586%2FCancer.0403.05%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520Journal%2520of%2520Sciences%2520Research%26atitle%3DRole%252Bof%252BCTSC%252Bin%252BGlioblastoma%252BBased%252Bon%252BOncomine%252Band%252BTCGA%252BDatabase%26aulast%3DNing%26aufirst%3DXinjie%26date%3D2019%26volume%3D4%26issue%3D3%26spage%3D121%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0001.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of GSK-2793660 and INS1007/AZD7986.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>1</b>–<b>8</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, dimethylformamide (DMF), 110 °C; (b) Cs<sub>2</sub>CO<sub>3</sub>, (±)-2,2′-bis(diphenylphosphino)-1,1′-binaphthyl (BINAP), Pd(OAc)<sub>2</sub>, dioxane, microwave, 130 °C, 1 h; (c) Fe, NH<sub>4</sub>Cl, EtOH/tetrahydrofuran (THF)/H<sub>2</sub>O, 80 °C; (d) acryloyl chloride, triethylamine (TEA), dichloromethane (DCM), 0 °C, 1 h; (e) trifluoroacetic acid (TFA), DCM, room temperature (RT), 2 h; (f) (bromomethyl)cyclopropane or (bromomethyl)cyclopentane, K<sub>2</sub>CO<sub>3</sub>, 70 °C, 4 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>10</b> and <b>11</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMF, 110 °C; (b) 2-methoxy-4-(4-methylpiperazin-1-yl)aniline, Cs<sub>2</sub>CO<sub>3</sub>, BINAP, Pd(OAc)<sub>2</sub>, dioxane, microwave, 130 °C, 1 h; (c) Fe, NH<sub>4</sub>Cl, EtOH/THF/H<sub>2</sub>O, 80 °C; (d) acryloyl chloride, TEA, DCM, 0 °C, 1 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>14</b> and <b>17</b>–<b>20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMF, 110 °C; (b) pyrrolidine, Cs<sub>2</sub>CO<sub>3</sub>, BINAP, Pd<sub>2</sub>(dba)<sub>3</sub>, toluene, 110 °C; (c) 2-methoxy-4-(4-methylpiperazin-1-yl)aniline, Cs<sub>2</sub>CO<sub>3</sub>, BINAP, Pd(OAc)<sub>2</sub>, dioxane, microwave, 130 °C, 1 h; (d) PtO<sub>2</sub>, H<sub>2</sub>, MeOH/THF, RT, overnight; (e) acryloyl chloride, TEA, DCM, 0 °C, 1 h.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0011.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>21</b>–<b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, BINAP, Pd<sub>2</sub>(dba)<sub>3</sub>, toluene, 110 °C or Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub> (2 M), 1,2-dimethoxyethane, 80 °C; (b) 2-methoxy-4-(4-methylpiperazin-1-yl)aniline, Cs<sub>2</sub>CO<sub>3</sub>, BINAP, Pd(OAc)<sub>2</sub>, dioxane, microwave, 130 °C, 1 h; (c) PtO<sub>2</sub>, H<sub>2</sub>, MeOH/THF, RT, overnight; (d) acryloyl chloride, TEA, DCM, 0 °C, 1 h; (e) tetra-<i>n</i>-butylammonium fluoride (TBAF), THF, 0 °C to RT, 2 h.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0012.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compounds <b>27</b>–<b>31</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, BINAP, Pd(OAc)<sub>2</sub>, dioxane, microwave, 130 °C, 1 h; (b) PtO<sub>2</sub>, H<sub>2</sub>, MeOH/THF, RT, overnight; (c) acryloyl chloride, TEA, DCM, 0 °C, 1 h.</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0013.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compounds <b>32</b>–<b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMF, 110 °C; (b) Fe, NH<sub>4</sub>Cl, EtOH/H<sub>2</sub>O, 80 °C; (c) (Boc)<sub>2</sub>O, 4-dimethylaminopyridine (DMAP), TEA, THF, RT, overnight; (d) pyrrolidine or piperidine, Cs<sub>2</sub>CO<sub>3</sub>, BINAP, tris(dibenzylideneacetone)dipalladium(0) (Pd<sub>2</sub>(dba)<sub>3</sub>), toluene, 110 °C; (e) 2-methoxy-4-(4-methylpiperazin-1-yl)aniline, Cs<sub>2</sub>CO<sub>3</sub>, BINAP, Pd(OAc)<sub>2</sub>, dioxane, microwave, 130 °C, 1 h; (f) TFA, DCM, RT; (g) acryloyl chloride, TEA, DCM, 0 °C, 1 h.</p></p></figure><figure data-id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0002.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures and CatC enzymatic inhibitory activity of selected irreversible inhibitors of EGFR and AZD5248<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (a known CatC inhibitor as a tool compound).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0003.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Putative binding mode of WZ4002 (orange) within the active site of CatC (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CDE">4CDE</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0004.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Hit validation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0005.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Putative binding mode of compound <b>22</b> (orange) within the active site of CatC (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CDE">4CDE</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0006.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vivo profiling data (mice) of compound <b>22</b>. Compound <b>22</b> inhibited CatC and the activation of NE, PR3, and CatG in bone marrow and blood, and did so in a dose-dependent manner. Compound <b>22</b> was administered orally twice daily to naive mice (6.7, 20, and 60 mg/kg) for 6 days. The activity inhibition data of compound-treating groups were showed as percentage activity of the vehicle mean (set to 100% activity).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/medium/jm-2019-006317_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0007.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>22</b> reduced the severity of acute pancreatitis: (a) CatC activity in homogenates prepared from mice pancreas samples. Compound <b>22</b> and AZD5248 were administered orally twice daily at 20 mg/kg. The activity inhibition data of the compound-treated groups are shown as the percentage activity of a sham mean (set to 100% activity). Values are means ± standard error of the mean. Statistical significance was considered: <sup>##</sup><i>p</i> < 0.05 vs sham; ** <i>p</i> < 0.05 vs caelurein + vehicle group. (b) Pancreas histology representative photomicrographs. Hematoxylin and eosin staining of formalin-fixed sections of pancreas tissue. Scale bar: 50 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.9b00631/20190621/images/large/jm-2019-006317_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00631&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i84">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00026" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00026" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 36 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janjić, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Štern, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podobnik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamba, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahl, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauritzen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, B.</span></span> <span> </span><span class="NLM_article-title">Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">6570</span>– <span class="NLM_lpage">6582</span>, <span class="refDoi"> DOI: 10.1093/emboj/20.23.6570</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1093%2Femboj%2F20.23.6570" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=11726493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptVaqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=6570-6582&author=D.+Turkauthor=V.+Janji%C4%87author=I.+%C5%A0ternauthor=M.+Podobnikauthor=D.+Lambaauthor=S.+W.+Dahlauthor=C.+Lauritzenauthor=J.+Pedersenauthor=V.+Turkauthor=B.+Turk&title=Structure+of+human+dipeptidyl+peptidase+I+%28cathepsin+C%29%3A+exclusion+domain+added+to+an+endopeptidase+framework+creates+the+machine+for+activation+of+granular+serine+proteases&doi=10.1093%2Femboj%2F20.23.6570"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases</span></div><div class="casAuthors">Turk, Dusan; Janjic, Vojko; Stern, Igor; Podobnik, Marjetka; Lamba, Doriano; Dahl, Soren Weis; Lauritzen, Connie; Pedersen, John; Turk, Vito; Turk, Boris</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6570-6582</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase I (DPPI) or cathepsin C is the physiol. activator of groups of serine proteases from immune and inflammatory cells vital for defense of an organism.  The structure presented shows how an addnl. domain transforms the framework of a papain-like endopeptidase into a robust oligomeric protease-processing enzyme.  The tetrahedral arrangement of the active sites exposed to solvent allows approach of proteins in their native state; the massive body of the exclusion domain fastened within the tetrahedral framework excludes approach of a polypeptide chain apart from its termini; and the carboxylic group of Asp1 positions the N-terminal amino group of the substrate.  Based on a structural comparison and interactions within the active site cleft, it is suggested that the exclusion domain originates from a metallo-protease inhibitor.  The location of missense mutations, characterized in people suffering from Haim-Munk and Papillon-Lefevre syndromes, suggests how they disrupt the fold and function of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoHVah8XLwJrVg90H21EOLACvtfcHk0lgYzJ4YSHImNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptVaqt7w%253D&md5=b505240f0ef236c26b0a6af99a90c63f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F20.23.6570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F20.23.6570%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DD.%26aulast%3DJanji%25C4%2587%26aufirst%3DV.%26aulast%3D%25C5%25A0tern%26aufirst%3DI.%26aulast%3DPodobnik%26aufirst%3DM.%26aulast%3DLamba%26aufirst%3DD.%26aulast%3DDahl%26aufirst%3DS.%2BW.%26aulast%3DLauritzen%26aufirst%3DC.%26aulast%3DPedersen%26aufirst%3DJ.%26aulast%3DTurk%26aufirst%3DV.%26aulast%3DTurk%26aufirst%3DB.%26atitle%3DStructure%2520of%2520human%2520dipeptidyl%2520peptidase%2520I%2520%2528cathepsin%2520C%2529%253A%2520exclusion%2520domain%2520added%2520to%2520an%2520endopeptidase%2520framework%2520creates%2520the%2520machine%2520for%2520activation%2520of%2520granular%2520serine%2520proteases%26jtitle%3DEMBO%2520J.%26date%3D2001%26volume%3D20%26spage%3D6570%26epage%3D6582%26doi%3D10.1093%2Femboj%2F20.23.6570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fonović, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, B.</span></span> <span> </span><span class="NLM_article-title">Cysteine cathepsins and extracellular matrix degradation</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1840</i></span>,  <span class="NLM_fpage">2560</span>– <span class="NLM_lpage">2570</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2014.03.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1016%2Fj.bbagen.2014.03.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=24680817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmt1WqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1840&publication_year=2014&pages=2560-2570&author=M.+Fonovi%C4%87author=B.+Turk&title=Cysteine+cathepsins+and+extracellular+matrix+degradation&doi=10.1016%2Fj.bbagen.2014.03.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cysteine cathepsins and extracellular matrix degradation</span></div><div class="casAuthors">Fonovic, Marko; Turk, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1840</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2560-2570</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Cysteine cathepsins are normally found in the lysosomes where they are involved in intracellular protein turnover.  Their ability to degrade the components of the extracellular matrix in vitro was first reported more than 25 years ago.  However, cathepsins were for a long time not considered to be among the major players in ECM degrdn. in vivo.  During the last decade it has, however, become evident that abundant secretion of cysteine cathepsins into extracellular milieu is accompanying numerous physiol. and disease conditions, enabling the cathepsins to degrade extracellular proteins.  In this review we will focus on cysteine cathepsins and their extracellular functions linked with ECM degrdn., including regulation of their activity, which is often enhanced by acidification of the extracellular microenvironment, such as found in the bone resorption lacunae or tumor microenvironment.  We will further discuss the ECM substrates of cathepsins with a focus on collagen and elastin, including the importance of that for pathologies.  Finally, we will overview the current status of cathepsin inhibitors in clin. development for treatment of ECM-linked diseases, in particular osteoporosis.  Cysteine cathepsins are among the major proteases involved in ECM remodeling, and their role is not limited to degrdn. only.  Deregulation of their activity is linked with numerous ECM-linked diseases and they are now validated targets in a no. of them.  Cathepsins S and K are the most attractive targets, esp. cathepsin K as a major therapeutic target for osteoporosis with drugs targeting it in advanced clin. trials.  Due to their major role in ECM remodeling cysteine cathepsins have emerged as an important group of therapeutic targets for a no. of ECM-related diseases, including, osteoporosis, cancer and cardiovascular diseases.  This article is part of a Special Issue entitled Matrix-mediated cell behavior and properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3SBbdcbnoELVg90H21EOLACvtfcHk0lgYzJ4YSHImNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmt1WqsLs%253D&md5=16b74089dd830919e624133cbc7d0421</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2014.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2014.03.017%26sid%3Dliteratum%253Aachs%26aulast%3DFonovi%25C4%2587%26aufirst%3DM.%26aulast%3DTurk%26aufirst%3DB.%26atitle%3DCysteine%2520cathepsins%2520and%2520extracellular%2520matrix%2520degradation%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2014%26volume%3D1840%26spage%3D2560%26epage%3D2570%26doi%3D10.1016%2Fj.bbagen.2014.03.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, B.</span></span> <span> </span><span class="NLM_article-title">The future of cysteine cathepsins in disease management</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">873</span>– <span class="NLM_lpage">898</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2017.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1016%2Fj.tips.2017.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=28668224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCht7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=873-898&author=L.+Kramerauthor=D.+Turkauthor=B.+Turk&title=The+future+of+cysteine+cathepsins+in+disease+management&doi=10.1016%2Fj.tips.2017.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The Future of Cysteine Cathepsins in Disease Management</span></div><div class="casAuthors">Kramer, Lovro; Turk, Dusan; Turk, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">873-898</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Since the discovery of the key role of cathepsin K in bone resorption, cysteine cathepsins have been investigated by pharmaceutical companies as drug targets.  The first clin. results from targeting cathepsins by activity-based probes and substrates are paving the way for the next generation of mol. diagnostic imaging, whereas the majority of antibody-drug conjugates currently in clin. trials depend on activation by cathepsins.  Finally, cathepsins have emerged as suitable vehicles for targeted drug delivery.  It is therefore timely to review the future of cathepsins in drug discovery.  We focus here on inflammation-assocd. diseases because dysregulation of the immune system accompanied by elevated cathepsin activity is a common feature of these conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpygt3-Q-qJ3bVg90H21EOLACvtfcHk0lgYzJ4YSHImNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCht7bI&md5=acf27aa07e741a6da38e866d4fe3f292</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2017.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2017.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DL.%26aulast%3DTurk%26aufirst%3DD.%26aulast%3DTurk%26aufirst%3DB.%26atitle%3DThe%2520future%2520of%2520cysteine%2520cathepsins%2520in%2520disease%2520management%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2017%26volume%3D38%26spage%3D873%26epage%3D898%26doi%3D10.1016%2Fj.tips.2017.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adkison, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raptis, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, C. T. N.</span></span> <span> </span><span class="NLM_article-title">Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">371</span>, <span class="refDoi"> DOI: 10.1172/JCI0213462</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1172%2FJCI0213462" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=11827996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtV2isLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=363-371&author=A.+M.+Adkisonauthor=S.+Z.+Raptisauthor=D.+G.+Kelleyauthor=C.+T.+N.+Pham&title=Dipeptidyl+peptidase+I+activates+neutrophil-derived+serine+proteases+and+regulates+the+development+of+acute+experimental+arthritis&doi=10.1172%2FJCI0213462"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis</span></div><div class="casAuthors">Adkison, April M.; Raptis, Sofia Z.; Kelley, Diane G.; Pham, Christine T. N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">363-371</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Leukocyte recruitment in inflammation is crit. for host defense, but excessive accumulation of inflammatory cells can lead to tissue damage.  Neutrophil-derived serine proteases (cathepsin G [CG], neutrophil elastase [NE], and proteinase 3 [PR3]) are expressed specifically in mature neutrophils and are thought to play an important role in inflammation.  To investigate the role of these proteases in inflammation, we generated a mouse deficient in dipeptidyl peptidase I (DPPI) and established that DPPI is required for the full activation of CG, NE, and PR3.  Although DPPI-/- mice have normal in vitro neutrophil chemotaxis and in vivo neutrophil accumulation during sterile peritonitis, they are protected against acute arthritis induced by passive transfer of monoclonal antibodies against type II collagen.  Specifically, there is no accumulation of neutrophils in the joints of DPPI-/- mice.  This protective effect correlates with the inactivation of neutrophil-derived serine proteases, since NE-/- × CG-/- mice are equally resistant to arthritis induction by anti-collagen antibodies.  In addn., protease-deficient mice have decreased response to zymosan- and immune complex-mediated inflammation in the s.c. air pouch.  This defect is accompanied by a decrease in local prodn. of TNF-α and IL-1β.  These results implicate DPPI and polymorphonuclear neutrophil-derived serine proteases in the regulation of cytokine prodn. at sites of inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe4N4iJlOG8bVg90H21EOLACvtfcHk0lhbBRWVVYXIhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtV2isLc%253D&md5=66adb9a264a0ed93597d6c36305d6375</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1172%2FJCI0213462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI0213462%26sid%3Dliteratum%253Aachs%26aulast%3DAdkison%26aufirst%3DA.%2BM.%26aulast%3DRaptis%26aufirst%3DS.%2BZ.%26aulast%3DKelley%26aufirst%3DD.%2BG.%26aulast%3DPham%26aufirst%3DC.%2BT.%2BN.%26atitle%3DDipeptidyl%2520peptidase%2520I%2520activates%2520neutrophil-derived%2520serine%2520proteases%2520and%2520regulates%2520the%2520development%2520of%2520acute%2520experimental%2520arthritis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2002%26volume%3D109%26spage%3D363%26epage%3D371%26doi%3D10.1172%2FJCI0213462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, C. T. N.</span></span> <span> </span><span class="NLM_article-title">Dipeptidyl peptidase I regulates the development of collagen-induced arthritis</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2553</span>– <span class="NLM_lpage">2558</span>, <span class="refDoi"> DOI: 10.1002/art.21192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1002%2Fart.21192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=16059912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpslGhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=2553-2558&author=Y.+Huauthor=C.+T.+N.+Pham&title=Dipeptidyl+peptidase+I+regulates+the+development+of+collagen-induced+arthritis&doi=10.1002%2Fart.21192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase I regulates the development of collagen-induced arthritis</span></div><div class="casAuthors">Hu, Ying; Pham, Christine T. N.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2553-2558</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: To examine the role of dipeptidyl peptidase I (DPPI), a widely expressed lysosomal cysteine protease, in the development of collagen-induced arthritis (CIA) in mice.  Methods: Wild-type (WT) and DPPI-deficient (DPPI-/-) mice backcrossed to DBA/1J mice for 10 generations were immunized with bovine type II collagen (CII), and disease susceptibility and severity were assessed over time.  Collagen-specific B cell and T cell responses and the prodn. of proinflammatory cytokines (tumor necrosis factor α, interleukin-1, and interleukin-6) were measured.  In addn., adoptive transfer of splenocytes from WT, CII-sensitized mice was performed to evaluate the specific role of DPPI-/- T lymphocytes.  Results: The majority of DPPI-/- mice were resistant to CIA induction, although clin. disease (i.e., evidence of inflammation and bone erosions) did develop in a small no. of DPPI-/- mice.  The protection against disease development was not attributable to a defect in the B and T cell response to collagen immunization, because both anticollagen antibody prodn. and T cell proliferation in response to CII were normal.  Release of the proinflammatory cytokines was largely unaffected in CII-stimulated DPPI-/- splenocytes.  In addn., when cells isolated from the joints of DPPI-/- mice were stimulated in vitro, they had no intrinsic defect in their ability to release inflammatory cytokines.  Last, adoptive transfer of splenocytes from WT, CII-immunized mice into naive WT and DPPI-/- mice led to development of arthritis in WT mice but not in DPPI-/- mice.  Conclusion: These results indicate that DPPI regulates a crit. step in the development of CIA that is independent of T cell and B cell functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6W442OlyjAbVg90H21EOLACvtfcHk0lhbBRWVVYXIhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpslGhtL8%253D&md5=3529b07eceea274133a690492acfe207</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fart.21192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.21192%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DPham%26aufirst%3DC.%2BT.%2BN.%26atitle%3DDipeptidyl%2520peptidase%2520I%2520regulates%2520the%2520development%2520of%2520collagen-induced%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2005%26volume%3D52%26spage%3D2553%26epage%3D2558%26doi%3D10.1002%2Fart.21192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mallen-St.
Clair, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, C. T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalta, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caughey, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolters, P. J.</span></span> <span> </span><span class="NLM_article-title">Mast cell dipeptidyl peptidase I mediates survival from sepsis</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">628</span>– <span class="NLM_lpage">634</span>, <span class="refDoi"> DOI: 10.1172/JCI200419062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1172%2FJCI200419062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=14966572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFKhtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2004&pages=628-634&author=J.+Mallen-St.%0AClairauthor=C.+T.+N.+Phamauthor=S.+A.+Villaltaauthor=G.+H.+Caugheyauthor=P.+J.+Wolters&title=Mast+cell+dipeptidyl+peptidase+I+mediates+survival+from+sepsis&doi=10.1172%2FJCI200419062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Mast cell dipeptidyl peptidase I mediates survival from sepsis</span></div><div class="casAuthors">Mallen-St. Clair, Jon; Pham, Christine T. N.; Villalta, S. Armando; Caughey, George H.; Wolters, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">628-634</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Sepsis is a common, life-threatening disease for which there is little treatment.  The cysteine protease dipeptidyl peptidase I (DPPI) activates granule-assocd. serine proteases, several of which play important roles in host responses to bacterial infection.  To examine DPPI's role in sepsis, we compared DPPI-/- and DPPI+/+ mice using the cecal ligation and puncture (CLP) model of septic peritonitis, finding that DPPI-/- mice are far more likely to survive sepsis.  Outcomes of CLP in mice lacking mast cell DPPI reveal that the absence of DPPI in mast cells, rather than in other cell types, is responsible for the survival advantage.  Among several cytokines surveyed in peritoneal fluid and serum, IL-6 is highly and differentially expressed in DPPI-/- mice compared with DPPI+/+ mice.  Remarkably, deleting IL-6 expression in DPPI-/- mice eliminates the survival advantage.  The increase in IL-6 in septic DPPI-/- mice, which appears to protect these mice from death, may be related to reduced DPPI-mediated activation of mast cell tryptase and other peptidases, which we show cleave IL-6 in vitro.  These results indicate that mast cell DPPI harms the septic host and that DPPI is a novel potential therapeutic target for treatment of sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7pmJzuL2jpbVg90H21EOLACvtfcHk0lhbBRWVVYXIhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFKhtrw%253D&md5=1c26daef798e0df4ccb7406e5f609279</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1172%2FJCI200419062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI200419062%26sid%3Dliteratum%253Aachs%26aulast%3DMallen-St.%2BClair%26aufirst%3DJ.%26aulast%3DPham%26aufirst%3DC.%2BT.%2BN.%26aulast%3DVillalta%26aufirst%3DS.%2BA.%26aulast%3DCaughey%26aufirst%3DG.%2BH.%26aulast%3DWolters%26aufirst%3DP.%2BJ.%26atitle%3DMast%2520cell%2520dipeptidyl%2520peptidase%2520I%2520mediates%2520survival%2520from%2520sepsis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2004%26volume%3D113%26spage%3D628%26epage%3D634%26doi%3D10.1172%2FJCI200419062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, C. T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luft, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettritz, R.</span></span> <span> </span><span class="NLM_article-title">Neutrophil serine proteases promote IL-1β generation and injury in necrotizing crescentic glomerulonephritis</span>. <i>J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">470</span>– <span class="NLM_lpage">482</span>, <span class="refDoi"> DOI: 10.1681/ASN.2010080892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1681%2FASN.2010080892" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=22241891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1Omtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=470-482&author=A.+Schreiberauthor=C.+T.+N.+Phamauthor=Y.+Huauthor=W.+Schneiderauthor=F.+C.+Luftauthor=R.+Kettritz&title=Neutrophil+serine+proteases+promote+IL-1%CE%B2+generation+and+injury+in+necrotizing+crescentic+glomerulonephritis&doi=10.1681%2FASN.2010080892"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Neutrophil serine proteases promote IL-1β generation and injury in necrotizing crescentic glomerulonephritis</span></div><div class="casAuthors">Schreiber, Adrian; Pham, Christine T. N.; Hu, Ying; Schneider, Wolfgang; Luft, Friedrich C.; Kettritz, Ralph</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">470-482</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">The pathogenesis of anti-neutrophil cytoplasmic antibody (ANCA)-assocd. necrotizing crescentic GN (NCGN) is incompletely understood.  Dipeptidyl peptidase I (DPPI) is a cysteine protease required for the activation of neutrophil serine proteases (NSPs) cathepsin G, neutrophil elastase, and proteinase 3, which are enzymes that modulate inflammation.  We used a mouse model of anti-myeloperoxidase (MPO) antibody-induced NCGN to det. whether active NSPs contribute to its pathogenesis.  MPO-deficient animals immunized with murine MPO, irradiated, and transplanted with wild-type bone marrow developed NCGN.  In contrast, transplantation with bone marrow that lacked DPPI or lacked both neutrophil elastase and proteinase 3 protected mice from NCGN induced by anti-MPO antibody.  The kidneys of mice reconstituted with DPPI-deficient bone marrow generated significantly less IL-1β than did those of mice reconstituted with wild-type bone marrow; similarly, in vitro, DPPI-deficient monocytes produced significantly less IL-1β in response to anti-MPO antibody than did wild-type monocytes.  This redn. in IL-1β was NSP dependent; exogenous addn. of PR3 restored IL-β prodn. in DPPI-deficient monocytes.  Last, the IL-1 receptor antagonist anakinra protected animals against anti-MPO antibody-induced NCGN (16.7% ± 6.0% vs. 2.4% ± 1.7% crescents), suggesting that IL-1β is a crit. inflammatory mediator in this model.  These data suggest that the development of anti-MPO antibody-induced NCGN requires NSP-dependent IL-1β generation and that these processes may provide therapeutic targets for ANCA-mediated diseases in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4kBPXPLIUObVg90H21EOLACvtfcHk0lik5eDu2chiTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1Omtrs%253D&md5=035520a00b3f4670e458c3589534a05f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1681%2FASN.2010080892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2010080892%26sid%3Dliteratum%253Aachs%26aulast%3DSchreiber%26aufirst%3DA.%26aulast%3DPham%26aufirst%3DC.%2BT.%2BN.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DSchneider%26aufirst%3DW.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DKettritz%26aufirst%3DR.%26atitle%3DNeutrophil%2520serine%2520proteases%2520promote%2520IL-1%25CE%25B2%2520generation%2520and%2520injury%2520in%2520necrotizing%2520crescentic%2520glomerulonephritis%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2012%26volume%3D23%26spage%3D470%26epage%3D482%26doi%3D10.1681%2FASN.2010080892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, P. J.</span></span> <span> </span><span class="NLM_article-title">Cellular and molecular mechanisms of chronic obstructive pulmonary disease</span>. <i>Clin. Chest Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1016/j.ccm.2013.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1016%2Fj.ccm.2013.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=24507838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A280%3ADC%252BC2crmsVKhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=71-86&author=P.+J.+Barnes&title=Cellular+and+molecular+mechanisms+of+chronic+obstructive+pulmonary+disease&doi=10.1016%2Fj.ccm.2013.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular and molecular mechanisms of chronic obstructive pulmonary disease</span></div><div class="casAuthors">Barnes Peter J</div><div class="citationInfo"><span class="NLM_cas:title">Clinics in chest medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chronic obstructive pulmonary disease is associated with chronic inflammation affecting predominantly lung parenchyma and peripheral airways and results in largely irreversible and progressive airflow limitation.  This inflammation is characterized by increased numbers of alveolar macrophages, neutrophils, and T lymphocytes, which are recruited from the circulation.  Oxidative stress plays a key role in driving this inflammation.  The pulmonary inflammation may enhance the development and growth of lung cancer.  The peripheral inflammation extends into the circulation, resulting in systemic inflammation with the same inflammatory proteins.  Systemic inflammation may worsen comorbidities.  Treatment of pulmonary inflammation may therefore have beneficial effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQWZ0g10qbTewHqQV89nF-2fW6udTcc2ebaAWpP0JuHNbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crmsVKhtg%253D%253D&md5=76c97406be7f91550a7cdac0cfaf3b9b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.ccm.2013.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccm.2013.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DP.%2BJ.%26atitle%3DCellular%2520and%2520molecular%2520mechanisms%2520of%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DClin.%2520Chest%2520Med.%26date%3D2014%26volume%3D35%26spage%3D71%26epage%3D86%26doi%3D10.1016%2Fj.ccm.2013.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><a href="http://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death" class="extLink">http://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death</a> (accessed May 5, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.who.int%2Fnews-room%2Ffact-sheets%2Fdetail%2Fthe-top-10-causes-of-death+%28accessed+May+5%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamon, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legowska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hervé, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallet-Choisy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand-Adam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderlynden, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demonte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si-Tahar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuzé-Vourc’h, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalmanach, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenne, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korkmaz, B.</span></span> <span> </span><span class="NLM_article-title">Neutrophilic cathepsin C is maturated by a multi-step proteolytic process and secreted by activated cells during inflammatory lung diseases</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">8486</span>– <span class="NLM_lpage">8499</span>, <span class="refDoi"> DOI: 10.1074/jbc.M115.707109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1074%2Fjbc.M115.707109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=26884336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVyitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=8486-8499&author=Y.+Hamonauthor=M.+Legowskaauthor=V.+Herv%C3%A9author=S.+Dallet-Choisyauthor=S.+Marchand-Adamauthor=L.+Vanderlyndenauthor=M.+Demonteauthor=R.+Williamsauthor=C.+J.+Scottauthor=M.+Si-Taharauthor=N.+Heuz%C3%A9-Vourc%E2%80%99hauthor=G.+Lalmanachauthor=D.+E.+Jenneauthor=A.+Lesnerauthor=F.+Gauthierauthor=B.+Korkmaz&title=Neutrophilic+cathepsin+C+is+maturated+by+a+multi-step+proteolytic+process+and+secreted+by+activated+cells+during+inflammatory+lung+diseases&doi=10.1074%2Fjbc.M115.707109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Neutrophilic Cathepsin C Is Maturated by a Multistep Proteolytic Process and Secreted by Activated Cells during Inflammatory Lung Diseases</span></div><div class="casAuthors">Hamon, Yveline; Legowska, Monika; Herve, Virginie; Dallet-Choisy, Sandrine; Marchand-Adam, Sylvain; Vanderlynden, Lise; Demonte, Michele; Williams, Rich; Scott, Christopher J.; Si-Tahar, Mustapha; Heuze-Vourc'h, Nathalie; Lalmanach, Gilles; Jenne, Dieter E.; Lesner, Adam; Gauthier, Francis; Korkmaz, Brice</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">8486-8499</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The cysteine protease cathepsin C (CatC) activates granule-assocd. proinflammatory serine proteases in hematopoietic precursor cells.  Its early inhibition in the bone marrow is regarded as a new therapeutic strategy for treating proteolysis-driven chronic inflammatory diseases, but its complete inhibition is elusive in vivo.  Controlling the activity of CatC may be achieved by directly inhibiting its activity with a specific inhibitor or/and by preventing its maturation.  We have investigated immunochem. and kinetically the occurrence of CatC and its proform in human hematopoietic precursor cells and in differentiated mature immune cells in lung secretions.  The maturation of proCatC obeys a multistep mechanism that can be entirely managed by CatS in neutrophilic precursor cells.  CatS inhibition by a cell-permeable inhibitor abrogated the release of the heavy and light chains from proCatC and blocked ∼80% of CatC activity.  Under these conditions the activity of neutrophil serine proteases, however, was not abolished in precursor cell cultures.  In patients with neutrophilic lung inflammation, mature CatC is found in large amts. in sputa.  It is secreted by activated neutrophils as confirmed through lipopolysaccharide administration in a nonhuman primate model.  CatS inhibitors currently in clin. trials are expected to decrease the activity of neutrophilic CatC without affecting those of elastase-like serine proteases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3pYa55IgDPLVg90H21EOLACvtfcHk0lik5eDu2chiTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVyitrc%253D&md5=e910fbabdfe80c79544fafd7332c6fdc</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.707109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.707109%26sid%3Dliteratum%253Aachs%26aulast%3DHamon%26aufirst%3DY.%26aulast%3DLegowska%26aufirst%3DM.%26aulast%3DHerv%25C3%25A9%26aufirst%3DV.%26aulast%3DDallet-Choisy%26aufirst%3DS.%26aulast%3DMarchand-Adam%26aufirst%3DS.%26aulast%3DVanderlynden%26aufirst%3DL.%26aulast%3DDemonte%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DScott%26aufirst%3DC.%2BJ.%26aulast%3DSi-Tahar%26aufirst%3DM.%26aulast%3DHeuz%25C3%25A9-Vourc%25E2%2580%2599h%26aufirst%3DN.%26aulast%3DLalmanach%26aufirst%3DG.%26aulast%3DJenne%26aufirst%3DD.%2BE.%26aulast%3DLesner%26aufirst%3DA.%26aulast%3DGauthier%26aufirst%3DF.%26aulast%3DKorkmaz%26aufirst%3DB.%26atitle%3DNeutrophilic%2520cathepsin%2520C%2520is%2520maturated%2520by%2520a%2520multi-step%2520proteolytic%2520process%2520and%2520secreted%2520by%2520activated%2520cells%2520during%2520inflammatory%2520lung%2520diseases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D8486%26epage%3D8499%26doi%3D10.1074%2Fjbc.M115.707109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korkmaz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caughey, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapple, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirschfeld, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenne, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettritz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalmanach, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamort, A.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauritzen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Łȩgowska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand-Adam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKaig, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seren, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thakker, N. S.</span></span> <span> </span><span class="NLM_article-title">Therapeutic targeting of cathepsin C: from pathophysiology to treatment</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>190</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2018.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1016%2Fj.pharmthera.2018.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=29842917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A280%3ADC%252BC1Mbhtlyhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2018&pages=202-236&author=B.+Korkmazauthor=G.+H.+Caugheyauthor=I.+Chappleauthor=F.+Gauthierauthor=J.+Hirschfeldauthor=D.+E.+Jenneauthor=R.+Kettritzauthor=G.+Lalmanachauthor=A.-S.+Lamortauthor=C.+Lauritzenauthor=M.+%C5%81%C8%A9gowskaauthor=A.+Lesnerauthor=S.+Marchand-Adamauthor=S.+J.+McKaigauthor=C.+Mossauthor=J.+Pedersenauthor=H.+Robertsauthor=A.+Schreiberauthor=S.+Serenauthor=N.+S.+Thakker&title=Therapeutic+targeting+of+cathepsin+C%3A+from+pathophysiology+to+treatment&doi=10.1016%2Fj.pharmthera.2018.05.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of cathepsin C: from pathophysiology to treatment</span></div><div class="casAuthors">Korkmaz Brice; Caughey George H; Chapple Iain; Hirschfeld Josefine; Roberts Helen; Gauthier Francis; Lalmanach Gilles; Marchand-Adam Sylvain; Seren Seda; Jenne Dieter E; Lamort Anne-Sophie; Kettritz Ralph; Schreiber Adrian; Lauritzen Conni; Pedersen John; L gowska Monika; Lesner Adam; McKaig Sarah J; Moss Celia; Thakker Nalin S</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">202-236</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cathepsin C (CatC) is a highly conserved tetrameric lysosomal cysteine dipeptidyl aminopeptidase.  The best characterized physiological function of CatC is the activation of pro-inflammatory granule-associated serine proteases.  These proteases are synthesized as inactive zymogens containing an N-terminal pro-dipeptide, which maintains the zymogen in its inactive conformation and prevents premature activation, which is potentially toxic to the cell.  The activation of serine protease zymogens occurs through cleavage of the N-terminal dipeptide by CatC during cell maturation in the bone marrow.  In vivo data suggest that pharmacological inhibition of pro-inflammatory serine proteases would suppress or attenuate deleterious effects mediated by these proteases in inflammatory/auto-immune disorders.  The pathological deficiency in CatC is associated with Papillon-Lefevre syndrome (PLS).  The patients however do not present marked immunodeficiency despite the absence of active serine proteases in immune defense cells.  Hence, the transitory pharmacological blockade of CatC activity in the precursor cells of the bone marrow may represent an attractive therapeutic strategy to regulate activity of serine proteases in inflammatory and immunologic conditions.  A variety of CatC inhibitors have been developed both by pharmaceutical companies and academic investigators, some of which are currently being employed and evaluated in preclinical/clinical trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRS91OmpXGfGcNIRw0GKUoEfW6udTcc2eYh1Hnruj7gvLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mbhtlyhsw%253D%253D&md5=e4d3a57b7b445195d109159c40897ff8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2018.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2018.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DKorkmaz%26aufirst%3DB.%26aulast%3DCaughey%26aufirst%3DG.%2BH.%26aulast%3DChapple%26aufirst%3DI.%26aulast%3DGauthier%26aufirst%3DF.%26aulast%3DHirschfeld%26aufirst%3DJ.%26aulast%3DJenne%26aufirst%3DD.%2BE.%26aulast%3DKettritz%26aufirst%3DR.%26aulast%3DLalmanach%26aufirst%3DG.%26aulast%3DLamort%26aufirst%3DA.-S.%26aulast%3DLauritzen%26aufirst%3DC.%26aulast%3D%25C5%2581%25C8%25A9gowska%26aufirst%3DM.%26aulast%3DLesner%26aufirst%3DA.%26aulast%3DMarchand-Adam%26aufirst%3DS.%26aulast%3DMcKaig%26aufirst%3DS.%2BJ.%26aulast%3DMoss%26aufirst%3DC.%26aulast%3DPedersen%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DH.%26aulast%3DSchreiber%26aufirst%3DA.%26aulast%3DSeren%26aufirst%3DS.%26aulast%3DThakker%26aufirst%3DN.%2BS.%26atitle%3DTherapeutic%2520targeting%2520of%2520cathepsin%2520C%253A%2520from%2520pathophysiology%2520to%2520treatment%26jtitle%3DPharmacol.%2520Ther.%26date%3D2018%26volume%3D190%26spage%3D202%26epage%3D236%26doi%3D10.1016%2Fj.pharmthera.2018.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Podolin, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognese, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpenter, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wixted, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kou, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capper-Spudich, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McQueney, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Booth-Genthe, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palovich, M. R.</span></span> <span> </span><span class="NLM_article-title">Cathepsin C inhibition: a novel approach for the treatment of chronic respiratory diseases</span>. <i>Am. J. Respir. Crit. Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>187</i></span>,  <span class="NLM_fpage">A1500</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2013&pages=A1500&author=P.+L.+Podolinauthor=B.+J.+Bologneseauthor=J.+P.+Foleyauthor=D.+C.+Carpenterauthor=G.+A.+Loganauthor=W.+E.+Wixtedauthor=J.+P.+Kouauthor=E.+A.+Capper-Spudichauthor=M.+S.+McQueneyauthor=C.+L.+Booth-Gentheauthor=M.+R.+Palovich&title=Cathepsin+C+inhibition%3A+a+novel+approach+for+the+treatment+of+chronic+respiratory+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPodolin%26aufirst%3DP.%2BL.%26aulast%3DBolognese%26aufirst%3DB.%2BJ.%26aulast%3DFoley%26aufirst%3DJ.%2BP.%26aulast%3DCarpenter%26aufirst%3DD.%2BC.%26aulast%3DLogan%26aufirst%3DG.%2BA.%26aulast%3DWixted%26aufirst%3DW.%2BE.%26aulast%3DKou%26aufirst%3DJ.%2BP.%26aulast%3DCapper-Spudich%26aufirst%3DE.%2BA.%26aulast%3DMcQueney%26aufirst%3DM.%2BS.%26aulast%3DBooth-Genthe%26aufirst%3DC.%2BL.%26aulast%3DPalovich%26aufirst%3DM.%2BR.%26atitle%3DCathepsin%2520C%2520inhibition%253A%2520a%2520novel%2520approach%2520for%2520the%2520treatment%2520of%2520chronic%2520respiratory%2520diseases%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2013%26volume%3D187%26spage%3DA1500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kam, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudig, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. C.</span></span> <span> </span><span class="NLM_article-title">Dipeptidyl peptidase I: importance of progranzyme activation sequences, other dipeptide sequences, and the N-terminal amino group of synthetic substrates for enzyme activity</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>403</i></span>,  <span class="NLM_fpage">160</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1016/S0003-9861(02)00217-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1016%2FS0003-9861%2802%2900217-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=12139965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFKgu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=403&publication_year=2002&pages=160-170&author=T.+V.+Tranauthor=K.+A.+Ellisauthor=C.-M.+Kamauthor=D.+Hudigauthor=J.+C.+Powers&title=Dipeptidyl+peptidase+I%3A+importance+of+progranzyme+activation+sequences%2C+other+dipeptide+sequences%2C+and+the+N-terminal+amino+group+of+synthetic+substrates+for+enzyme+activity&doi=10.1016%2FS0003-9861%2802%2900217-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase I: importance of progranzyme activation sequences, other dipeptide sequences, and the N-terminal amino group of synthetic substrates for enzyme activity</span></div><div class="casAuthors">Tran, Tinh V.; Ellis, Karen A.; Kam, Chih-Min; Hudig, Dorothy; Powers, James C.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">403</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">160-170</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">The broadly reactive cysteine protease dipeptidyl peptidase I (DPPI, cathepsin C) is thought to activate all progranzymes (zymogens of lymphocyte serine proteases) to form mature granzymes.  We synthesized dipeptide 7-amino-4-methylcoumarin (AMC) substrates contg. progranzyme activation sequences and showed that they were efficiently hydrolyzed by DPPI.  However, DPPI will not hydrolyze Ile-Ile-AMC, the N-terminal dipeptide sequence found in mature granzymes.  Introduction of the nonphysiol. homophenylalanine (Hph) residue at P1 resulted in the best substrate Ala-Hph-AMC for DPPI (kcat/Km=9,000,000 M-1 s-1).  The charged N-terminal amino group of the substrate was essential and replacement of the NH2 group with OH or NH(CH3) in Gly-Phe-AMC reduced the kcat/Km value by two to three orders of magnitude.  A hydrazide azaglycine analog, NH2NHCO-Phe-AMC, was not hydrolyzed at pH 5.5, but underwent slow hydrolysis at lower pHs where the amino group is partially protonated.  DPPI also failed to hydrolyze NH2COCH2-Phe-AMC, where the NH2 group is unprotonated.  The results reported in this paper should be useful in the design of better DPPI inhibitors to block granzyme maturation and granzyme-dependent apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp70G9oGB-iibVg90H21EOLACvtfcHk0lgNGzd7rTXu7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFKgu70%253D&md5=6d9e37195921419eebfd0839dcfe5f9d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0003-9861%2802%2900217-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0003-9861%252802%252900217-5%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DT.%2BV.%26aulast%3DEllis%26aufirst%3DK.%2BA.%26aulast%3DKam%26aufirst%3DC.-M.%26aulast%3DHudig%26aufirst%3DD.%26aulast%3DPowers%26aufirst%3DJ.%2BC.%26atitle%3DDipeptidyl%2520peptidase%2520I%253A%2520importance%2520of%2520progranzyme%2520activation%2520sequences%252C%2520other%2520dipeptide%2520sequences%252C%2520and%2520the%2520N-terminal%2520amino%2520group%2520of%2520synthetic%2520substrates%2520for%2520enzyme%2520activity%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2002%26volume%3D403%26spage%3D160%26epage%3D170%26doi%3D10.1016%2FS0003-9861%2802%2900217-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laine, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busch-Petersen, J.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of cathepsin C (dipeptidyl peptidase I)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1517/13543771003657172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1517%2F13543771003657172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=20205619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslamuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=497-506&author=D.+I.+Laineauthor=J.+Busch-Petersen&title=Inhibitors+of+cathepsin+C+%28dipeptidyl+peptidase+I%29&doi=10.1517%2F13543771003657172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of cathepsin C (dipeptidyl peptidase I)</span></div><div class="casAuthors">Laine, Dramane I.; Busch-Petersen, Jakob</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">497-506</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance to the field: Cathepsin C (dipeptidyl peptidase I) plays a key role in the activation of several degradative enzymes linked to tissue destruction in inflammatory diseases.  Thus, cathepsin C inhibitors could potentially be effective therapeutics for the treatment of such diseases as chronic obstructive pulmonary disease and cystic fibrosis.  Areas covered in this review: Although this article focuses on cathepsin C inhibitor patents, the journal literature concerning small mol. inhibitors of the enzyme is also covered comprehensively (1981 - 2009).  What the reader will gain: It is our aim to give the reader a complete overview of the cathepsin C inhibitor chemotypes that have been disclosed to date.  In addn., key biol. data have been included for both irreversible and reversible inhibitors.  Take home message: All known cathepsin C inhibitors are believed to have a covalent interaction with the Cys-234 residue of the enzyme.  The electrophilic and sometimes peptidic nature of these mols. is assocd. with poor metabolic stability and is also a potential safety concern.  Thus, overcoming developability issues is a serious hurdle for these compds. and there can be little doubt that this is the principal reason why no cathepsin C inhibitors appear to have reached clin. development so far.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdwKOpSi2hZ7Vg90H21EOLACvtfcHk0lg7o_KvyPoO3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslamuro%253D&md5=f53116f8e20d29cc8eb8ed5643a30625</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1517%2F13543771003657172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543771003657172%26sid%3Dliteratum%253Aachs%26aulast%3DLaine%26aufirst%3DD.%2BI.%26aulast%3DBusch-Petersen%26aufirst%3DJ.%26atitle%3DInhibitors%2520of%2520cathepsin%2520C%2520%2528dipeptidyl%2520peptidase%2520I%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D497%26epage%3D506%26doi%3D10.1517%2F13543771003657172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Green, G. D. J.</span>; <span class="NLM_string-name">Shaw, E.</span></span> <span> </span><span class="NLM_article-title">Peptidyl diazomethyl ketones are specific inactivators of thiol proteinases</span>.  <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1981</span> <span class="NLM_fpage">1923</span>– <span class="NLM_lpage">1928</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=7007374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADyaL3MXhsFantbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1981&pages=1923-1928&author=G.+D.+J.+Green&author=E.+Shaw&title=Peptidyl+diazomethyl+ketones+are+specific+inactivators+of+thiol+proteinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidyl diazomethyl ketones are specific inactivators of thiol proteinases</span></div><div class="casAuthors">Green, George D. J.; Shaw, Elliott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1923-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Peptidyl diazomethyl ketones are specific inactivators of thiol proteinases, being unreactive toward other classes of proteinases.  Variation of the peptide portion of the reagents has provided affinity labels for the selective inactivation of the thiol endopeptidases, cathepsin B, streptococcal proteinase, and clostripain, and for the aminodipeptidase, cathepsin C.  Comparison of rates of inactivation of cathepsin B and streptococcal proteinase revealed a similarity in specificity, both enzymes showing a preference for a phenylalanine residue in the penultimate position of the peptide portion of the reagent.  Reagents not satisfying the specificity of a particular thiol proteinase either did not inactivate or did so only very slowly.  In some cases, the reagents bound to the enzyme in a manner unproductive for alkylation but productive for substrate behavior leading to destruction of the inhibitor by cleavage of the peptide portion.  Thus, benzyloxycarbonyl-Phe-Gly-Phe diazomethyl ketone was rapidly cleaved by cathepsin B into benzyloxycarbonyl-Phe-Gly and phenylalanine diazomethyl ketone.  Clostripain, an enzyme of trypsin-like specificity, was selectively inactivated by benzyloxycarbonyllysine diazomethyl ketone at micromolar concns., but was inactivated extremely slowly by 2.5 × 10-4M benzyloxycarbonyl-Phe-Ala diazomethyl ketone, a very effective inactivator of cathepsin B.  Cathepsin C, a thiol aminodipeptidase, was inactivated by Gly-Phe diazomethyl ketone in the range of 10-7 to 10-8M.  By comparison, peptidyl diazomethyl ketones with blocked N-terminals were considerably less effective.  Peptidyl diazomethyl ketones are unreactive with such thiols, as mercaptoethanol and glutathione.  This property and the lack of reactivity toward other classes of proteinases suggest the usefulness of this class of inhibitors as diagnostic reagents for both in vitro and in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOZmm7XqRtDrVg90H21EOLACvtfcHk0lg7o_KvyPoO3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXhsFantbY%253D&md5=2c019d5fb8e8c9adb42942f42877ad76</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DG.%2BD.%2BJ.%26atitle%3DPeptidyl%2520diazomethyl%2520ketones%2520are%2520specific%2520inactivators%2520of%2520thiol%2520proteinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1981%26spage%3D1923%26epage%3D1928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korver, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kam, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudig, D.</span></span> <span> </span><span class="NLM_article-title">Dipeptide vinyl sulfones suitable for intracellular inhibition of dipeptidyl peptidase I</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1016/S0162-3109(00)00267-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1016%2FS0162-3109%2800%2900267-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=11367515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtlWnsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=21-32&author=G.+E.+Korverauthor=C.-M.+Kamauthor=J.+C.+Powersauthor=D.+Hudig&title=Dipeptide+vinyl+sulfones+suitable+for+intracellular+inhibition+of+dipeptidyl+peptidase+I&doi=10.1016%2FS0162-3109%2800%2900267-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptide vinyl sulfones suitable for intracellular inhibition of dipeptidyl peptidase I</span></div><div class="casAuthors">Korver, Gretchen E.; Kam, Chih-Min; Powers, James C.; Hudig, Dorothy</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-32</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">In granules of hematopoietic cells, dipeptidyl peptidase I (DPPI) processes inactive proenzymes into active enzymes, e.g., lymphocyte progranzyme A.  Our goal was to develop irreversible inhibitors of intracellular DPPI.  First, we identified inhibitors with aq. stability.  Then we detd. which inhibitors were nontoxic, could enter cells and inactivate intracellular DPPI.  We screened nine dipeptide vinyl sulfone (VS) inhibitors (kobs/[I] > 72 M-1 s-1) and found six that were nontoxic.  Four affected intracellular DPPI at < 25 μM.  These compds. contained only uncharged amino acid residues; the two less reactive compds. contained charged Glu residues.  The best one, Leu-Phe-VS-CH3, inactivated DPPI in cells with an ID50 of ∼ 5 μM.  This inhibitor was not the best inhibitor of purified DPPI.  Longer aq. stabilities were important predictors of cellular efficacy.  Leu-Phe-VS-CH3 had a half life of 97 min at the pH of the extracellular medium (7.5) and 1302 min at pH 5.5 (the intracellular environment of DPPI).  This VS had no direct effect on granzyme activities.  In contrast, the diazomethyl ketone inhibitor Gly-Phe-CHN2 inhibited chymase activity.  Several good intracellular DPPI VS inhibitors lacked reactivity with cathepsins B, H and L.  In conclusion, we have identified DPPI inhibitors suitable for cellular applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcFqtyilH1S7Vg90H21EOLACvtfcHk0lg7o_KvyPoO3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtlWnsLY%253D&md5=e774a7937e958f7c11989e5bd6fb4abb</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0162-3109%2800%2900267-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0162-3109%252800%252900267-8%26sid%3Dliteratum%253Aachs%26aulast%3DKorver%26aufirst%3DG.%2BE.%26aulast%3DKam%26aufirst%3DC.-M.%26aulast%3DPowers%26aufirst%3DJ.%2BC.%26aulast%3DHudig%26aufirst%3DD.%26atitle%3DDipeptide%2520vinyl%2520sulfones%2520suitable%2520for%2520intracellular%2520inhibition%2520of%2520dipeptidyl%2520peptidase%2520I%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2001%26volume%3D1%26spage%3D21%26epage%3D32%26doi%3D10.1016%2FS0162-3109%2800%2900267-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kam, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Götz, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koot, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuire, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiele, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudig, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. C.</span></span> <span> </span><span class="NLM_article-title">Design and evaluation of inhibitors for dipeptidyl peptidase I (Cathepsin C)</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>427</i></span>,  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2004.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1016%2Fj.abb.2004.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=15196986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvVClt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2004&pages=123-134&author=C.-M.+Kamauthor=M.+G.+G%C3%B6tzauthor=G.+Kootauthor=M.+McGuireauthor=D.+Thieleauthor=D.+Hudigauthor=J.+C.+Powers&title=Design+and+evaluation+of+inhibitors+for+dipeptidyl+peptidase+I+%28Cathepsin+C%29&doi=10.1016%2Fj.abb.2004.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Design and evaluation of inhibitors for dipeptidyl peptidase I (Cathepsin C)</span></div><div class="casAuthors">Kam, Chih-Min; Gotz, Marion G.; Koot, Gretchen; McGuire, Michael; Thiele, Dwain; Hudig, Dorothy; Powers, James C.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">427</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-134</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase I (DPPI, cathepsin C) is a lysosomal cysteine protease that can activate zymogens of several different serine proteases by one step or sequential removal of dipeptides from the N-termini of the pro-protease protein substrates.  To find DPPI inhibitors more suitable for cellular applications than diazomethyl ketones, we synthesized three types of inhibitors: dipeptide acyloxymethyl ketones, fluoromethyl ketones, and vinyl sulfones (VS).  The acyloxymethyl ketones inhibited DPPI slowly and are moderate inhibitors of cellular DPPI.  The fluoromethyl ketones were potent, but the inhibited DPPI regained activity quickly.  The dipeptide vinyl sulfones were effective inhibitors for DPPI, but they also inhibited cathepsins B, H, and L weakly.  The best inhibitor, Ala-Hph-VS-Ph, had a k2/KI of 2,000,000 M-1 s-1.  The vinyl sulfones also inhibited intracellular DPPI, and for this application the more stable inhibitors exhibit better potency.  We conclude that vinyl sulfones are promising inhibitors to study the intracellular functions of DPPI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2ecoE_aDnEbVg90H21EOLACvtfcHk0lg7o_KvyPoO3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvVClt7o%253D&md5=6fb8dd13f10c90b704d0b323ab2ae163</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2004.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2004.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKam%26aufirst%3DC.-M.%26aulast%3DG%25C3%25B6tz%26aufirst%3DM.%2BG.%26aulast%3DKoot%26aufirst%3DG.%26aulast%3DMcGuire%26aufirst%3DM.%26aulast%3DThiele%26aufirst%3DD.%26aulast%3DHudig%26aufirst%3DD.%26aulast%3DPowers%26aufirst%3DJ.%2BC.%26atitle%3DDesign%2520and%2520evaluation%2520of%2520inhibitors%2520for%2520dipeptidyl%2520peptidase%2520I%2520%2528Cathepsin%2520C%2529%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2004%26volume%3D427%26spage%3D123%26epage%3D134%26doi%3D10.1016%2Fj.abb.2004.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lainé, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palovich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCleland, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petitjean, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delhom, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevins, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDevitt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Midgett, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kmett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umbrecht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettoun, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel cyanamide-based inhibitors of cathepsin C</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">142</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1021/ml100212k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100212k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2rsL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=142-147&author=D.+Lain%C3%A9author=M.+Palovichauthor=B.+McClelandauthor=E.+Petitjeanauthor=I.+Delhomauthor=H.+Xieauthor=J.+Dengauthor=G.+Linauthor=R.+Davisauthor=A.+Jolitauthor=N.+Nevinsauthor=B.+Zhaoauthor=J.+Villaauthor=J.+Schneckauthor=P.+McDevittauthor=R.+Midgettauthor=C.+Kmettauthor=S.+Umbrechtauthor=B.+Peckauthor=A.+B.+Davisauthor=D.+Bettoun&title=Discovery+of+novel+cyanamide-based+inhibitors+of+cathepsin+C&doi=10.1021%2Fml100212k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel cyanamide-based inhibitors of cathepsin C</span></div><div class="casAuthors">Laine, Dramane; Palovich, Michael; McCleland, Brent; Petitjean, Emilie; Delhom, Isabelle; Xie, Haibo; Deng, Jianghe; Lin, Guoliang; Davis, Roderick; Jolit, Anais; Nevins, Neysa; Zhao, Baoguang; Villa, Jim; Schneck, Jessica; McDevitt, Patrick; Midgett, Robert; Kmett, Casey; Umbrecht, Sandra; Peck, Brian; Davis, Alicia Bacon; Bettoun, David</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">142-147</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of potent and selective cyanamide-based inhibitors of the cysteine protease cathepsin C is detailed.  Optimization of the template with regard to plasma stability led to the identification of (2S,4R)-1-cyano-2-methyl-4-(2,5-dibromophenylsulfonylamino)pyrrolidine (I), a potent cathepsin C inhibitor with excellent selectivity over other cathepsins and potent in vivo activity in a cigarette smoke mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnAQabB_znSrVg90H21EOLACvtfcHk0lgm61mrfQLCxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2rsL%252FK&md5=5b8478f6abc28e4d273eb9aa7c93aeb1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fml100212k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100212k%26sid%3Dliteratum%253Aachs%26aulast%3DLain%25C3%25A9%26aufirst%3DD.%26aulast%3DPalovich%26aufirst%3DM.%26aulast%3DMcCleland%26aufirst%3DB.%26aulast%3DPetitjean%26aufirst%3DE.%26aulast%3DDelhom%26aufirst%3DI.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DG.%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DJolit%26aufirst%3DA.%26aulast%3DNevins%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DVilla%26aufirst%3DJ.%26aulast%3DSchneck%26aufirst%3DJ.%26aulast%3DMcDevitt%26aufirst%3DP.%26aulast%3DMidgett%26aufirst%3DR.%26aulast%3DKmett%26aufirst%3DC.%26aulast%3DUmbrecht%26aufirst%3DS.%26aulast%3DPeck%26aufirst%3DB.%26aulast%3DDavis%26aufirst%3DA.%2BB.%26aulast%3DBettoun%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520novel%2520cyanamide-based%2520inhibitors%2520of%2520cathepsin%2520C%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D142%26epage%3D147%26doi%3D10.1021%2Fml100212k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Furber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiden, A.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mete, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millichip, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinchin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luckhurst, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cage, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanganee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chohan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oreffo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchinson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debreczeni, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breed, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wissler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edman, K.</span></span> <span> </span><span class="NLM_article-title">Cathepsin C inhibitors: property optimization and identification of a clinical candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2357</span>– <span class="NLM_lpage">2367</span>, <span class="refDoi"> DOI: 10.1021/jm401705g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401705g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVehsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2357-2367&author=M.+Furberauthor=A.-K.+Tidenauthor=P.+Gardinerauthor=A.+Meteauthor=R.+Fordauthor=I.+Millichipauthor=L.+Steinauthor=A.+Matherauthor=E.+Kinchinauthor=C.+Luckhurstauthor=S.+Barberauthor=P.+Cageauthor=H.+Sanganeeauthor=R.+Austinauthor=K.+Chohanauthor=R.+Beriauthor=B.+Thongauthor=A.+Wallaceauthor=V.+Oreffoauthor=R.+Hutchinsonauthor=S.+Harperauthor=J.+Debreczeniauthor=J.+Breedauthor=L.+Wisslerauthor=K.+Edman&title=Cathepsin+C+inhibitors%3A+property+optimization+and+identification+of+a+clinical+candidate&doi=10.1021%2Fjm401705g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin C Inhibitors: Property Optimization and Identification of a Clinical Candidate</span></div><div class="casAuthors">Furber, Mark; Tiden, Anna-Karin; Gardiner, Philip; Mete, Antonio; Ford, Rhonan; Millichip, Ian; Stein, Linda; Mather, Andrew; Kinchin, Elizabeth; Luckhurst, Christopher; Barber, Simon; Cage, Peter; Sanganee, Hitesh; Austin, Rupert; Chohan, Kamaldeep; Beri, Raj; Thong, Bob; Wallace, Alan; Oreffo, Victor; Hutchinson, Ray; Harper, Steve; Debreczeni, Judit; Breed, Jason; Wissler, Lisa; Edman, Karl</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2357-2367</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A lead generation and optimization program delivered the highly selective and potent CatC inhibitor 10 as an in vivo tool compd. and potential development candidate.  Structural studies were undertaken to generate SAR understanding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMrzoFYqcSSrVg90H21EOLACvtfcHk0lgm61mrfQLCxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVehsLg%253D&md5=35e3eca5dc118251ba5e3e39219c6f60</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm401705g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401705g%26sid%3Dliteratum%253Aachs%26aulast%3DFurber%26aufirst%3DM.%26aulast%3DTiden%26aufirst%3DA.-K.%26aulast%3DGardiner%26aufirst%3DP.%26aulast%3DMete%26aufirst%3DA.%26aulast%3DFord%26aufirst%3DR.%26aulast%3DMillichip%26aufirst%3DI.%26aulast%3DStein%26aufirst%3DL.%26aulast%3DMather%26aufirst%3DA.%26aulast%3DKinchin%26aufirst%3DE.%26aulast%3DLuckhurst%26aufirst%3DC.%26aulast%3DBarber%26aufirst%3DS.%26aulast%3DCage%26aufirst%3DP.%26aulast%3DSanganee%26aufirst%3DH.%26aulast%3DAustin%26aufirst%3DR.%26aulast%3DChohan%26aufirst%3DK.%26aulast%3DBeri%26aufirst%3DR.%26aulast%3DThong%26aufirst%3DB.%26aulast%3DWallace%26aufirst%3DA.%26aulast%3DOreffo%26aufirst%3DV.%26aulast%3DHutchinson%26aufirst%3DR.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DDebreczeni%26aufirst%3DJ.%26aulast%3DBreed%26aufirst%3DJ.%26aulast%3DWissler%26aufirst%3DL.%26aulast%3DEdman%26aufirst%3DK.%26atitle%3DCathepsin%2520C%2520inhibitors%253A%2520property%2520optimization%2520and%2520identification%2520of%2520a%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2357%26epage%3D2367%26doi%3D10.1021%2Fjm401705g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lönn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Käck, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Poël, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swallow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wikell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenvall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johannesson, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of second generation reversible covalent DPP1 inhibitors leading to an oxazepane amidoacetonitrile based clinical candidate (AZD7986)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9457</span>– <span class="NLM_lpage">9472</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01127</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01127" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1SmtLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9457-9472&author=K.+Doyleauthor=H.+L%C3%B6nnauthor=H.+K%C3%A4ckauthor=A.+Van+de+Po%C3%ABlauthor=S.+Swallowauthor=P.+Gardinerauthor=S.+Connollyauthor=J.+Rootauthor=C.+Wikellauthor=G.+Dahlauthor=K.+Stenvallauthor=P.+Johannesson&title=Discovery+of+second+generation+reversible+covalent+DPP1+inhibitors+leading+to+an+oxazepane+amidoacetonitrile+based+clinical+candidate+%28AZD7986%29&doi=10.1021%2Facs.jmedchem.6b01127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986)</span></div><div class="casAuthors">Doyle, Kevin; Lonn, Hans; Kack, Helena; Van de Poel, Amanda; Swallow, Steve; Gardiner, Philip; Connolly, Stephen; Root, James; Wikell, Cecilia; Dahl, Goran; Stenvall, Kristina; Johannesson, Petra</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9457-9472</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of second generation DPP1 inhibitors free from aorta binding liabilities found for earlier compd. series was discovered.  This work culminated in the identification of compd. 30 (AZD7986) as a highly potent, reversible, and selective clin. candidate for COPD, with predicted human PK properties suitable for once daily human dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouJ_YtbyrmtbVg90H21EOLACvtfcHk0lg0JGKz9PHesw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1SmtLbF&md5=73daf54da4a47b7b11db53e0b5a98e50</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01127%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DK.%26aulast%3DL%25C3%25B6nn%26aufirst%3DH.%26aulast%3DK%25C3%25A4ck%26aufirst%3DH.%26aulast%3DVan%2Bde%2BPo%25C3%25ABl%26aufirst%3DA.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DGardiner%26aufirst%3DP.%26aulast%3DConnolly%26aufirst%3DS.%26aulast%3DRoot%26aufirst%3DJ.%26aulast%3DWikell%26aufirst%3DC.%26aulast%3DDahl%26aufirst%3DG.%26aulast%3DStenvall%26aufirst%3DK.%26aulast%3DJohannesson%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520second%2520generation%2520reversible%2520covalent%2520DPP1%2520inhibitors%2520leading%2520to%2520an%2520oxazepane%2520amidoacetonitrile%2520based%2520clinical%2520candidate%2520%2528AZD7986%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9457%26epage%3D9472%26doi%3D10.1021%2Facs.jmedchem.6b01127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamboni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Methot, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ethier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Percival, M. D.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of dipeptidyl nitriles as potent, selective, and reversible inhibitors of cathepsin C</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">5392</span>– <span class="NLM_lpage">5396</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.07.114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1016%2Fj.bmcl.2009.07.114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=19665376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVeqsLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5392-5396&author=D.+Guayauthor=C.+Beaulieuauthor=T.+J.+Reddyauthor=R.+Zamboniauthor=N.+Methotauthor=J.+Rubinauthor=D.+Ethierauthor=M.+D.+Percival&title=Design+and+synthesis+of+dipeptidyl+nitriles+as+potent%2C+selective%2C+and+reversible+inhibitors+of+cathepsin+C&doi=10.1016%2Fj.bmcl.2009.07.114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of dipeptidyl nitriles as potent, selective, and reversible inhibitors of cathepsin C</span></div><div class="casAuthors">Guay, Daniel; Beaulieu, Christian; Jagadeeswar Reddy, T.; Zamboni, Robert; Methot, Nathalie; Rubin, Joel; Ethier, Diane; David Percival, M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5392-5396</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of dipeptide nitriles with a thienyl alanine in P2 were identified as potent and selective cathepsin C inhibitors.  Incorporation of a substituted cyclopropyl moiety in P1 effectively protects these derivs. against hydrolase activity in whole blood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3YY4UjyYe67Vg90H21EOLACvtfcHk0lg0JGKz9PHesw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVeqsLrI&md5=5e3a92361de2c537def8770271494de4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.07.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.07.114%26sid%3Dliteratum%253Aachs%26aulast%3DGuay%26aufirst%3DD.%26aulast%3DBeaulieu%26aufirst%3DC.%26aulast%3DReddy%26aufirst%3DT.%2BJ.%26aulast%3DZamboni%26aufirst%3DR.%26aulast%3DMethot%26aufirst%3DN.%26aulast%3DRubin%26aufirst%3DJ.%26aulast%3DEthier%26aufirst%3DD.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520dipeptidyl%2520nitriles%2520as%2520potent%252C%2520selective%252C%2520and%2520reversible%2520inhibitors%2520of%2520cathepsin%2520C%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5392%26epage%3D5396%26doi%3D10.1016%2Fj.bmcl.2009.07.114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Percival, M. D.</span></span> <span> </span><span class="NLM_article-title">Therapeutic utility and medicinal chemistry of cathepsin C inhibitors</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">708</span>– <span class="NLM_lpage">716</span>, <span class="refDoi"> DOI: 10.2174/156802610791113469</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.2174%2F156802610791113469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=20337582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsF2ksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=708-716&author=D.+Guayauthor=C.+Beaulieuauthor=M.+D.+Percival&title=Therapeutic+utility+and+medicinal+chemistry+of+cathepsin+C+inhibitors&doi=10.2174%2F156802610791113469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic utility and medicinal chemistry of cathepsin C inhibitors</span></div><div class="casAuthors">Guay, Daniel; Beaulieu, Christian; Percival, M. David</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">708-716</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The lysosomal cysteine protease cathepsin C (Cat C), also known as dipeptidyl peptidase 1, activates a no. of granule-assocd. serine proteases with pro-inflammatory and immune functions by removal of their inhibitory N-terminal dipeptides.  Thus, Cat C is a therapeutic target for the treatment of a no. of inflammatory and autoimmune diseases.  Cathepsin C null mice and humans with Cat C loss of function mutations (Papillon-Lefevre syndrome) show deficiencies in disease-relevant proteases including neutrophil elastase, cathepsin G, chymases and granzymes and the Cat C mice are protected in a no. of disease models.  Several methodologies have been recently reported for assessing the effects of Cat C inhibitors on serine protease activities in cellular assays and prolonged treatment of rats with a reversible, selective Cat C inhibitor reduced the activity of three leukocyte serine proteases.  Nearly all potent and selective Cat C inhibitors described are based on the preferred dipeptide substrates bearing either irreversible (e.g. diazomethylketone, acyloxymethyl ketone, o-acyl hydroxamic acid and vinyl sulfone) or reversible (e.g. semicarbazide, nitrile and cyanamide) electrophilic warheads.  While potent and highly selective, the best inhibitors described to date still have poor stability and/or rodent pharmacokinetics, likely resulting from their peptidic nature.  The lack of selective compds. with appropriate rodent pharmacokinetic properties has hampered the assessment of the effects of Cat C inhibitors on the activation of disease-relevant proteases in vivo and the full evaluation of the therapeutic utility of Cat C inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp9SHPfL5KVrVg90H21EOLACvtfcHk0lhBdqqtl9HVXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsF2ksbc%253D&md5=ff226a5ad4f7967ac5791ae2baf05d71</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F156802610791113469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610791113469%26sid%3Dliteratum%253Aachs%26aulast%3DGuay%26aufirst%3DD.%26aulast%3DBeaulieu%26aufirst%3DC.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DTherapeutic%2520utility%2520and%2520medicinal%2520chemistry%2520of%2520cathepsin%2520C%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D708%26epage%3D716%26doi%3D10.2174%2F156802610791113469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallow, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyce, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpenter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churchill, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heslop, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazaar, A. L.</span></span> <span> </span><span class="NLM_article-title">Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK2793660)</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">2813</span>– <span class="NLM_lpage">2820</span>, <span class="refDoi"> DOI: 10.1111/bcp.13398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1111%2Fbcp.13398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=28800383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvV2ns7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2017&pages=2813-2820&author=B.+E.+Millerauthor=R.+J.+Mayerauthor=N.+Goyalauthor=J.+Balauthor=N.+Dallowauthor=M.+Boyceauthor=D.+Carpenterauthor=A.+Churchillauthor=T.+Heslopauthor=A.+L.+Lazaar&title=Epithelial+desquamation+observed+in+a+phase+I+study+of+an+oral+cathepsin+C+inhibitor+%28GSK2793660%29&doi=10.1111%2Fbcp.13398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK2793660)</span></div><div class="casAuthors">Miller, Bruce E.; Mayer, Ruth J.; Goyal, Navin; Bal, Joanne; Dallow, Nigel; Boyce, Malcolm; Carpenter, Donald; Churchill, Alison; Heslop, Teresa; Lazaar, Aili L.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2813-2820</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">1365-2125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aims : Cathepsin C (CTSC) is necessary for the activation of several serine proteases including neutrophil elastase (NE), cathepsin G and proteinase 3.  GSK2793660 is an oral, irreversible inhibitor of CTSC that is hypothesized to provide an alternative route to achieve NE inhibition and was tested in a Phase I study.  Methods : Single escalating oral doses of GSK2793660 from 0.5 to 20 mg or placebo were administered in a randomized crossover design to healthy male subjects; a sep. cohort received once daily doses of 12 mg or placebo for 21 days.  Data were collected on safety, pharmacokinetics, CTSC enzyme inhibition and blood biomarkers.  Results : Single, oral doses of GSK2793660 were able to dose-dependently inhibit whole blood CTSC activity.  Once daily dosing of 12 mg GSK2793660 for 21 days achieved ≥90% inhibition (95% CI: 56, 130) of CTSC within 3 h on day 1.  Only modest redns. of whole blood enzyme activity of approx. 20% were obsd. for NE, cathepsin G and proteinase 3.  Seven of 10 subjects receiving repeat doses of GSK2793660 manifested epidermal desquamation on palmar and plantar surfaces beginning 7-10 days after dosing commencement.  There were no other clin. important safety findings.  Conclusions : GSK2793660 inhibited CTSC activity but not the activity of downstream neutrophil serine proteases.  The palmar-plantar epidermal desquamation suggests a previously unidentified role for CTSC or one of its target proteins in the maintenance and integrity of the epidermis at these sites, with some similarities to the phenotype of CTSC-deficient humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgzbhfHPivxrVg90H21EOLACvtfcHk0lhBdqqtl9HVXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvV2ns7zM&md5=7adcac6bc9dc5a24bffda1afd89e1f88</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1111%2Fbcp.13398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcp.13398%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DB.%2BE.%26aulast%3DMayer%26aufirst%3DR.%2BJ.%26aulast%3DGoyal%26aufirst%3DN.%26aulast%3DBal%26aufirst%3DJ.%26aulast%3DDallow%26aufirst%3DN.%26aulast%3DBoyce%26aufirst%3DM.%26aulast%3DCarpenter%26aufirst%3DD.%26aulast%3DChurchill%26aufirst%3DA.%26aulast%3DHeslop%26aufirst%3DT.%26aulast%3DLazaar%26aufirst%3DA.%2BL.%26atitle%3DEpithelial%2520desquamation%2520observed%2520in%2520a%2520phase%2520I%2520study%2520of%2520an%2520oral%2520cathepsin%2520C%2520inhibitor%2520%2528GSK2793660%2529%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2017%26volume%3D83%26spage%3D2813%26epage%3D2820%26doi%3D10.1111%2Fbcp.13398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palovich, M.</span>; <span class="NLM_string-name">Bolognese, B.</span>; <span class="NLM_string-name">Booth-Genthe, C.</span>; <span class="NLM_string-name">Churchill, A.</span>; <span class="NLM_string-name">Foley, J.
P.</span>; <span class="NLM_string-name">Goyal, N.</span>; <span class="NLM_string-name">Landis, P.</span>; <span class="NLM_string-name">Logan, G.</span>; <span class="NLM_string-name">Long, E.,  III</span>; <span class="NLM_string-name">Mayer, R.
J.</span>; <span class="NLM_string-name">Miller, B.</span>; <span class="NLM_string-name">Neipp, C.</span>; <span class="NLM_string-name">Podolin, P. L.</span>; <span class="NLM_string-name">Umbrecht, S. T.</span></span> In  <i>Inhibitors of Cathepsin C: Not Your Typical Small Oral Molecules</i>, Presented at RSC/SCI Symposium on Proteinase Inhibitor Design, Basel, Switzerland April 13, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+Palovich&author=B.+Bolognese&author=C.+Booth-Genthe&author=A.+Churchill&author=J.%0AP.+Foley&author=N.+Goyal&author=P.+Landis&author=G.+Logan&author=E.+Long&author=R.%0AJ.+Mayer&author=B.+Miller&author=C.+Neipp&author=P.+L.+Podolin&author=S.+T.+Umbrecht&title=Inhibitors+of+Cathepsin+C%3A+Not+Your+Typical+Small+Oral+Molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DPalovich%26aufirst%3DM.%26jtitle%3DInhibitors%2520of%2520Cathepsin%2520C%253A%2520Not%2520Your%2520Typical%2520Small%2520Oral%2520Molecules%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><a href="https://clinicaltrials.gov/ct2/show/NCT02058407" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02058407</a> (accessed May 5, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02058407+%28accessed+May+5%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palmér, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mäenpää, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jauhiainen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prothon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chialda, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forte, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egelrud, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenvall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, P.</span></span> <span> </span><span class="NLM_article-title">Dipeptidyl peptidase 1 inhibitor AZD7986 induces a sustained, exposure-dependent reduction in neutrophil elastase activity in healthy subjects</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">1155</span>– <span class="NLM_lpage">1164</span>, <span class="refDoi"> DOI: 10.1002/cpt.1053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1002%2Fcpt.1053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=29484635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1Sgtr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2018&pages=1155-1164&author=R.+Palm%C3%A9rauthor=J.+M%C3%A4enp%C3%A4%C3%A4author=A.+Jauhiainenauthor=B.+Larssonauthor=J.+Moauthor=M.+Russellauthor=J.+Rootauthor=S.+Prothonauthor=L.+Chialdaauthor=P.+Forteauthor=T.+Egelrudauthor=K.+Stenvallauthor=P.+Gardiner&title=Dipeptidyl+peptidase+1+inhibitor+AZD7986+induces+a+sustained%2C+exposure-dependent+reduction+in+neutrophil+elastase+activity+in+healthy+subjects&doi=10.1002%2Fcpt.1053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl Peptidase 1 Inhibitor AZD7986 Induces a Sustained, Exposure-Dependent Reduction in Neutrophil Elastase Activity in Healthy Subjects</span></div><div class="casAuthors">Palmer, Robert; Maeenpaeae, Jukka; Jauhiainen, Alexandra; Larsson, Bengt; Mo, John; Russell, Muir; Root, James; Prothon, Susanne; Chialda, Ligia; Forte, Pablo; Egelrud, Torbjoern; Stenvall, Kristina; Gardiner, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1155-1164</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Neutrophil serine proteases (NSPs), such as neutrophil elastase (NE), are activated by dipeptidyl peptidase 1 (DPP1) during neutrophil maturation.  High NSP levels can be detrimental, particularly in lung tissue, and inhibition of NSPs is therefore an interesting therapeutic opportunity in multiple lung diseases, including chronic obstructive pulmonary disease (COPD) and bronchiectasis.  We conducted a randomized, placebo-controlled, first-in-human study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple oral doses of the DPP1 inhibitor AZD7986 in healthy subjects.  Pharmacokinetic and pharmacodynamic data were analyzed using nonlinear mixed effects modeling and showed that AZD7986 inhibits whole blood NE activity in an exposure-dependent, indirect manner-consistent with in vitro and preclin. predictions.  Several dose-dependent, possibly DPP1-related, nonserious skin findings were obsd., but these were not considered to prevent further clin. development.  Overall, the study results provided confidence to progress AZD7986 to phase II and supported selection of a clin. relevant dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNNpZU5DYCmrVg90H21EOLACvtfcHk0lhBdqqtl9HVXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1Sgtr3I&md5=be63909f3c5374982b0cdbf7ca8e5202</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fcpt.1053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpt.1053%26sid%3Dliteratum%253Aachs%26aulast%3DPalm%25C3%25A9r%26aufirst%3DR.%26aulast%3DM%25C3%25A4enp%25C3%25A4%25C3%25A4%26aufirst%3DJ.%26aulast%3DJauhiainen%26aufirst%3DA.%26aulast%3DLarsson%26aufirst%3DB.%26aulast%3DMo%26aufirst%3DJ.%26aulast%3DRussell%26aufirst%3DM.%26aulast%3DRoot%26aufirst%3DJ.%26aulast%3DProthon%26aufirst%3DS.%26aulast%3DChialda%26aufirst%3DL.%26aulast%3DForte%26aufirst%3DP.%26aulast%3DEgelrud%26aufirst%3DT.%26aulast%3DStenvall%26aufirst%3DK.%26aulast%3DGardiner%26aufirst%3DP.%26atitle%3DDipeptidyl%2520peptidase%25201%2520inhibitor%2520AZD7986%2520induces%2520a%2520sustained%252C%2520exposure-dependent%2520reduction%2520in%2520neutrophil%2520elastase%2520activity%2520in%2520healthy%2520subjects%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2018%26volume%3D104%26spage%3D1155%26epage%3D1164%26doi%3D10.1002%2Fcpt.1053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><a href="https://clinicaltrials.gov/ct2/show/NCT03218917" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03218917</a> (accessed May
5, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03218917+%28accessed+May%0A5%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span> <span> </span><span class="NLM_article-title">Focusing on probe-modified peptides: a quick and effective method for target identification</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">10225</span>– <span class="NLM_lpage">10228</span>, <span class="refDoi"> DOI: 10.1039/C6CC04030F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1039%2FC6CC04030F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=27443632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFOgsr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2016&pages=10225-10228&author=H.+Sunauthor=Y.+Renauthor=W.+Houauthor=L.+Liauthor=F.+Zengauthor=S.+Liauthor=Y.+Maauthor=X.+Liuauthor=S.+Chenauthor=Z.+Zhang&title=Focusing+on+probe-modified+peptides%3A+a+quick+and+effective+method+for+target+identification&doi=10.1039%2FC6CC04030F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Focusing on probe-modified peptides: a quick and effective method for target identification</span></div><div class="casAuthors">Sun, Huan; Ren, Yan; Hou, Weijie; Li, Lin; Zeng, Fanqi; Li, Sisi; Ma, Yongfen; Liu, Xiao; Chen, She; Zhang, Zhiyuan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">67</span>),
    <span class="NLM_cas:pages">10225-10228</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A new and efficient method focusing on probe-modified peptides was developed to identify the target protein and modification site of a hit compd. or a drug.  This method exhibited high click conjugation efficiency and few false-pos. results.  The modification site further facilitated target validation, biol. mechanism study and new indications exploration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLd8P3vyX8OrVg90H21EOLACvtfcHk0lj7_85Ua_6QJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFOgsr7K&md5=c717532da42e1b100162c02baadb23b3</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1039%2FC6CC04030F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6CC04030F%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DHou%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DZeng%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DZ.%26atitle%3DFocusing%2520on%2520probe-modified%2520peptides%253A%2520a%2520quick%2520and%2520effective%2520method%2520for%2520target%2520identification%26jtitle%3DChem.%2520Commun.%26date%3D2016%26volume%3D52%26spage%3D10225%26epage%3D10228%26doi%3D10.1039%2FC6CC04030F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bragg, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brocklehurst, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickling, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFaul, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swallow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tugwood, J.</span></span> <span> </span><span class="NLM_article-title">Aortic binding of AZD5248: mechanistic insight and reactivity assays to support lead optimzation</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1991</span>– <span class="NLM_lpage">1999</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.5b00236</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.5b00236" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVOnsrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2015&pages=1991-1999&author=R.+A.+Braggauthor=S.+Brocklehurstauthor=F.+Gustafssonauthor=J.+Goodmanauthor=K.+Hicklingauthor=P.+A.+MacFaulauthor=S.+Swallowauthor=J.+Tugwood&title=Aortic+binding+of+AZD5248%3A+mechanistic+insight+and+reactivity+assays+to+support+lead+optimzation&doi=10.1021%2Facs.chemrestox.5b00236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Aortic Binding of AZD5248: Mechanistic Insight and Reactivity Assays To Support Lead Optimization</span></div><div class="casAuthors">Bragg, Ryan A.; Brocklehurst, Simon; Gustafsson, Frida; Goodman, James; Hickling, Kevin; MacFaul, Philip A.; Swallow, Steve; Tugwood, Jonathan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1991-1999</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The oral dipeptidyl peptidase 1 (DPP1) inhibitor AZD5248 showed aortic binding in a rat quant. whole-body autoradiog. (QWBA) study, and its development was terminated prior to human dosing.  A mechanistic hypothesis for this finding was established invoking reactivity with aldehydes involved in the crosslinking of elastin, a major component of aortic tissue.  This was tested by developing a simple aldehyde chem. reactivity assay and a novel in vitro competitive covalent binding assay.  Results obtained with AZD5248, literature compds., and close analogs of AZD5248 support the mechanistic hypothesis and provide validation for the use of these assays in a two tier screening approach to support lead optimization.  The strengths and limitations of these assays are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVsQOf7qsJOLVg90H21EOLACvtfcHk0lgQtqYOit8CTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVOnsrbO&md5=d9e73a25a1a8153121ba1e29e65819dc</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.5b00236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.5b00236%26sid%3Dliteratum%253Aachs%26aulast%3DBragg%26aufirst%3DR.%2BA.%26aulast%3DBrocklehurst%26aufirst%3DS.%26aulast%3DGustafsson%26aufirst%3DF.%26aulast%3DGoodman%26aufirst%3DJ.%26aulast%3DHickling%26aufirst%3DK.%26aulast%3DMacFaul%26aufirst%3DP.%2BA.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DTugwood%26aufirst%3DJ.%26atitle%3DAortic%2520binding%2520of%2520AZD5248%253A%2520mechanistic%2520insight%2520and%2520reactivity%2520assays%2520to%2520support%2520lead%2520optimzation%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2015%26volume%3D28%26spage%3D1991%26epage%3D1999%26doi%3D10.1021%2Facs.chemrestox.5b00236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ercan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capelletti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortot, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chirieac, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacob, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padera, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eck, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jänne, P. A.</span></span> <span> </span><span class="NLM_article-title">Novel mutant-selective EGFR kinase inhibitors against EGFR T790M</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>462</i></span>,  <span class="NLM_fpage">1070</span>, <span class="refDoi"> DOI: 10.1038/nature08622</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1038%2Fnature08622" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=20033049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1SktbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=462&publication_year=2009&pages=1070&author=W.+Zhouauthor=D.+Ercanauthor=L.+Chenauthor=C.-H.+Yunauthor=D.+Liauthor=M.+Capellettiauthor=A.+B.+Cortotauthor=L.+Chirieacauthor=R.+E.+Iacobauthor=R.+Paderaauthor=J.+R.+Engenauthor=K.-K.+Wongauthor=M.+J.+Eckauthor=N.+S.+Grayauthor=P.+A.+J%C3%A4nne&title=Novel+mutant-selective+EGFR+kinase+inhibitors+against+EGFR+T790M&doi=10.1038%2Fnature08622"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Novel mutant-selective EGFR kinase inhibitors against EGFR T790M</span></div><div class="casAuthors">Zhou, Wenjun; Ercan, Dalia; Chen, Liang; Yun, Cai-Hong; Li, Danan; Capelletti, Marzia; Cortot, Alexis B.; Chirieac, Lucian; Iacob, Roxana E.; Padera, Robert; Engen, John R.; Wong, Kwok-Kin; Eck, Michael J.; Gray, Nathanael S.; Janne, Pasi A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">462</span>
        (<span class="NLM_cas:issue">7276</span>),
    <span class="NLM_cas:pages">1070-1074</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The clin. efficacy of epidermal growth factor receptor (EGFR) kinase inhibitors in EGFR-mutant non-small-cell lung cancer (NSCLC) is limited by the development of drug-resistance mutations, including the gatekeeper T790M mutation.  Strategies targeting EGFR T790M with irreversible inhibitors have had limited success and are assocd. with toxicity due to concurrent inhibition of wild-type EGFR.  All current EGFR inhibitors possess a structurally related quinazoline-based core scaffold and were identified as ATP-competitive inhibitors of wild-type EGFR.  Here we identify a covalent pyrimidine EGFR inhibitor by screening an irreversible kinase inhibitor library specifically against EGFR T790M.  These agents are 30- to 100-fold more potent against EGFR T790M, and up to 100-fold less potent against wild-type EGFR, than quinazoline-based EGFR inhibitors in vitro.  They are also effective in murine models of lung cancer driven by EGFR T790M.  Co-crystn. studies reveal a structural basis for the increased potency and mutant selectivity of these agents.  These mutant-selective irreversible EGFR kinase inhibitors may be clin. more effective and better tolerated than quinazoline-based inhibitors.  Our findings demonstrate that functional pharmacol. screens against clin. important mutant kinases represent a powerful strategy to identify new classes of mutant-selective kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcksZlIe-1bbVg90H21EOLACvtfcHk0lgQtqYOit8CTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1SktbvI&md5=9b5d41a2be401c67a4b9f04a41cf1725</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnature08622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08622%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DErcan%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DYun%26aufirst%3DC.-H.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DCapelletti%26aufirst%3DM.%26aulast%3DCortot%26aufirst%3DA.%2BB.%26aulast%3DChirieac%26aufirst%3DL.%26aulast%3DIacob%26aufirst%3DR.%2BE.%26aulast%3DPadera%26aufirst%3DR.%26aulast%3DEngen%26aufirst%3DJ.%2BR.%26aulast%3DWong%26aufirst%3DK.-K.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DJ%25C3%25A4nne%26aufirst%3DP.%2BA.%26atitle%3DNovel%2520mutant-selective%2520EGFR%2520kinase%2520inhibitors%2520against%2520EGFR%2520T790M%26jtitle%3DNature%26date%3D2009%26volume%3D462%26spage%3D1070%26doi%3D10.1038%2Fnature08622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGuire, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipsky, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiele, D. L.</span></span> <span> </span><span class="NLM_article-title">Generation of active myeloid and lymphoid granule serine proteases requires processing by the granule thiol protease dipeptidyl peptidase I</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>268</i></span>,  <span class="NLM_fpage">2458</span>– <span class="NLM_lpage">2467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=8428921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADyaK3sXhvV2qsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1993&pages=2458-2467&author=M.+J.+McGuireauthor=P.+E.+Lipskyauthor=D.+L.+Thiele&title=Generation+of+active+myeloid+and+lymphoid+granule+serine+proteases+requires+processing+by+the+granule+thiol+protease+dipeptidyl+peptidase+I"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of active myeloid and lymphoid granule serine proteases requires processing by the granule thiol protease dipeptidyl peptidase I</span></div><div class="casAuthors">McGuire, Michael J.; Lipsky, Peter E.; Thiele, Dwain L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2458-67</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The proenzyme activation peptides predicted from cDNAs encoding each of the granule serine proteases synthesized by cytotoxic lymphocytes and myeloid and mast cells are composed of 2 residues.  The mechanism by which these amino-terminal dipeptides are cleaved to generate the active enzymes has not been elucidated.  The comparable distribution of dipeptidyl peptidase I (DPPI) and serine proteases and the ability of DPPI to hydrolyze relevant dipeptide sequences suggested a role for DPPI in the processing and activation of granule serine proteases.  This study demonstrates that inhibition of DPPI activity is assocd. with impairment of the generation of granule serine protease activity in CD8(+) T cells, lymphokine-activated killer cells, P815 mastocytoma cells, and U-937 myeloid cells.  Inhibition of DPPI resulted in impairment of the generation of cathepsin G enzymic activity without redn. in the amt. of immunoreactive cathepsin G product.  In U-937 cells pulsed with [3H]isoleucine, inhibition of DPPI activity was assocd. with the accumulation of the inactive proenzyme form of cathepsin G bearing an amino-terminal dipeptide extension to the isoleucine residue that normally occupies the amino terminus of the enzymically active protein.  These results indicate that DPPI plays a requisite role in the post-translational processing and activation of members of the family of granule serine proteases expressed in bone marrow-derived effector cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps2BbXeqrD2LVg90H21EOLACvtfcHk0lgQtqYOit8CTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhvV2qsr8%253D&md5=afa6355e3bad7fcc44b678f4e30294e8</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuire%26aufirst%3DM.%2BJ.%26aulast%3DLipsky%26aufirst%3DP.%2BE.%26aulast%3DThiele%26aufirst%3DD.%2BL.%26atitle%3DGeneration%2520of%2520active%2520myeloid%2520and%2520lymphoid%2520granule%2520serine%2520proteases%2520requires%2520processing%2520by%2520the%2520granule%2520thiol%2520protease%2520dipeptidyl%2520peptidase%2520I%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1993%26volume%3D268%26spage%3D2458%26epage%3D2467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fouret, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">du Bois, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernaudin, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrans, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crystal, R. G.</span></span> <span> </span><span class="NLM_article-title">Expression of the neutrophil elastase gene during human bone marrow cell differentiation</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">833</span>– <span class="NLM_lpage">845</span>, <span class="refDoi"> DOI: 10.1084/jem.169.3.833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1084%2Fjem.169.3.833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=2538548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADyaL1MXhsFalsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=1989&pages=833-845&author=P.+Fouretauthor=R.+M.+du+Boisauthor=J.+F.+Bernaudinauthor=H.+Takahashiauthor=V.+J.+Ferransauthor=R.+G.+Crystal&title=Expression+of+the+neutrophil+elastase+gene+during+human+bone+marrow+cell+differentiation&doi=10.1084%2Fjem.169.3.833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of the neutrophil elastase gene during human bone marrow cell differentiation</span></div><div class="casAuthors">Fouret, Pierre; Du Bois, Roland M.; Bernaudin, Jean Francois; Takahashi, Hideki; Ferrans, Victor J.; Crystal, Ronald G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">833-45</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    </div><div class="casAbstract">Neutrophil elastase, a potent serine protease carried and released by activated neutrophils, is not synthesized by neutrophils, but by their bone marrow precursor cells.  Using in situ hybridization with 35S-labeled antisense and sense neutrophil elastase cRNA probes, the present study demonstrates that expression of the neutrophil elastase gene is tightly controlled in bone marrow precursors and occurs during a very limited stage of differentiation of the neutrophil myeloid series, almost entirely at the promyelocyte stage.  Neutrophil elastase mRNA transcript levels are detectable to a limited extent in blasts, increase markedly in the promyelocyte stage, and then disappear as promyelocytes further differentiate.  Control probes specific for myeloperoxidase, lactoferrin, and β-globin mRNA transcripts, resp., demonstrated contrasting gene expression.  Myeloperoxidase mRNA transcripts were also found almost exclusively at the promyelocyte stage, but myeloperoxidase mRNA levels disappeared earlier than do neutrophil elastase mRNA levels, suggesting that expression of these genes may be differently controlled.  In comparison, lactoferrin mRNA transcripts were detected late in the neutrophil lineage, while β-globin mRNA was detected only in cells of the erythroid lineage.  The expression of the neutrophil elastase gene is likely under very tight control, and is likely different than that for other constituents of the neutrophil granules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmsy1yMlUtfrVg90H21EOLACvtfcHk0lj0zpj6vm-Xrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhsFalsbs%253D&md5=bd01714bb0290a0bdcfae6d5841bfbcd</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1084%2Fjem.169.3.833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.169.3.833%26sid%3Dliteratum%253Aachs%26aulast%3DFouret%26aufirst%3DP.%26aulast%3Ddu%2BBois%26aufirst%3DR.%2BM.%26aulast%3DBernaudin%26aufirst%3DJ.%2BF.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DFerrans%26aufirst%3DV.%2BJ.%26aulast%3DCrystal%26aufirst%3DR.%2BG.%26atitle%3DExpression%2520of%2520the%2520neutrophil%2520elastase%2520gene%2520during%2520human%2520bone%2520marrow%2520cell%2520differentiation%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1989%26volume%3D169%26spage%3D833%26epage%3D845%26doi%3D10.1084%2Fjem.169.3.833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Méthot, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ethier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Normandin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riendeau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Percival, M. D.</span></span> <span> </span><span class="NLM_article-title">In vivo inhibition of serine protease processing requires a high fractional inhibition of cathepsin C</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">1857</span>– <span class="NLM_lpage">1865</span>, <span class="refDoi"> DOI: 10.1124/mol.108.045682</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1124%2Fmol.108.045682" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=18326050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BD1cXms1emsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=1857-1865&author=N.+M%C3%A9thotauthor=D.+Guayauthor=J.+Rubinauthor=D.+Ethierauthor=K.+Ortegaauthor=S.+Wongauthor=D.+Normandinauthor=C.+Beaulieuauthor=T.+J.+Reddyauthor=D.+Riendeauauthor=M.+D.+Percival&title=In+vivo+inhibition+of+serine+protease+processing+requires+a+high+fractional+inhibition+of+cathepsin+C&doi=10.1124%2Fmol.108.045682"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo inhibition of serine protease processing requires a high fractional inhibition of cathepsin C</span></div><div class="casAuthors">Methot, Nathalie; Guay, Daniel; Rubin, Joel; Ethier, Diane; Ortega, Karen; Wong, Simon; Normandin, Denis; Beaulieu, Christian; Reddy, T. Jagadeeswar; Riendeau, Denis; Percival, M. David</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1857-1865</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Inhibition of cathepsin C, a dipeptidyl peptidase that activates many serine proteases, represents an attractive therapeutic strategy for inflammatory diseases with a high neutrophil burden.  We recently showed the feasibility of blocking the activation of neutrophil elastase, cathepsin G, and proteinase-3 with a single cathepsin C selective inhibitor in cultured cells.  Here we measured the fractional inhibition of cathepsin C that is required for blockade of downstream serine protease processing, in cell-based assays and in vivo.  Using a radiolabeled active site probe and U937 cells, a 50% redn. of cathepsin G processing required ∼50% of cathepsin C active sites to be occupied by an inhibitor.  In EcoM-G cells, inhibition of 50% of neutrophil elastase activity required ∼80% occupancy.  Both of these serine proteases were fully inhibited at full cathepsin C active site occupancy, whereas granzyme B processing in TALL-104 cells was partially inhibited, despite complete occupancy.  In vivo, leukocytes from cathepsin C+/- mice exhibited comparable levels of neutrophil elastase activity to wild-type animals, even though their cathepsin C activity was reduced by half.  The long-term administration of a cathepsin C inhibitor to rats, at doses that resulted in the nearly complete blockade of cathepsin C active sites in bone marrow, caused significant redns. of neutrophil elastase, cathepsin G and proteinase-3 activities.  Our results demonstrate that the inhibition of cathepsin C leads to a decrease of activity of multiple serine proteases involved in inflammation but also suggest that high fractional inhibition is necessary to reach therapeutically significant effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHl78T2oKjDLVg90H21EOLACvtfcHk0lj0zpj6vm-Xrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXms1emsL0%253D&md5=17bfbce4f3e3cbc7be59ad3a8f86b715</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fmol.108.045682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.108.045682%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A9thot%26aufirst%3DN.%26aulast%3DGuay%26aufirst%3DD.%26aulast%3DRubin%26aufirst%3DJ.%26aulast%3DEthier%26aufirst%3DD.%26aulast%3DOrtega%26aufirst%3DK.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DNormandin%26aufirst%3DD.%26aulast%3DBeaulieu%26aufirst%3DC.%26aulast%3DReddy%26aufirst%3DT.%2BJ.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DIn%2520vivo%2520inhibition%2520of%2520serine%2520protease%2520processing%2520requires%2520a%2520high%2520fractional%2520inhibition%2520of%2520cathepsin%2520C%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D73%26spage%3D1857%26epage%3D1865%26doi%3D10.1124%2Fmol.108.045682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Méthot, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ethier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riendeau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Percival, M. D.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the activation of multiple serine proteases with a cathepsin C inhibitor requires sustained exposure to prevent pro-enzyme processing</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">20836</span>– <span class="NLM_lpage">20846</span>, <span class="refDoi"> DOI: 10.1074/jbc.M702615200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1074%2Fjbc.M702615200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=17535802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BD2sXns1ygurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=20836-20846&author=N.+M%C3%A9thotauthor=J.+Rubinauthor=D.+Guayauthor=C.+Beaulieuauthor=D.+Ethierauthor=T.+J.+Reddyauthor=D.+Riendeauauthor=M.+D.+Percival&title=Inhibition+of+the+activation+of+multiple+serine+proteases+with+a+cathepsin+C+inhibitor+requires+sustained+exposure+to+prevent+pro-enzyme+processing&doi=10.1074%2Fjbc.M702615200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the Activation of Multiple Serine Proteases with a Cathepsin C Inhibitor Requires Sustained Exposure to Prevent Pro-enzyme Processing</span></div><div class="casAuthors">Methot, Nathalie; Rubin, Joel; Guay, Daniel; Beaulieu, Christian; Ethier, Diane; Reddy, T. Jagadeeswar; Riendeau, Denis; Percival, M. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">20836-20846</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cathepsin C is a cysteine protease required for the activation of several pro-inflammatory serine proteases and, as such, is of interest as a therapeutic target.  In cathepsin C-deficient mice and humans, the N-terminal processing and activation of neutrophil elastase, cathepsin G, and proteinase-3 is abolished and is accompanied by a redn. of protein levels.  Pharmacol., the consequence of cathepsin C inhibition on the activation of these serine proteases has not been described, due to the lack of stable and non-toxic inhibitors and the absence of appropriate exptl. cell systems.  Using novel reversible peptide nitrile inhibitors of cathepsin C, and cell-based assays with U937 and EcoM-G cells, we detd. the effects of pharmacol. inhibition of cathepsin C on serine protease activity.  We show that indirect and complete inhibition of neutrophil elastase, cathepsin G, and proteinase-3 is achievable in intact cells with selective and non-cytotoxic cathepsin C inhibitors, at concns. ∼10-fold higher than those required to inhibit purified cathepsin C. The concn. of inhibitor needed to block processing of these three serine proteases was similar, regardless of the cell system used.  Importantly, cathepsin C inhibition must be sustained to maintain serine protease inhibition, because removal of the reversible inhibitors resulted in the activation of pro-enzymes in intact cells.  These findings demonstrate that near complete inhibition of multiple serine proteases can be achieved with cathepsin C inhibitors and that cathepsin C inhibition represents a viable but challenging approach for the treatment of neutrophil-based inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs7l1PM7ZKMLVg90H21EOLACvtfcHk0lj0zpj6vm-Xrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXns1ygurg%253D&md5=7ab97011a54f10a476313eead154feb2</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M702615200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M702615200%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A9thot%26aufirst%3DN.%26aulast%3DRubin%26aufirst%3DJ.%26aulast%3DGuay%26aufirst%3DD.%26aulast%3DBeaulieu%26aufirst%3DC.%26aulast%3DEthier%26aufirst%3DD.%26aulast%3DReddy%26aufirst%3DT.%2BJ.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DInhibition%2520of%2520the%2520activation%2520of%2520multiple%2520serine%2520proteases%2520with%2520a%2520cathepsin%2520C%2520inhibitor%2520requires%2520sustained%2520exposure%2520to%2520prevent%2520pro-enzyme%2520processing%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D20836%26epage%3D20846%26doi%3D10.1074%2Fjbc.M702615200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">John, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aschenbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krüger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sendler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, F. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayerle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerch, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aghdassi, A. A.</span></span> <span> </span><span class="NLM_article-title">Deficiency of cathepsin C ameliorates severity of acute pancreatitis by reduction of neutrophil elastase activation and cleavage of E-cadherin</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>294</i></span>,  <span class="NLM_fpage">697</span>– <span class="NLM_lpage">707</span>, <span class="refDoi"> DOI: 10.1074/jbc.RA118.004376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1074%2Fjbc.RA118.004376" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=30455353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1Cis74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2019&pages=697-707&author=D.+S.+Johnauthor=J.+Aschenbachauthor=B.+Kr%C3%BCgerauthor=M.+Sendlerauthor=F.+U.+Weissauthor=J.+Mayerleauthor=M.+M.+Lerchauthor=A.+A.+Aghdassi&title=Deficiency+of+cathepsin+C+ameliorates+severity+of+acute+pancreatitis+by+reduction+of+neutrophil+elastase+activation+and+cleavage+of+E-cadherin&doi=10.1074%2Fjbc.RA118.004376"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Deficiency of cathepsin C ameliorates severity of acute pancreatitis by reduction of neutrophil elastase activation and cleavage of E-cadherin</span></div><div class="casAuthors">John, Daniel S.; Aschenbach, Julia; Krueger, Burkhard; Sendler, Matthias; Weiss, F. Ulrich; Mayerle, Julia; Lerch, Markus M.; Aghdassi, Ali A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">697-707</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Acute pancreatitis is characterized by premature intracellular protease activation and infiltration of inflammatory cells, mainly neutrophil granulocytes and macrophages, into the organ.  The lysosomal proteases cathepsin B, D, and L have been identified as regulators of early zymogen activation and thus modulators of the severity of pancreatitis.  Cathepsin C (CTSC, syn. dipeptidly-peptidase I) is a widely expressed, exo-cystein-protease involved in the proteolytic processing of various other lysosomal enzymes.  We have studied its role in pancreatitis.  We used CTSC-deleted mice and their WT littermates in two exptl. models of pancreatitis.  The mild model involved eight hourly caerulein injections and the severe model partial duct ligation.  Isolated pancreatic acini and spleen-derived leukocytes were used for ex vivo expts.  CTSC is expressed in the pancreas and in inflammatory cells.  CTSC deletion reduced the severity of pancreatitis (more prominently in the milder model) without directly affecting intra-acinar cell trypsin activation in vitro.  The absence of CTSC reduced infiltration of neutrophil granulocytes impaired their capacity for cleaving E-cadherin in adherens junctions between acinar cells and reduced the activity of neutrophil serine proteases polymorphonuclear (neutrophil) elastase, cathepsin G, and proteinase 3, but not neutrophil motility.  Macrophage invasion was not dependent on the presence of CTSC.  CTSC is a regulator and activator of various lysosomal enzymes such as cathepsin B, D, and L.  Its loss mitigates the severity of pancreatitis not by reducing intra-acinar cell zymogen activation but by reducing infiltration of neutrophil granulocytes into the pancreas.  In this context one of its key roles is that of an activator of neutrophil elastase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEC_CF7_vU7bVg90H21EOLACvtfcHk0lj7q1PjNj-rzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1Cis74%253D&md5=4eef871380c4ecd99fb4c437f9181076</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA118.004376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA118.004376%26sid%3Dliteratum%253Aachs%26aulast%3DJohn%26aufirst%3DD.%2BS.%26aulast%3DAschenbach%26aufirst%3DJ.%26aulast%3DKr%25C3%25BCger%26aufirst%3DB.%26aulast%3DSendler%26aufirst%3DM.%26aulast%3DWeiss%26aufirst%3DF.%2BU.%26aulast%3DMayerle%26aufirst%3DJ.%26aulast%3DLerch%26aufirst%3DM.%2BM.%26aulast%3DAghdassi%26aufirst%3DA.%2BA.%26atitle%3DDeficiency%2520of%2520cathepsin%2520C%2520ameliorates%2520severity%2520of%2520acute%2520pancreatitis%2520by%2520reduction%2520of%2520neutrophil%2520elastase%2520activation%2520and%2520cleavage%2520of%2520E-cadherin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2019%26volume%3D294%26spage%3D697%26epage%3D707%26doi%3D10.1074%2Fjbc.RA118.004376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lerch, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lutz, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidenbach, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller-Pillasch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gress, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leser, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adler, G.</span></span> <span> </span><span class="NLM_article-title">Dissociation and reassembly of adherens junctions during experimental acute pancreatitis</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">1355</span>– <span class="NLM_lpage">1366</span>, <span class="refDoi"> DOI: 10.1053/gast.1997.v113.pm9322531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=10.1053%2Fgast.1997.v113.pm9322531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=9322531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;key=1%3ACAS%3A280%3ADyaK2svmtlygsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1997&pages=1355-1366&author=M.+M.+Lerchauthor=M.+P.+Lutzauthor=H.+Weidenbachauthor=F.+Muller-Pillaschauthor=T.+M.+Gressauthor=J.+Leserauthor=G.+Adler&title=Dissociation+and+reassembly+of+adherens+junctions+during+experimental+acute+pancreatitis&doi=10.1053%2Fgast.1997.v113.pm9322531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Dissociation and reassembly of adherens junctions during experimental acute pancreatitis</span></div><div class="casAuthors">Lerch M M; Lutz M P; Weidenbach H; Muller-Pillasch F; Gress T M; Leser J; Adler G</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1355-66</span>
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    </div><div class="casAbstract">BACKGROUND & AIMS:  The initial pathophysiological events that characterize acute pancreatitis include the formation of pancreatic edema.  An interstitial accumulation of fluid, however, is incompatible with the presence of intact intercellular junctions between acinar cells.  This study examined the major components of adherens junctions, E-cadherin, alpha-catenin, beta-catenin, and actin, during the initial phase of experimental pancreatitis.  METHODS:  Pancreatitis was induced in rats by 10 micrograms.kg-1.h-1 intravenous cerulein for up to 12 hours.  Adherens junction proteins were localized by immunocytochemistry for fluorescence microscopy or electron microscopy, their expression was studied by slot blot analysis, and their association was investigated by immunoprecipitation and Western blot.  RESULTS:  During a rapid increase of E-cadherin-encoding RNA, E-cadherin protein declined only moderately and, unlike its cytoskeletal binding partner actin, was not proteolytically cleaved during pancreatitis.  Morphologically, E-cadherin and beta-catenin were localized at the basolateral cell membrane from where they rapidly dissociated early in pancreatitis and to where they slowly relocalized during the subsequent course.  E-cadherin/beta-catenin complexes disintegrated and reassembled completely in parallel on immunoprecipitation experiments.  CONCLUSIONS:  The dissociation of adherens junctions and the internalization, relocalization, and reassembly of their major components seem to represent the critical biochemical event at cell-cell contacts during edema formation and resolution in acute pancreatitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQf1kHxgdNWNw20zIbnCCI3fW6udTcc2eZJOegqEGcWcLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2svmtlygsg%253D%253D&md5=616ebc3f037b6f9fa3ac811ee5bb2d12</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1053%2Fgast.1997.v113.pm9322531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fgast.1997.v113.pm9322531%26sid%3Dliteratum%253Aachs%26aulast%3DLerch%26aufirst%3DM.%2BM.%26aulast%3DLutz%26aufirst%3DM.%2BP.%26aulast%3DWeidenbach%26aufirst%3DH.%26aulast%3DMuller-Pillasch%26aufirst%3DF.%26aulast%3DGress%26aufirst%3DT.%2BM.%26aulast%3DLeser%26aufirst%3DJ.%26aulast%3DAdler%26aufirst%3DG.%26atitle%3DDissociation%2520and%2520reassembly%2520of%2520adherens%2520junctions%2520during%2520experimental%2520acute%2520pancreatitis%26jtitle%3DGastroenterology%26date%3D1997%26volume%3D113%26spage%3D1355%26epage%3D1366%26doi%3D10.1053%2Fgast.1997.v113.pm9322531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CDE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4CDE','PDB','4CDE'); return false;">PDB: 4CDE</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i79"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00631">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_74544"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00631">10.1021/acs.jmedchem.9b00631</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Summary of liver microsome stability data of the selected compounds; exploration of electrophilic warheads; cytochromes P450 (CYPs) inhibition and plasma protein binding study of the selected compounds; EGFR inhibitory activity of the selected compounds; tissue distribution of compound <b>22</b> in mouse (PO); some in vivo data of compound <b>22</b>; preparation and NMR data of compounds <b>65</b>–<b>72</b>; <sup>1</sup>H and <sup>13</sup>C NMR spectra of compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00631/suppl_file/jm9b00631_si_002.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00631/suppl_file/jm9b00631_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00631/suppl_file/jm9b00631_si_001.csv">jm9b00631_si_001.csv (3.3 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00631/suppl_file/jm9b00631_si_002.pdf">jm9b00631_si_002.pdf (1.53 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00631&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00631%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-12" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00631" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a637f4b31d94a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
